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Résumé 
Le développement de la multirésistance chez  Escherichia coli est un problème 
important en médecine animale et humaine.  En outre, l’émergence et la diffusion des 
déterminants de  résistance aux céphalosporines à larges spectres de troisième génération 
(ESCs) parmi les isolats, incluant des céphalosporines essentielles en médecine humaine 
(ex. ceftriaxone et ceftiofur), est un problème majeur de santé publique. Cette thèse visait 
trois objectifs.    D’abord étudier la dynamique de la résistance aux antimicrobiens (AMR) 
ainsi que la virulence et les profils génétiques de la AMR des E. coli isolées de porcs 
recevant une nourriture post-sevrage supplémentée avec de la chlortétracycline et de la 
pénicilline G, et, accessoirement, évaluer les effets d'additifs alimentaires sur cette 
dynamique en prenant pour exemple d'étude un minéral argileux, la clinoptilolite, étant 
donné son possible lien avec le gène blaCMY-2 qui confère la résistance au ceftiofur. 
L'objectif suivant était d'investiguer les mécanismes menant à une augmentation de la 
prévalence du gène blaCMY-2 chez les porcs qui reçoivent de la nourriture médicamentée et 
qui n'ont pas été exposés au ceftiofur Ici encore,nous avons examiné les effets d’un 
supplément alimentaire avec un minéral argileux sur ce phénomène.  Enfin, notre dernier 
objectif était  d’étudier, dans le temps, les génotypes  des isolats cliniques d'E. coli résistant 
au ceftiofur, isolés de porcs malades au Québec à partir du moment où la résistance au 
ceftiofur a été rapportée, soit de 1997 jusqu'à 2012.  
Dans l'étude initiale, la prévalence de la résistance à 10 agents antimicrobiens, 
incluant le ceftiofur, s’accroît avec le temps chez les E.coli isolées de porcelets sevrés. Une 
augmentation tardive de la fréquence du gène blaCMY-2, encodant pour la résistance au 
ceftiofur, et la présence des gènes de virulence iucD et tsh a été observée chez les isolats. 
La nourriture supplémentée avec de la clinoptilolite a été associée à une augmentation 
rapide mais, par la suite, à une diminution de la fréquence des gènes blaCMY-2 dans les 
isolats. En parallèle, une augmentation tardive dans la fréquence des gènes blaCMY-2 et des 
gènes de virulence iucD et tsh a été observée dans les isolats des porcs contrôles, étant 
significativement plus élevé que dans les porcs ayant reçu l'additif au jour 28. La diversité, 
au sein des E. coli positives pour blaCMY-2 , a été observée au regard des profils AMR. 
Certaines lignées clonales d'E.coli sont devenues prédominantes avec le temps. La lignée 
clonale du phylotype A prédominait dans le groupe supplémenté, alors que les lignées 
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clonales du phylotype B1, qui possèdent souvent le gène de virulence iucD associé aux 
ExPEC, prédominaient dans le groupe contrôle. Les plasmides d'incompatibilité (Inc) des 
groupes, I1, A/C, et ColE, porteurs de blaCMY-2, ont été observés dans les transformants. 
Parmi les souches cliniques d'E.coli ESC-résistantes, isolées de porcs malades au Québec 
de 1997 à 2012, blaCMY-2 était le gène codant pour une β-lactamase le plus fréquemment 
détecté; suivi par blaTEM et blaCTX-M,. De plus, les analyses clonales montrent une grande 
diversité génétique. Par contre, des isolats d'E. coli avec des profils PFGE identiques ont 
été retrouvés dans de multiples fermes la même année mais aussi dans des années 
différentes. La résistance à la gentamicine, kanamycine, chloramphenicol, et la fréquence 
de blaTEM et de IncA/C diminuent significativement au cour de la période étudiée, alors que 
la fréquence de IncI1 et de la multirésistance à sept catégories d'agents antimicrobiens 
augmente significativement avec le temps. L'émergence d'isolats d'E. coli positifs pour 
blaCTX-M, une β-lactamase à large spectre et produisant des ESBL, a été observée en 2011 
et 2012 à partir de lignées clonales distinctes et chez de nombreuses fermes. 
Ces résultats, mis ensemble, apportent des précisions sur la dissémination de la 
résistance au ceftiofur dans les E. coli isolées de porcs. Au sein des échantillons prélevés 
chez les porcs sevrés recevant l'alimentation médicamentée sur une ferme, et pour laquelle 
une augmentation de la résistance au ceftiofur a été observée, les données révèlent que les 
souches d'E. coli positives pour blaCMY-2 et résistantes aux ESCs appartenaient à plusieurs 
lignées clonales différentes arborant divers profils AMR. Le gène blaCMY-2 se répand à la 
fois horizontalement et clonalement chez ces E. coli. L'ajout de clinoptilotite à la nourriture 
et le temps  après le sevrage influencent la clonalité et la prévalence du gène blaCMY-2 dans 
les E. coli. Durant les 16 années d'étude, plusieurs lignées clonales  différentes ont été 
observées parmi les souches d'E. coli résistantes au ceftiofur isolées de porc malades de 
fermes québécoises, bien qu’aucune lignée n'était persistante ou prédominante pendant 
l'étude. Les résultats suggèrent aussi que le gène blaCMY-2 s'est répandu à la fois 
horizontalement et clonalement au sein des fermes. De plus, blaCMY-2 est le gène majeur 
des β-lactamases chez ces isolats. À partir de 2011, nous rapportons l'émergence du gène 
blaCTX-M dans des lignées génétiques distinctes. 
 
Mots clé: Porc; E. coli; gène de virulence; résistance antimicrobienne; plasmide, gène 
blaCMY-2, gène blaCTX-M, résistance aux ESC, argile minéral (clinoptilolite). 
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Abstract 
Development of multidrug resistance in Escherichia coli is an important problem in 
animal and human medicine. Further, emergence and spread of determinants for resistance 
to third generation extended-spectrum cephalosporins (ESCs) such as the critically 
important cephalosporins in human medicine (e.g. ceftriaxone and ceftiofur) among 
isolates is a public health concern. Thus, the objectives of the present thesis were (1) to 
study the dynamic of antimicrobial resistance (AMR) phenotypes as well as virulence and 
AMR gene profiles in E. coli from pigs receiving a feed medicated with chlortetracycline 
and penicillin G following weaning and to study the effect of feed supplementation with a 
clay mineral, clinoptilolite, on this dynamic; (2) To investigate the mechanisms leading to 
an increase in the prevalence of blaCMY-2 conferring resistance to ceftiofur in pigs receiving 
medicated feed but which had not received ceftiofur, and to examine the effect of feed 
supplementation with a clay mineral on this phenomenon; and (3) to investigate the 
temporal characterization of clinical isolates of ceftiofur-resistant E.coli from diseased pigs 
in Quebec, Canada from 1997, when ceftiofur resistance was first reported, to 2012.  
In the initial study, prevalence of resistance to 10 antimicrobial agents, including 
ceftiofur, increased over time in E.coli isolates from weaned pigs. A late increase in the 
frequency of blaCMY-2, the gene encoding resistance to ceftiofur, and the presence of 
virulence genes iucD and tsh were observed in the isolates. Feed supplementation with 
clinoptilolite was associated with an early increase but later decrease in the frequency of 
the blaCMY-2 gene in isolates. Concurrently, a later increase in the frequency of the blaCMY-2 
and the virulence genes iucD and tsh was observed in the control pig isolates, being 
significantly greater than in the supplemented pigs at day 28. Diversity among the blaCMY-
2-positive E. coli isolates with respect to AMR patterns was observed. Certain clonal 
lineages of E. coli became predominant with time. The clonal lineage of phylotype A 
predominated in the supplemented group, whereas the clonal lineages of phylotype B1 
which often possessed the ExPEC-associated virulence gene iucD, predominated in the 
control group. The blaCMY-2-carrying plasmids of incompatibility (Inc) groups, I1, A/C, and 
ColE were observed in transformants. In ESC-resistant E.coli clinical isolates from 
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diseased pigs in Quebec, from 1997 to 2012, blaCMY-2 was the most frequently detected β-
lactamase gene, followed by blaTEM and blaCTX-M and clonal analysis showed high 
diversity. E. coli isolates with identical PFGE patterns were found in multiple farms in the 
same year and also in different years. Resistance to gentamicin, kanamycin, 
chloramphenicol, and the frequency of blaTEM and IncA/C significantly decreased over the 
study time, whereas the frequency of IncI1 and multidrug-resistance to seven antimicrobial 
categories significantly increased over time. Emergence of blaCTX-M-positive, extended-
spectrum β-lactamase (ESBL)-producing E. coli isolates was observed in 2011 and 2012 
from distinct clonal lineages and multiple farms.  
Taken together, this work gives some insight into the spread of ceftiofur resistance 
in E.coli isolates from pigs. Results reveal that in weaned pigs receiving medicated feed on 
one farm in which an increase in ceftiofur resistance was observed, the blaCMY-2-positive 
E.coli resistant to ESCs belonged to several different clonal lineages with diverse AMR 
patterns. The blaCMY-2 gene spread both horizontally and clonally in E. coli. Feed 
supplementation with clinoptilolite and time period after weaning influenced the clonality 
and the prevalence of blaCMY-2 gene in E. coli. In ceftiofur-resistant E.coli strains isolated 
from diseased pigs in farms throughout Quebec over a 16 year period, several different 
pathogenic clonal lineages were observed, although none was persistent or predominant 
over the study time. The results suggest that blaCMY-2 gene spreads both horizontally and 
clonally on and between farms. Furthermore, blaCMY-2 was the major β-lactamase gene in 
these isolates. From 2011, we report the emergence of blaCTX-M in distinct clonal lineages. 
 
 
 
 
 
Keywords: Pig; E. coli; virulence gene; antimicrobial resistance; plasmid, blaCMY-2 gene, 
blaCTX-M gene, ESC-resistance, clay mineral (clinoptilolite). 
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Introduction 
The use of antimicrobials in food producing animals has been surveyed over the 
past two decades because of their impact on animal and human health associated with 
antimicrobial resistance (AMR). Development of AMR increases the risk of failure of 
antimicrobial treatment in animals and humans. In particular, emergence and prevalence of 
ESC-resistant E. coli in food producing animals is a public health concern, as 
cephalosporins (e.g. ceftriaxone, ceftiofur) are critically important β-lactam antimicrobials 
in human and animal medicine (WHO 2011). Ceftiofur, a third- generation cephalosporin, 
is used in pigs to treat respiratory disease, lameness and enteric disease (Deckert et al. 
2010). As ceftiofur is in the same general class of antimicrobials as ceftriaxone, resistance 
to ceftiofur is a problem because shared resistance determinants may confer resistance to 
ceftriaxone. Ceftiofur has been administrated therapeutically in food producing animals 
since 1989 (Daniels et al. 2009) and ceftiofur resistance via the blaCMY-2 gene was first 
reported in 1998 (Fey et al. 2000; Winokur et al. 2000). During the past decade, ESC-
resistance has been reported among clinical isolates of Enterobacteriaceae from humans 
and animals in Canada (Mulvey et al. 2009; Mataseje et al. 2010). The Ministère de 
l'Agriculture, des Pêcheries et de l'Alimentation du Québec reported a significant increase 
in resistance to ceftiofur in E. coli isolated from pigs comparing two windows of time, 
1993-2009 (4%) and 2010-2014 (19%), being 22%  in 2014 (MAPAQ 2015).  
Administration of antimicrobials as therapeutic agents, or as growth promoters, or 
for disease prevention during animal production can result in the development of AMR. 
These resistant bacteria may spread to humans directly or through food chain, resulting in 
potential public health risks (Johnston 2001; Wegener 2003). In addition, the resistant 
bacteria and/or resistance genes are shed into the environment where they may persist for 
long periods (Chantziaras et al. 2014). Thus, animal feeds may be supplemented with feed 
ingredients as an alternative for or a complement to, the administration of antimicrobials. 
For example, the clay mineral, clinoptilolite, has been used to improve performance and 
health but also as an alternative to the use of antimicrobials or together with antimicrobials 
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for prevention of post-weaning diarrhea in piglets (Papaioannou et al. 2004). However, the 
mechanisms of action of clinoptilolite are little understood. Some in vitro studies showed 
that DNA bound to clay minerals is more resistant to degradation by DNase I 
(Romanowski et al. 1991), and also, minerals induce bacterial mutation and boost genetic 
diversity of bacteria (Yoshida et al. 2004). Likewise, It has been shown in an in vitro study 
that clay minerals promote horizontal gene transfer of AMR genes in different bacterial 
species (Lotareva and Prozorov 2000; Rodriguez-Beltran et al. 2013). These data imply 
that clay minerals may modulate the frequency of AMR and virulence genes of bacteria in 
the animal intestinal. In weaned pigs, antimicrobials are used in feed mainly as a 
medication to prevent disease and thus reduce mortality and morbidity (Cromwell 2002). 
Penicillin and tetracycline are among the administrated in-feed antimicrobials in pigs and 
often in mixture (Akwar et al. 2008). Administration of in-feed antimicrobials in pigs has 
been related to raise resistance of fecal E. coli within and between antimicrobial classes 
(Kim et al. 2005; Akwar et al. 2008). 
In Enterobacteriaceae, ESC-resistance has been related to production of AmpC-
like β-lactamases (e.g. CMY-2) and ESBLs (e.g. CTX-M and OXA) encoded by genes 
often found on transferable plasmids. The CTX-M family are important ESBLs in human 
medicine and have become a threat to public health (Li et al. 2007). The increasing relation 
of resistance to other classes of antimicrobials such as aminoglycosides, sulphonamides, 
phenicols and tetracyclines in ESC-resistant E. coli has promoted multidrug-resistant 
(MDR) strains which severely limit therapeutic options (Pitout et al. 2007). CMY-2-
encoding genes are commonly located on transferable elements (integrons, transposons, 
insertion sequences) carried by plasmids that facilitate the horizontal spread of resistance 
and most AmpC beta-lactamase producing strains may carry additional resistance genes. 
Hence, certain resistance genes can be conserved due to a link with the genes encoding 
resistance to other antimicrobials that are registered for use in animal production (Dunne et 
al. 2000; Allen and Poppe 2002; Funk et al. 2006; Singer and Hofacre 2006). Although the 
E.coli phylotypes are different between isolates from humans and animals (Johnson et al. 
2003; Maynard et al. 2004), common replicon types of plasmids encoding β-lactamase 
genes were observed in E. coli isolates from humans and food producing animals (Carattoli 
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2009). Plasmids bearing both virulence and resistance genes may also spread in a 
pathogenic bacterial population due to antimicrobial selection pressure (Martinez and 
Baquero 2002). In animal production, a variety of risk factors related to farm management 
may be associated with the introduction and spread of AMR in bacteria, however, these are 
not yet fully elucidated. Further research is needed to understand factors that contribute to 
the circulation and persistence of antimicrobial resistance determinants among both 
commensal and pathogenic enteric bacteria on-farm and worldwide. 
 
Hypothesis 
Feed supplements influence the prevalence of virulence and antimicrobial 
resistance genes of E. coli in the intestine of pigs and could affect the fecal excretion of E. 
coli possessing these genes.  
 
Objectives 
The primary objective of this study was to study the temporal characterization of 
virulence genes and antimicrobial resistance in E. coli from pig fecal samples and the 
effect of a feed supplement. 
In particular, the specific objectives of this research are: 
 
1. To examine the dynamic of AMR phenotype, virulence and AMR gene profiles in 
E. coli isolates from pigs receiving a diet containing chlortetracycline and penicillin 
G at therapeutic doses following weaning on a commercial farm and to investigate 
the effect of simultaneous feeding of the clay mineral, clinoptilolite, on this 
dynamic. 
 
2. To elucidate the mechanisms leading to an increase of the prevalence of blaCMY-2 
conferring resistance to ceftiofur in a nursery barn in pigs with no ceftiofur use but 
which received a feed medicated with chlortetracycline and penicillin G, and to 
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investigate the effect of feed supplementation with a clay mineral on this 
phenomenon. 
 
3. To study the temporal characterization of clinical ceftiofur-resistant E.coli isolates 
from diseased pigs in Quebec-Canada from 1997 to 2012. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Chapter 1: Literature review 
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1 Escherichia coli 
1.1 General aspects of E.coli 
E. coli, a common inhabitant of the intestinal tract of humans and other warm-
blooded animals is a gram negative, facultative anaerobic organism and a member of 
Enterobacteriaceae family (Kaper et al. 2004; Gyles and Fairbrother 2010). It was first 
described by Theodore Escherich in 1885 as a slim rod in the feces of an infant 
(Escherich 1988). E. coli typically colonizes the intestine shortly after birth and remains 
there as a part of the normal microflora of the gastrointestinal tract of animals (Gyles 
and Fairbrother 2010). E. coli may be part of both the resident and a transient population 
in the gastrointestinal tract. Resident strains may persist for months or years whereas 
transient strains may be present for only a few days or weeks (Caugant et al. 1981). In 
addition, E. coli is the most frequently used indicator bacterium for examining the 
spread of antimicrobial resistance (AMR) in different environments and host species, as 
it often displays multi-drug resistance (MDR) and is a common inhabitant of the 
gastrointestinal tract microbiota of humans and other animal species, and is also found 
in the environment (Guenther et al. 2011; Stedt et al. 2014). 
E.coli can be classified into two main groups: a non-pathogenic commensal 
group and a pathogenic group, causing intestinal or extra-intestinal diseases. Most of E. 
coli strains live as commensals in a mutually beneficial association with the host. They 
partially occupy the intestine and can help to exclude other bacteria, including 
pathogens (Russo and Johnson 2000). However, these commensal E. coli strains can 
occasionally cause opportunistic infections in immune-compromised hosts or where the 
normal gastrointestinal barriers are breached (Russo and Johnson 2000). Only a small 
proportion of E. coli strains are pathogenic and responsible for a broad spectrum of 
diseases, being classified into pathotypes based on the type of virulence factors present 
and on the mechanisms by which they cause disease. In most diseases caused by E. coli, 
pathogenicity is associated with virulence genes located on plasmids, bacteriophages, or 
pathogenicity islands (PAIs) that can be mobilized into different strains to create novel 
combinations of virulence factors. For identification and characterization of pathogenic 
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E. coli, it is important to detect virulence factors that are unique to, or associated with, 
certain types of pathogenic E. coli (Levine 1987; Nataro and Kaper 1998; Milon et al. 
1999; Kaper et al. 2004). The term virotype will be used to refer to variants within 
pathotypes, based on differences in the combination of virulence genes. 
In animals, the most important pathotypes are Enterotoxigenic E. coli (ETEC), 
Enteropathogenic E. coli (EPEC), Shiga toxin producing E. coli (STEC), and 
Extraintestinal pathogenic E. coli (ExPEC) (Gyles and Fairbrother 2010). E.coli 
pathotypes are important for separating pathogenic from non-pathogenic types and for 
epidemiological studies. The susceptibility of the host to these different categories of E. 
coli pathotypes is related to many factors such as age, immune status, diet, number of 
pathogenic bacteria encountered and genetic (Quinn et al. 2011). In addition, STEC may 
be highly pathogenic for humans whereas it is part of normal flora of cattle and other 
ruminants. Likewise, ExPEC and EPEC typically are considered as part of the normal 
intestinal microbiota of their host and may be considered as opportunistic pathogens. 
Altogether, the set of E. coli which are pathogenic in animals or causative of zoonotic 
diseases in humans may be referred to as animal pathogenic and zoonotic E. coli 
(APZEC) (Gyles and Fairbrother 2010). 
Serotyping is a well-established assay that is based on differences in the O, K, 
and H antigens detected on the polysaccharide portion of lipopolysaccharide (LPS), 
capsular polysaccharide, and flagellar proteins, respectively (Scheutz et al. 2004). The 
other molecular based typing techniques that are used to characterize E.coli isolates 
include polymerase chain reaction (PCR)-based genotyping, pulsed-field gel 
electrophoresis (PFGE), random amplified polymorphic DNA PCR (RAPD-PCR), 
amplified fragment length polymorphism (AFLP), multilocus sequence typing (MLST), 
restriction fragment length polymorphism (RFLP) method, repetitive element PCR 
(Rep-PCR), multiple-locus variable-number tandem-repeat analysis (MLVA) and whole 
genome sequencing (Foley et al. 2009). 
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1.2 E. coli pathotypes  
1.2.1 Enterotoxigenic E. coli (ETEC)  
ETEC is the most frequent cause of watery diarrhea in farm animals, and is a 
significant causative agent of diarrhea in children and travellers in developing countries. 
This pathotype is defined by producing enterotoxins and adhesins which are mostly 
regulated on large plasmids. Almost all ETEC bacteria are known to attach to specific 
receptors on the intestinal epithelium by fimbrial or non-fimbrial adhesion and promote 
colonization and produce enterotoxins without inducing pathological lesions. This action 
results in the hypersecretion of water and electrolytes and in reduced absorption. ETEC 
bacteria cause severe watery diarrhea during the first days of life and also in the first 
week following weaning in pigs. Enterotoxins of ETEC are heat stable (STa, STb, or 
enteroaggregative E. coli heat-stable enterotoxin 1 [EAST1]) or heat labile (LT) (Gyles 
and Fairbrother 2010). The LT is very similar physiologically, structurally, and 
antigenically to the cholera toxin (CT) which is expressed by Vibrio cholerae and also 
have a similar mode of action (Nagy and Fekete 2005; Svennerholm 2011). In pigs, the 
most common fimbrial adhesins of ETEC are F4 (K88), F5 (K99), F6 (987P), F41, and 
F18. A non-fimbrial adhesion (adhesin involved in diffuse adherence [AIDA-I]) has 
been recently found in certain ETEC in pigs. The enterotoxins STa and STb differ in 
structure and mechanism of action. Only toxins of the STa class have been associated 
with human disease whereas the STb toxin is involved with animal disease. Animal 
ETEC strains possess fimbrial adhesins such as F4 and F5, which are not found in 
human ETEC strains (Kaper et al. 2004).  
A schematic representation of the steps involved in the pathogenesis of ETEC 
infection in pig is shown in Figure 1. ETEC is ingested by animals and enter the 
intestinal tract, and when present in sufficient numbers, colonize the small intestine 
following attachment by fimbrial adhesins to specific receptors on the small intestinal 
epithelium. The adherent bacteria produce enterotoxins which stimulate water and 
electrolytes production into the intestinal lumen. This causes watery diarrhea, which 
may lead to dehydration, listlessness, metabolic acidosis, and death (Figure 1) (Gyles 
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and Fairbrother 2010).  Post weaning diarrhea (PWD) is a major cause of death in 
weaned pigs worldwide.  Fimbrial adhesins F18 and F4 are the types that are commonly 
found on ETEC from PWD in pigs. The predominant O serogroup of ETEC associated 
with PWD in pigs worldwide is O149 (Fairbrother et al. 2005). ETEC: F5 causes 
diarrhea in neonatal pigs and F4-producing ETEC occasionally increase rapidly in the 
small intestine of young pigs and induce symptoms of shock and rapid death. The most 
important virotypes and O serogroups in ETEC in pigs are listed in Table 1. 
 
 
 
 
 
Figure 1. Schematic representation of the pathogenesis of ETEC infections in pig. 
Source: http://www.ecl-lab.com/en/ecoli/pathogenesis.asp  
With the authorization of Dr. John M. Fairbrother 
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Table 1. Important pathotypes, virotypes, and O serogroups of E. coli causing disease in 
pigs. 
Disease Pathotype Virotypes O serogroups 
Enteric       
        Neonatal diarrhea ETEC STa:K99:F41, STa:F41, STa:987P, 
LT:STb:EasT1:K88ac, 
LT:STb:STa:EAST1:K88ac, 
STb:EAST1:AIDA 
8,9,20,45,64,101,138, 
141,147,149,157 
        Postweaning diarrhea ETEC LT:STb:EAST1:K88ac, 
LT:STb:STa:EAST1:K88ac, 
STa:STb, STa:STb:F18ac, 
STa:F18ac 
8,138,139,141,147,149, 
157 
  EPEC Eae, Tir, EspA, EspB, EspD, EspC 
(enterotoxin) 
45,103,123 
        Edema disease STEC Stx2e:F18ab:(AIDA),_Hly+ 138,139,141 
        
Extraintestinal       
        Colisepticemia SEPEC Aerobactin, F165-1(P fimbrial 
family), F165 - 2 (S fimbrial 
family), CNF1 or CNF2, CDT 
6,8,9,11,15,17,18,20,45,
60,78,83,93,101,112, 
115,116 
        Urogenital tract 
infection 
UPEC P, S, aerobactin, CNF1 1,4,6,18 
 
Source: Adapted from (Gyles and Fairbrother 2010) 
 
1.2.2 Enteropathogenic E. coli (EPEC) 
EPEC is considered as one of causative agent of childhood diarrhea in 
developing countries and is implicated as an important cause of diarrhea in humans and 
animals. The EPEC cause attaching and effacing (AE) lesions on the intestinal mucosa, 
which are characterized by microvilli destruction, intimate adherence of bacteria to the 
intestinal epithelium, pedestal formation, and aggregation of polarized actin and other 
elements of the cytoskeleton at sites of bacterial attachment. Ability to produce AE 
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lesions has also been found in strains of shiga toxin producing E. coli (Nataro and Kaper 
1998; Kaper et al. 2004).  
The genes for the production of AE lesions are located on the locus of enterocyte 
effacement (LEE), a pathogenicity island that harbor the genes encoding intimin, a type 
III secretion system, a number of secreted (Esp) proteins, and the translocated intimin 
receptor named Tir. Intimin is an outer membrane protein encoded by the eae (E. coli 
attaching and effacing) gene, responsible for the attachment of bacteria to enterocyte 
membranes Tir which is one of the EPEC translocated proteins. Tir is inserted into the 
host cell membrane, where it acts as a receptor to intimin (Trabulsi et al. 2002; Kaper et 
al. 2004). 
EPEC are grouped into typical and atypical strains and they differ in several 
characteristics. Typical EPEC strains possess a plasmid carrying EAF (EPEC adherence 
factor) whereas atypical EPEC do not contain the EAF plasmid (Trabulsi et al. 2002). 
This plasmid encodes bundle-forming pilus (BFP), which mediates inter-bacterial 
adherence and possibly adherence to epithelial cells (Kaper et al. 2004). Thus, typical 
EPEC strains are identified by the presence of both eae and bfp genes, whereas atypical 
EPEC strains have been defined as those which possess only eae gene (Henderson et al. 
2009). Humans are a reservoir for typical EPEC, whereas for atypical EPEC, both 
animals and humans can be reservoirs suggesting that atypical EPEC may be a potential 
zoonotic cause of human diarrhea. Typical and atypical EPEC seem to be two groups of 
distinct organisms that have in common the LEE pathogenicity island (Trabulsi et al. 
2002). Atypical EPEC strains have been detected among E. coli isolates from pork, 
indicating that pigs may also be potential reservoirs for the pathogen (Xia et al. 2010). 
The most important virotypes and O serogroups in EPEC in pigs are presented in Table 
1. 
 
1.2.3 Shiga toxin producing E.coli (STEC) 
STEC refers to those E. coli strains that produce at least one member of a class 
of potent cytotoxins termed shiga toxin (Stx),  because of the close relation to the Stx of 
 12 
Shigella dysenteriae type 1 (Gyles 2007). This toxin was initially named verotoxin 
because of its distinct effect on Vero cells (Karmali 1989). The common feature of all 
STEC is the production of bacteriophage encoding Stx. STEC strains may cause watery 
diarrhea, hemorrhagic colitis, and/or hemolytic uremic syndrome (HUS) in human and 
edema disease (ED) in pigs (Fairbrother and Nadeau 2006).  
STEC have been characterized by a variety of methods, including serotyping. 
O157:H7 strains, as well as an increasing frequency of certain non-O157 strains are 
zoonotic STEC (Fairbrother and Nadeau 2006). O157:H7 isolates are the most common 
STEC pathogens associated with outbreaks of foodborne diseases in North America, but 
isolates of other serotypes such as  O26 and O111, can also cause disease and are more 
important than O157:H7 in other countries (Kaper et al. 2004). It is well demonstrated 
that cattle are a main reservoir of STEC O157:H7 in North America but in countries 
such as Australia, sheep are of greater significance (Gyles 2007). Attachment to 
intestinal epithelial cells is an early feature of STEC infection and two patterns of 
attachment and interaction have been observed, in relation to eae-positive and eae-
negative STEC isolates (Kaper et al. 2004). The combined presence of the eae and stx2 
genes has been shown to be an important predictor of HUS (Ethelberg et al. 2004).  
Shiga toxin (Stx) is the key virulence factor in STEC diseases. The ED in pigs is 
the only animal disease for which the role of Stx is clearly established and associated 
with STEC:F18. An overview of the relation of STEC with ED of pigs is shown in 
Figure. 2. The initial step is the ingestion of STEC bacteria by the animal and entry into 
the intestinal tract. Then bacteria with fimbrial adhesins F18 (eae-negative STEC) attach 
to specific receptors on the intestinal epithelial cells and colonize in the jejunum and 
ileum over three to six days. The adherent bacteria produce shiga toxin 2e (Stx2e) which 
is transported across the epithelial cells to the circulation. The Stx2e binds to receptors 
on the vascular endothelium in the central nervous system and other sites including the 
stomach and subcutaneous tissues of the forehead and eyelids, giving rise to edema, 
ataxia, and death (Figure 2). Pigs that lack the intestinal receptors for F18 fimbriae are 
resistant to ED. There are no receptors for F18 in newborn pigs, so ED usually occurs in 
older pigs after weaning (Gyles and Fairbrother 2010). 
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The two major E. coli Stx toxins are Stx1, which is identical to Stx of Shigella 
dysenteriae, and Stx2, which is 56% homologous to Stx1(Gyles and Fairbrother 2010). 
Stx1 and Stx2 share a similar function and have the same genetic operon structure, 
encoding an A (enzymatic toxin) and a B (cell receptor binding) subunit. Stx1 and Stx2 
are further grouped into distinct genetic variants which differ in animal reservoirs, 
animal disease, and severity of disease in humans (Gyles 2007). The most important 
virotype and O serogroups in STEC in pigs are listed in Table 1. 
 
 
Figure 2. Schematic representation of the pathogenesis of STEC in edema disease in 
pig. 
Source: http://www.ecl-lab.com/en/ecoli/pathogenesis.asp  
With the authorization of Dr. John M. Fairbrother  
 
1.2.4 Extraintestinal pathogenic E. coli (ExPEC) 
E. coli strains that induce diseases outside of the intestinal tract are termed 
extraintestinal pathogenic E. coli (Russo and Johnson 2000). These bacteria are 
considered to be opportunistic pathogens, as they are often found in the normal intestinal 
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microflora and colonize intestinal, respiratory or other mucosal surfaces, possibly due to 
fimbrial adhesins. When the animal is weakened, such as following a viral infection, 
ingestion of mycotoxins, or when a newborn has not received enough colostrum, 
bacteria pass more readily through the mucosa to the circulation (Gyles and Fairbrother 
2010). Diarrheagenic E. coli do not generally cause extraintestinal diseases, and ExPEC 
strains do not normally induce diarrhea. ExPEC strains are phylogenetically and 
epidemiologically distinct from intestinal pathogenic strains (Johnson and Russo 2002; 
Russo and Johnson 2003). ExPEC cause a diversity of infections in all animal species 
and in humans, including septicaemia, urinary tract infections (UTIs), meningitis, 
genital tract and the mammary gland infection (Kaper et al. 2004; Smith et al. 2007; 
Gyles and Fairbrother 2010). 
  A schematic representation of the steps involved in the development of disease 
due to ExPEC in animals is shown in Figure 3. ExPEC strains are ingested by the animal 
host and colonize the intestinal, respiratory or other mucosal surfaces. In certain 
conditions, they pass through and between epithelial cells to gain access to the 
underlying tissue. These bacteria can resist the lethal effects of complement and 
phagocytes, possibly due to the presence of P fimbriae in pigs (Fairbrother and Ngeleka 
1994). They can persist and multiply in the blood stream and are transported to distant 
organs. The toxins producing by the bacteria, such as cytotoxic necrotizing factor, may 
contribute to tissue damage (Fairbrother and Ngeleka 1994). Endotoxins released by 
dead bacteria may stimulate a cytokine response leading to shock and death of the 
animal. In localized infections, there may be bacterial interaction with extracellular 
matrices, leading to pneumonia, serositis, mastitis, metritis, urinary tract infection, 
meningitis, etc (Figure 3). Septicemic disease occurs in animals due to septicemic E. 
coli (SEPEC) that belong to a limited number of serotypes (Fairbrother and Ngeleka 
1994). Bacteria persist and multiply in the blood and other extraintestinal sites mostly 
due to the presence of iron acquisition systems such as aerobactin and partly through 
their ability to adapt and grow in the iron-restricted extracellular environments of the 
host (Griffiths 1994). E. coli septicemia occurs in neonatal pigs and less frequently in 
suckling pigs (Fairbrother and Ngeleka 1994). It is characterized by an acute generalized 
infection, with signs of shock, often followed by death in 3-8 hours, with lethality of up 
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to 100%. (Gyles and Fairbrother 2010). The predominant O serotypes and virotypes 
associated with ExPEC in pigs are shown in Table 1.1. 
ExPEC isolated from disease in humans and animals share several virulence 
factors and animals may be reservoirs of some of these pathogens that cause disease in 
humans (Gyles and Fairbrother 2010). In contrast to ETEC, EPEC, and STEC, ExPEC 
strains are not defined by the presence of a certain virulence factor or group of factors 
but usually have a large number of virulence factors which may vary greatly between 
strains. These factors contribute to bacterial colonization, invasion, iron acquisition, 
resistance to the bactericidal effects of complement and phagocytosis, and toxic activity 
(Gyles and Fairbrother 2010). A multiplex PCR protocol for identification of possible 
ExPEC in the various animal species has been developed in the Reference Laboratory 
for E. coli (EcL) based on detection of tsh (temperature sensitive hemagglutinin), papC 
(P fimbriae assembly), iucD (aerobactin receptor) and cnf (cytotoxic necrotizing factor) 
genes simultaneously (http://apzec.ca/en/Protocols). Another multiplex PCR has been 
described by Johnson et al. for identification of human ExPEC by screening of 5 
virulence markers, including papA (P fimbriae structural subunit) and/or papC (P 
fimbriae assembly), sfa/foc (S and F1C fimbriae subunits), afa/dra (Dr-antigen-binding 
adhesins), kpsMTII (group 2 capsular polysaccharide units), and iutA (aerobactin 
receptor). In this method, the criterion of “presence of two of the five markers,” was 
used to differentiate ExPEC and non-ExPEC isolates (Johnson et al. 2003). 
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Figure 3. Schematic representation of the pathogenesis of ExPEC infections in animal. 
Source: http://www.ecl-lab.com/en/ecoli/pathogenesis.asp  
With the authorization of Dr. John M. Fairbrother  
 
1.3 Clonal diversity of E. coli 
 Clones are those isolates of a bacterial population that are identical or 
indistinguishable in genotype emphasizing they are the descendants of the same ancestor 
(Spratt 2004). However, since bacterial reproduction is not truly asexual, numerous 
mechanisms such as mutation, conjugation, transformation, and transduction are the 
sources of recombinational replacements that result in diversification of the ancestral 
genotype of a clone. Thus, according to a new definition, the term "Clonality" refers, 
more precisely, to a bacterial population that results from a restriction of genetic 
recombination to the extent that the prevalent pattern of clonal structure is not broken 
(Tibayrenc and Ayala 2012). Over the past decades, scientists demonstrated a strong 
association among particular pathogenic E. coli serotypes. Subsequent investigations led 
to a E. coli clone concept which emphasized that not all isolates of pathogenic species 
are equal and that in a bacterial population there are a small number of genotypes 
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(clones) that are greatly over-represented among those recovered from a particular 
phenotype or type of disease (Spratt 2004). Subsequently, the clonality of E. coli strains 
became an important aspect of epidemiological study. Dissemination of antimicrobial 
resistant E. coli clones was defined as one of the main mechanisms involved in multiple 
outbreaks around the globe. This included the dissemination of urinary tract infections 
(UTIs) in the United States due to trimethoprim-sulfamethoxazole resistant strains of E. 
coli clonal group A in 1990's (Burman et al. 2003) or the latest widespread infections in 
Canada, Europe, and Asia due to CTX-M-15 harbouring strains of E. coli sequence type 
131 that exhibit extended-spectrum cephalosporin (ESC) resistance (Coque et al. 2008; 
Nicolas-Chanoine et al. 2008). More and more evidence suggests that E. coli clonal 
spread is a major contributor to emerging resistance. Thus, in addition to reducing 
selection pressure by limiting antimicrobial use, it was necessary to recognize and 
define E. coli clones to permit the interruption of transmission pathways. 
To achieve this goal, the first step was to recognize that particular clones are 
much more strongly associated with a given pathogenicity and/or antimicrobial 
resistance than others. After exploration of the genetic structure of bacterial populations, 
certain methods were developed to distinguish the diversity of genotypes and to help in 
classifying E. coli clones. 
 
1.3.1 Conventional techniques for E. coli typing 
Serotyping is based on the immunogenicity of the bacterial surface structures. 
Initially, the combination of three major surface antigens (the O lipopolysaccharide 
(LPS), the flagellar H and the capsular K (O:K:H)) was considered for sub-typing of E. 
coli strains. As typing of the K antigen was difficult for most laboratories, serotyping 
based on the O and H antigens became the ‘gold standard’ (DebRoy et al. 2011). As O 
antigen has higher diversity of the protein in Gram-negative bacteria, it is a more 
common antigen to be targeted for E. coli serotyping (Sun et al. 2011). Gene-based 
methods (such as PCR and RFLP) have been widely used recently for serotype profiling. 
Nevertheless, the agglutination reaction-based serotyping for O group identification still 
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remains one of the most comprehensive and simple methods for testing O groups 
(DebRoy et al. 2011). 
PCR genotyping takes advantage of the variability in genetic composition of 
microorganisms (due in part to horizontal gene transfer (HGT)) to subtype bacterial 
strains. In this method, multiple host-specific factors such as virulence and antimicrobial 
resistance genes are screened by PCR and the presence or absence of genetic factors is 
used to carry out phylogenetic analysis and typing (Foley et al. 2009). More advanced 
technologies such as multiplexed real-time PCR and Microarray have been developed 
for rapid and cost effective approaches of simultaneous detection of multiple genes 
(Bruant et al. 2006). Clermont et. al in 2000 described a triplex PCR strategy to assign 
E. coli isolates rapidly to one of the four major phylogenetic groups (A, B1, B2 and D ) 
of E. coli strains based on PCR detection of 3 genes; chuA a heme transport factor in E. 
coli O157:H7, yjaA  a gene from E. coli K-12 genome with unknown function and the 
DNA fragment TSPE4.C2 (Clermont et al. 2000). This method has been widely used in 
phylogenetic sub-typing of E. coli strains from human clinical samples (Alonso et al. 
2015; Pietsch et al. 2015) as well as food-producing animal originated E. coli strains 
(Liao et al. 2015; Muller et al. 2016) and has been recently extended to become more 
discriminatory, identifying additional groups C, E, F (Clermont et al. 2013). 
 
1.3.2 Advanced molecular fingerprinting of E. coli clones 
 Genotypic methods by molecular typing techniques have been designed as rapid 
methods for characterization of bacterial clones. Three main mechanisms of 
discrimination aid molecular epidemiologists and surveillance studies to identify clones: 
1- restriction-based analysis of the bacterial DNA; 2- PCR amplification of particular 
genetic targets and 3- DNA sequence-based techniques to identify polymorphism at 
specific loci in the genome. 
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1.3.2.1 Restriction-based methods 
Plasmid profiling is one of the earliest genotyping methods used for 
epidemiological studies of pathogens (Schaberg et al. 1981). This technique is based on 
the presumption that the bacteria from the same clonal lines typically carry the same 
plasmids. Following the plasmid isolation, the cell debris, proteins, and chromosomal 
DNA are removed. The plasmids are then separated by gel electrophoresis along with 
plasmids of known size, such as those from E. coli 39R861, to determine the sizes of the 
isolated plasmids. Finally, the number and size of plasmid bands are analyzed to define 
the plasmid profile for a particular isolate (Foley et al. 2009). The major drawback of 
this method is that the migration of plasmids during gel electrophoresis can be 
influenced by conformational changes in plasmids (linear versus supercoiled) (Olsen et 
al. 1993).  
Restriction fragment length polymorphism (RFLP) analysis was developed 
based on the comparison of bacterial DNA fragmented by restriction endonuclease and 
separated by gel electrophoresis. However, due to great number of restriction sites on 
genomic DNA, the fragments have to be labeled with a probe for specific repetitive 
DNA fragments such as the ribosomal RNA genes (called Ribotyping) (Bouchet et al. 
2008) or insertion sequences (such as IS1) (Fernandez et al. 2007) and the size and 
number of restriction fragments are used to compare bacterial strains. 
Pulsed-field gel electrophoresis (PFGE) is similar to RFLP typing as it 
involves bacterial DNA digestion. However, utilizing rare restriction enzymes (like 
XbaI, BlnI or SpeI for E. coli isolates) will generate smaller fragments of a wide range of 
sizes after specialized electrophoresis (Foley and Walker 2005). PFGE has remarkable 
discriminatory power and reproducibility and it is a widely applicable method for 
comparative typing of most bacterial species (van Belkum et al. 2007). PFGE has been 
used successfully for identification of E. coli strains originating from food animals, 
especially when combined with other typing methods like serotyping (Fischer et al. 
2014; Shin et al. 2014). PFGE was successfully used for molecular subtyping of ESBL-
producing E. coli ST131 (Pitout et al. 2009b). 
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1.3.2.2 Amplification-based methods 
Amplified fragment length polymorphisms (AFLP) is a combination of 
restriction digestion and PCR amplification. Basically, cutter enzymes such as EcoRI or 
MseI generate a large number of genomic DNA fragments followed by ligation of short 
adapter sequences which will be used as targets for PCR primers. Following PCR, the 
amplified fragments are electrophoretically separated and the separation profiles are 
used for inter-strain comparisons (Jonas et al. 2003). AFLP demonstrated a similar 
discriminatory index to PFGE in molecular fingerprinting of E. coli O157 (Tsai et al. 
2005). AFLP was also used to provide evidence for selection of ciprofloxacin-resistant 
E. coli strains under antimicrobial pressure in clinical samples as well as for clonal 
dissemination of ciprofloxacin-resistant in patients (van Hees et al. 2011). 
Repetitive element PCR (Rep-PCR) is another PCR-based typing method 
based on the repeated DNA sequence elements distributed throughout the genome. PCR 
primers specific to repeat elements are designed for amplification. The amplicons are 
then separated by gel electrophoresis to generate the pattern profiles which will be used 
to study the genetic relatedness of strains (Sukhumungoon et al. 2016). Rep-PCR 
(DiversiLab fingerprinting system) was used to identify E. coli clone ST131 producing 
β-lactamase CTX-M-15. In spite of the significant cost of procedure, the method was 
evaluated as a rapid standardized typing protocol for monitoring of the worldwide 
spread of E. coli clone ST131 (Pitout et al. 2009a). 
Multiple locus variable number of tandem repeat analysis (MLVA) 
generates the profile of the bacterial genomic regions with repeated DNA motifs and 
utilizes the differences in the number of repeated copies at multiple loci among strains to 
carry out the genotyping analysis (Denoeud and Vergnaud 2004). The MLVA method 
demonstrated better discriminatory ability compared to PFGE for the study of E. coli 
O157:H7 (Noller et al. 2003). 
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1.3.2.3 Sequencing-based methods 
Multilocus sequence typing (MLST) is a sequence-based molecular typing 
method that relies on specific nucleotide changes. The nucleotide sequences of 
housekeeping genes are the basis of this method as these genes are conserved among 
isolates within a species and are not subject to strong selective pressures. The 
relatedness between isolates is then determined by profiling of the polymorphisms 
within these target genes (Sullivan et al. 2005; Matsumura 2013). Web-based databases 
(developed for a number of bacterial species) facilitate the classification of tested 
sequences and assign the isolate to a particular sequence types (ST) and those with 
identical STs are defined as being clonal by MLST (Enright and Spratt 1999). Although 
MLST only examines approximately 0.1% of the core genome of bacterial (typically 
seven core loci), clonal assignments by MLST are confirmed by analysis of complete 
genome sequences (Feil 2004). Although it is an excellent method for tracing multidrug-
resistant clones or STs across the globe (Sullivan et al. 2005), MLST often uses Sanger 
sequencing which makes it an expensive method for widespread use (Feil 2004). As in 
the case of other bacterial species, MLST provides a sketch of E. coli population by 
profiling its core genome (Wirth et al. 2006). MLST has been recognized as an accurate 
technique for characterization of bacterial isolates in cases of disease clusters, which has 
made it a suitable method for the prospective or retrospective study of outbreaks 
(Sullivan et al. 2005). Identification of a highly virulent extraintestinal E. coli clone, B2-
O25b:H4-ST131-CTX-M-15 in 2008 is a good example to show the usefulness of 
MLST in case of pandemic outbreaks (Nicolas-Chanoine et al. 2008). However, 
Bednorz et al. (2013) described that MLST typing of the 181 E.coli clones defined by 
PFGE resulted in the assignment of 91 sequence types (STs), indicating MLST is less 
discriminatory than PFGE. Nevertheless, MLST data allows for comparison between 
laboratories (Bednorz et al. 2013).  On the other hand, de Been et al. (2014) who used 
whole-genome sequencing (WGS) to study the relatedness of cephalosporin resistant E. 
coli from humans, chicken meat, poultry and pigs. WGS analysis revealed considerable 
heterogeneity between human and poultry-associated isolates which had previously been 
considered to be identical based on MLST, plasmid typing and AMR gene sequencing 
(de Been et al. 2014). By applying the whole-genome sequencing (WGS) technology we 
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are now able to recognize the genetic relationship among bacteria with a much higher 
resolution. The whole-genome MLST (wgMLST) that benefits the WGS technology is 
rapidly becoming a powerful discriminatory tool for the typing of isolates and will 
replace many of the above techniques. Nowadays, the publically accessible repositories 
like Bacterial Isolate Genome Sequence Database (BIGSdb) help researchers in 
determining the gene loci and allele number in bacterial species (Jolley and Maiden 
2010).  
Single nucleotide polymorphism (SNP) analysis is another technique that was 
developed to identify nucleotide mutations (called single nucleotide polymorphism or 
SNP) at specific loci in the bacterial genome to be used to differentiate isolates. 
Profiling of multiple SNPs (especially synonymous SNPs, those that do not change the 
identity of their encoded amino acid) in bacteria can be used to trace the relatedness of 
strains (Cebula et al. 2005). Several methodologies have been introduced to detect and 
study SNPs, including real-time PCR (Griffing et al. 2015) and DNA sequencing 
(Mortimer et al. 2004), although PCR is still the most popular approach used to screen 
bacteria through their SNPs profile (Mathers et al. 2015). Several studies have been 
designed to use SNPs for identification of E. coli clonality. In 2009, SNPs within the 
mdh and gyrB genes were used for detection of clonal groups among E. coli pathogens 
causing antimicrobial-resistant urinary tract infection (Johnson et al. 2009). 
Furthermore, Weissman and colleagues have mapped the sequences of fumC and fimH 
loci (called CH typing or clonotyping) to identify the fimH30 ST131 lineage as 
clonotype CH40-30 (Weissman et al. 2012). Most recently, SNP genotyping technique 
was successfully used for genetic characterization and typing of a shiga toxin-producing 
E. coli O26:H11 strain in food producing animals (Ison et al. 2015). 
 
1.3.3 Pathogenicity and AMR profiles of E. coli clones 
The clonal dissemination of intestinal pathogenic E. coli (like O157:H7 strain) 
(Glode et al. 1977) as well as extraintestinal pathogenic E. coli (ExPEC) lineages 
including sequence types (ST) 95, ST73, ST393, ST69, and ST131 have been identified 
and traced geographically and all were associated with both community-onset and 
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healthcare-associated infections (Riley 2014). ST95 ExPEC strains are mostly 
associated with neonatal meningitis in humans and avian colibacillosis (Nandanwar et 
al. 2014). They belong to phylogenetic group B2 (Mora et al. 2013). In France, they 
were the most common clonal group among E. coli isolated from blood of patients with 
cirrhosis (Bert et al. 2010). Between 2007 and 2010, ST73 was the third most common 
ST in San Francisco hospitalized patients with Blood Stream Infection (BSI) symptoms 
(Adams-Sapper et al. 2013). ST73 strains belong to phylogroup B2 and serotype O6:H1 
(Martinez-Medina et al. 2009) and are among the predominant CTX-M-15 ESBL-
producing ExPEC in North Africa (Fam et al. 2011). ST393 was one of seven major 
ExPEC STs in the late 2000s in Canada (Peirano et al. 2012). It was the predominant 
ExPEC clonal group and one of the five most common ESBL-producing STs in Spain 
between 2005 to 2008 (Mora et al. 2011)  and was also reported from Korea (Lee et al. 
2010). Among all ExPEC E. coli clones, ST131 is currently the most frequently studied 
of the pandemic CTX-M–type ESBL–producing ExPEC Escherichia coli clonal lineage 
(Nicolas-Chanoine et al. 2008). It was initially identified by multi-locus sequence typing 
(MLST) during 2000–2006 and has been spread rapidly in several countries through 
food/water sources and/or via returning travellers from contaminated areas (Nicolas-
Chanoine et al. 2008). So, sometimes EXPEC has been referred as a new class of food 
borne pathogens (Smith et al. 2007).  The complete sequences of plasmids carrying 
CTX-M ESBLs within three different lineages of E. coli ST131 showed that IncFII 
plasmids harbouring blaCTX-M-15, blaOXA-1 and blaTEM-1 play a major role in the global 
spread of CTX-M-15 ESBLs in E. coli (Woodford et al. 2009). ST131 strains are also 
resistant to fluoroquinolones, owing to chromosomal gene mutations (gyrA and parC) 
(Johnson et al. 2013). Unfortunately, recent reports revealed that ST131 strains are 
gaining resistance to other classes of antimicrobials by expressing enzymes such as 
NDM-1 metallo-β-lactamase (Peirano et al. 2011). This clearly underlines the need for 
more research to better understand the epidemiology and biology of high-risk clonal E. 
coli lineages in order to find new strategies to prevent the evolution of drug resistance 
among pandemic strains. 
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2 Antimicrobials and resistance 
 Currently, a possible apocalyptic scenario would be the non-effective treatment 
of bacterial infections due to development of global resistance to antimicrobials. 
Development of resistance in zoonotic bacteria that mostly originate from food animals 
is now considered a major threat to public health, primarily through the increased risk of 
treatment failures in patients with infection complications.  
Unfortunately, intensive use of antimicrobials in food animal production, 
especially as growth promoters and prophylactic purposes, exposes the bacterial species 
to substantial selective pressure that facilitates the spread of resistance. Notably, the 
selection occurs at the same rate among non-pathogenic bacteria which can transfer the 
resistance to pathogenic species. Due to the rapid and vast spread of antimicrobial-
resistant bacteria from food animal reservoirs, the European Union decided in 2006 to 
ban the administration of antimicrobial agents as growth promoters in food animal 
production (EuropeanUnion 2006). In North American countries although the non-
therapeutic usage of antimicrobials in animal production is not strictly banned, 
surveillance programs such as the Canadian Integrated Program for Antimicrobial 
Resistance Surveillance (CIPARS) and National Antimicrobial Resistance Monitoring 
System (NARMS) in the United States have been developed to monitor trends in 
antimicrobial use and antimicrobial resistance in selected bacterial organisms from food 
animal sources nationwide.  
E. coli has been the center of attention in most of these studies due to its zoonotic 
role that can lead to a wide variety of infections such as diarrhea, urinary tract infection, 
meningitis, peritonitis and septicemia in humans. Several studies reported the direct 
effect of administration of antimicrobials in pig farms and the risk of antimicrobial 
resistance development in E. coli to several classes of antimicrobials such as 
aminoglycosides (Bourque et al. 1980), tetracyclines (Wagner et al. 2008), quinolones 
(Taylor et al. 2009), sulphonamides (Rosengren et al. 2007) and β-lactams (Makita et al. 
2015).  
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In E. coli, the importance of resistance to β-lactams (cephalosporins) has been 
highlighted in a report published by World Health Organization (WHO 2011). In this 
report, first- and second-generation cephalosporins are listed as highly important 
antimicrobial agents for the treatment of E. coli infection in humans whereas third- 
(cefovecin, cefpodoxime, and ceftiofur), and a fourth-generation (cefquinome) 
cephalosporins with wide range of application in veterinary medicine were regarded as 
critically important as they not only are alternatives to treat serious human disease but 
also their resistance genes are highly transmittable via non-human sources (WHO 2011). 
Acknowledging this warning, the broad spectrum of activity and wide therapeutic 
applications of β-lactams makes them the most commonly used antimicrobials in the 
food animal industry, but also underlines the need for a special focus on the impact of 
these antimicrobials on livestock and public health. 
 
2.1 β-lactam antibiotics and their mechanism of action 
 β-lactam antibiotics are the most common antimicrobial agents used against both 
human and animal infections caused by gram-positive and -negative bacteria. They have 
dominated the clinical market since their introduction in the 1940’s and today consist of 
nearly 75% of the market. Their core structure consists of a nitrogen-containing β-
lactam ring with the variable side chain R attached via the amide bridge to the ring 
carbon 6 atom. They act through inhibition of cell wall synthesis specifically by 
targeting a group of anchoring proteins in the cell membrane named penicillin-binding 
proteins (PBPs). Osmotic instability followed by autolysis occurs in bacteria after 
binding of the β-lactam ring to PBPs and alteration of the cell wall synthesis (Wivagg et 
al. 2014). Based on the spectrum of activity and binding affinity, several classes of β-
lactams have been synthesized including penicillins, cephalosporins, monobactams and 
carbapenems. Some β -lactams, like penicillins and carbapenems, have a similar 
structure whereas penicillins and cephalosporins are quite different in architecture. In 
penicillins, the β-lactam ring is fused to thiazolidine, whereas in the cephalosporins the 
dihydrothiazine ring replaced the thiazolidine. The difference will be even more 
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complex by changing the lateral chains of the original β-lactam that results in the 
formation of different semi-synthetic penicillins or cephalosporins, either with broader 
antibacterial spectrum or with changes in their pharmacokinetic properties (Elander 
2003). 
Derived from a fungi named Penicillium, penicillins were the most widely 
effective antibiotics particularly against gram-positive bacteria, with the least toxicity 
known (Kirby and Bulger 1964). Based upon their effectiveness and bactericidal action, 
penicillins are classified into four classes. The first clinically used penicillins were 
natural penicillins (penicillin V, penicillin G, benzathine, and procaine penicillin) that 
are mainly useful against gram-positive bacteria such as strains staphylococci and 
streptococci as well as a few gram-negative bacteria. The second class is the narrow-
spectrum activity penicillinase-resistant penicillins (oxacillin, dicloxacillin, cloxacillin, 
methicillin, and nafcillin) that were mainly developed against penicillinase-producing 
staphylococci. Aminopenicillins (amoxicillin, bacampicillin, and ampicillin) are the next 
class of penicillins which are active agents against several gram-negative bacteria (like 
E. coli). These penicillins are resistant to acidic environment, so they could be 
administered orally. The fourth class, the extended spectrum Penicillins are sub-
categorized to acylaminopenicillins (mezlocillin, piperacillin, and azlocillin) and alpha-
carboxypenicillins (ticarcillin and carbenicillin). These penicillins have a similar 
spectrum of anti-bacterial activity to aminopenicillins although they can also be used 
against gram-negative species of the Enterobacteriaceae family (Moran et al. 2009; 
Brunton et al. 2011). 
Cephalosporins are chronologically classified into five generations based on their 
activity. Alterations at R sites (side chains) form the variation among cephalosporin 
generations directly influences the spectrum of activity against different bacterial 
species, and longer half-life. Hence, each of the generations has added another level of 
advantage over the previous ones. The first generation of cephalosporins (eg. cefacetrile, 
cefadroxil, and cephalexin) were effective only against gram-positive bacteria. Each 
newer generation has significantly extended spectrum against gram-negative bacteria 
although in most cases the activity against gram-positive organisms was decreased. 
Later generations are often considered as extended-spectrum cephalosporins (ESCs) and 
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are reserved for use against penicillin resistant infections to prevent the spread of 
cephalosporin resistant bacteria. The third- (eg. ceftiofur, ceftiolene, and ceftriaxone), 
fourth- (eg. cefclidine, cefepime, and cefluprenam) and fifth-generation (ceftobiprole, 
ceftaroline, and ceftolozane) cephalosporins have true broad-spectrum activity (Moran 
et al. 2009; Brunton et al. 2011). 
Due to widespread use of β-lactams, bacteria have evolved three mechanisms to 
combat the effects of these drugs (Babic et al. 2006). Production of β-lactamases that is 
encoded on chromosomes or by plasmids is known to be the most common and 
important mechanism in gram-negative bacteria like E. coli against β-lactam antibiotics 
(Livermore 1995). Other mechanisms of defence against β-lactam antibiotics includes 
the alteration of penicillin binding proteins (PBPs) that exhibit low affinity for β -lactam 
antibiotics; and inhibiting the expression of outer membrane proteins (Babic et al. 2006). 
 
2.1.1 Classification of β-lactamases 
Discovered in 1940, β-lactamase was first described as a penicillin-inactivating 
mechanism in bacteria that threatened the future use of β-lactam antibiotics and were 
originally named penicillinases (Abraham and Chain 1988). Basically, β-lactamases are 
enzymes that hydrolyze the amide bond of the β-lactam ring, deactivating the drug, 
although they are not covalently bound to the drug as PBPs are. Today β-lactamases are 
either directly or indirectly responsible for most of the multidrug resistance observed in 
gram-negative bacteria in isolates from both humans and animals. Since the discovery of 
β-lactamases, over 890 members of this class of enzyme have been identified in 
naturally occurring bacteria (Bush and Jacoby 2010). Initially, these enzymes have been 
classified (A through D) according to the amino acid sequences of the enzymes (Ambler 
1980; Bush 1989). Three classes (A, C and D) catalyze the reaction using a serine 
residue, the B class of metallo-β-lactamases catalyzing the reaction using zinc (Ambler 
1980; Bush 2010). Subsequently, a new functional grouping of β-lactamases has been 
introduced according to their ability to hydrolyze specific lactam classes and on the 
inactivation properties of the lactamase inhibitors such as clavulanic acid, sulbactam, 
and tazobactam (Bush et al. 1995). Hence, this classification scheme is much more 
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relevant to physicians and microbiologists in a diagnostic laboratory, because it 
considers β-lactamase inhibitors and β-lactam substrates that are clinically relevant. 
Table 1.2. depicts the most up-to-date version of this classification. Based on functional 
classification three major groups of β-lactamases have been identified. 
 
2.1.1.1 Group 1 cephalosporinases 
The first group consists of the cephalosporinases belonging to molecular class C 
that are encoded on the chromosomes of many Enterobacteriaceae and a few other 
organisms (Jacoby 2009). They mediate resistance to cefoxitin, cefotetan, ceftriaxone, 
cefotaxime, and most penicillins except carbapenems. These enzymes are inhibited by 
cloxacillin, oxacillin, and aztreonam (Bush et al. 1995). AmpC β-lactamase was the first 
bacterial enzyme reported to destroy penicillin in E. coli (Abraham and Chain 1988). 
AmpC lactamases are usually encoded by bla genes located on the bacterial 
chromosome, including CMY-2, P99, ACT-1, and DHA-1. However, plasmid-borne 
AmpC enzymes are also becoming more prevalent since 1989 although are less common 
than extended-spectrum β-lactamases (ESBLs) (Philippon et al. 2002) and they could be 
detected in those enterobacteria not expected to produce an AmpC β-lactamase. The 
blaCMY genes are the major group of this family with 43 currently known alleles (Jacoby 
2009). Based on the origin, two classes of CMY are identified (Table 2). Six (CMY-1, -
8, -9, -10, -11, and -19) are related to be chromosomally determined AmpC enzymes in 
Aeromonas spp., whereas the remainder (including CMY-2, the most common plasmid-
mediated AmpC β-lactamase worldwide) are related to AmpC β-lactamases of 
Citrobacter freundii (Jacoby 2009). The plasmid-mediated AmpC β-lactamase not only 
are able to develop resistance to a broad spectrum of β-lactams but also the same 
plasmids could carry β-lactamases genes from group 2 of β-lactamases (Hanson et al. 
1999; Chen et al. 2007). CMY-2 is an important cause of β-lactam resistance in 
livestock, with the broadest geographical spread. The first isolates in cattle and pigs 
were reported in 1998–2000 in United States (US) where CMY-2-producing Salmonella 
spp. were isolated and were even transferred from infected calves to the farmer's son 
(Fey et al. 2000; Winokur et al. 2000). Subsequently, CMY-2-producing E. coli isolates 
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were also found in fecal samples of healthy chickens in Spain (Brinas et al. 2003). 
Similar strains have also been isolated from cats, cattle, chickens, dogs, horses, pigs, and 
turkeys (Jacoby 2009). A study showed 60 percent of the tested E. coli isolates 
randomly collected from environment of community veterinary hospitals in southern 
Ontario, Canada were positive for the blaCMY-2 gene from which ninety-five percent 
were resistant to ampicillin, amoxicillin-clavulanic acid and cefoxitin (Murphy et al. 
2010). 
 
2.1.1.2 Group 2 serine-lactamases 
Functional group 2 serine β-lactamases, including molecular classes A and D, 
represent the largest group of β-lactamases, due primarily to the increasing identification 
of ESBLs during the past 20 years (Bush and Jacoby 2010). The spreading rate of genes 
encoding the enzymes of this group is very high because of their incorporation into 
plasmids, to gain great efficiency in transferring among different strains. The most 
abundant members of functional group 2 classify in molecular class A with more than 
550 enzymes mostly reflecting the original TEM and SHV (at least 40 variants) (Bush 
and Fisher 2011). Hence, to avoid complexity the TEM- and SHV-derived β-lactamases 
were divided into two subclasses, 2a and 2b (Table 2). Subgroup 2a β-lactamases belong 
to Class A and mostly are chromosomally-encoded penicillinases with some exceptions. 
They do not cause significant clinical resistance for β-lactams other than penicillin 
(Bush and Jacoby 2010). Subgroup 2b β-lactamases are broad-spectrum β-lactamases 
that are capable of inactivating both penicillins and cephalosporins at the same rate. The 
best-known members of group 2b are β-lactamases TEM-1, TEM-2, and SHV-1. They 
are sub-divided into 2be,2ber and 2br. Subgroup 2be includes so-called ESBLs that are 
the results of mutations in the parent blaTEM-1 and blaSHV-1 genes leading to a single 
amino acid change in the original β-lactamases or enzymes which enabled them to 
cleave efficiently both penicillins and cephalosporins of generations I-IV (oxyimino-
cephalosporins). ESBLs include other β-lactamases of the CTX-M type which arose by 
plasmid transfer from pre-existing chromosomal ESBL genes from non-pathogenic 
commensal Kluyvera spp. CTX-M ESBLs can efficiently hydrolyze cefotaxime and are 
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inhibited by tazobactam more than by clavulanic acid (Walther-Rasmussen and Hoiby 
2004). They represent important enzymes found in isolates from the food animals. 
Recently, the type of ESBL was significantly extended to other β-lactamases such as 
OXA type from class D β-lactamase mutants with increased enzymatic activity towards 
cefepime (Livermore 2008). There are also numbers of less common ESBLs unrelated 
to TEM, SHV, or CTX-M, including BEL-1, BES-1, SFO-1, TLA-1, TLA-2, and 
members of the PER and VEB enzyme families (Naas et al. 2008). The transmission of 
zoonotic ESBL-producing Gram-negative bacteria (eg. E. coli) between food-producing 
animals and humans is considered as a serious threat to public health in human medicine 
as well as increasingly in the veterinary context worldwide. Although TEM and SHV 
type β-lactamases were mainly detected in Europe in the 1990s, during the last decades 
ESBL-producing Enterobacteriaceae, particularly E. coli, have emerged globally and 
currently CTX-M β-lactamases are the most frequently detected ESBL in livestock in 
Europe (Ewers et al. 2012). A recent study in Germany revealed that among the isolates 
collected from cattle and pig farms, all isolated ESBL-producing bacteria from animal 
sources were E. coli and CTX-M was the most prevalent β -lactamase. Further 
investigation showed that isolates found in cattle feces shared an identical MLST 
sequence type and CTX-M allele to human isolates (Dahms et al. 2015).  
 
2.1.1.3 Group 3 metallo-β-lactamases (MBLs)  
MBLs constitute a unique group of β-lactamases. They are structurally different 
from other lactamases as they require zinc ion at their active site. They also differ 
functionally in the ability to hydrolyze carbapenems, although some serine-lactamases 
now have also acquired that ability. They are inhibited by metal ion chelators such as 
ethylenediaminetetraacetic acid (EDTA) and dipicolinic acid but are resistant to 
clavulanic acid and tazobactam inhibition (Laraki et al. 1999). Like serine-lactamases, 
the metallo enzymes have been functionally subdivided into two sub-groups 3a and 3b 
(Table 2) (Rasmussen and Bush 1997; Bush and Fisher 2011). Originally the blaMBL 
genes were located on the chromosome; however, due to evolutionary pressures in a 
variety of hosts, several dozen unique variants were generated and began to appear on 
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mobile genetic elements specially in important Gram-negative pathogens such as 
Enterobacteriaceae (Bush and Jacoby 2010).  Several MBLs have been described, the 
most important types for epidemiological dissemination and clinical relevance being 
identified as imipenemase (IMP) and verona integron-encoded metallo- β-lactamase 
(VIM). Both are plasmid-encoded and belong to subgroup 3a, and include SPM and the 
most recently discovered New Delhi metallo- β-lactamase (NDM) (Cornaglia et al. 
2011). NDM-1 was first detected in E. coli isolated in Sweden in 2008 from an Indian 
patient (Yong et al. 2009). The serious problem in infections with NDM-1-positive 
bacteria is that these bacteria have developed resistance to other antimicrobial classes 
such as aminoglycosides and fluoroquinolones, leaving few treatment options (Mochon 
et al. 2011). Recently, MBL genes (blaVIM and blaNDM-1) belong to subgroup 3a, have 
been found in different integrons from Salmonella spp. (Fischer et al. 2013), E. coli 
(Fischer et al. 2012), Acinetobacter junii and Acinetobacter calcoaceticus (Wang and 
Sun 2015) isolated from livestock farms. Subclass 3b of MBLs includes CphA from 
Aeromonas spp. (Hernandez Valladares et al. 1997) generally isolated from 
water/wastewater sources and Sfh-I from another environmental isolate, Serratia 
fonticola (Saavedra et al. 2003) (Table 2), both enzymes are mono-zinc that strongly 
prefer carbapenem substrates (Fonseca et al. 2011). Although, the identified bacterial 
species (in above studies) are not of human or animal origins, as part of environmental 
microbiota, they can constitute an important reservoir of genetic determinants of 
antibiotic resistance. In general, the presence of such carbapenemase-encoding genes, 
the importance of carbapenems for human treatment, and the location of genes on highly 
effective mobile genetic elements (MGEs) in the livestock environment underline the 
possibility of their transmission via food in the community and/or hospitals which is a 
potential threat for public health. 
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Table 2. Functional grouping of major β-lactamases aligned with molecular 
assignments. 
 
             Adapted from (Bush and Fisher 2011) 
 
Abbreviations: CLA, clavulanic acid; CMT, complex mutant TEM; ESBL, 
extended spectrum β-lactamase; IRT, inhibitor-resistant TEM; TZB, tazobactam. 
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2.2 Acquisition and transfer of antimicrobial resistance genes 
Acquiring resistance genes through the gene transfer process is one of the several 
mechanisms bacteria have developed to fight against the action of antimicrobials 
(Davies 1994). Generally, two ways has been identified for this process. Firstly, vertical 
gene transfer includes the intragenomic reorganization of genomic sequences during 
replication of bacteria and their transfer to daughter cells, Secondly, horizontal transfer 
refers to the acquisition of foreign DNA sequences from the same or different genera or 
bacterial species via MGEs (Davies 1994).  Both type of transfer play an important role 
in bacterial evolution and adaptation through distribution of genes that increase 
virulence and resistance to antimicrobials (Rodriguez-Rojas et al. 2013). 
 
2.2.1 Mobile genetic elements (MGEs) 
MGEs are the mediators for horizontal gene transfer that carry fitness genes 
associated with survival in the host (Hayashi et al. 2001). Commonly, they have a huge 
impact on bacterial genomes with marked changes in genome size and/or pathogenicity. 
A good example would be the comparison between pathogenic E. coli O157:H7 with 
genome size of 5.5 Mb and 4.6 Mb non-pathogenic E. coli K-12, where the gain of 
MGEs is responsible for evolution of commensal E. coli to a pathogenic bacteria with 
the ability to survive in a range of environments inside and outside the host (Hayashi et 
al. 2001). Based on their sizes, structures, biological properties and ways of spreading, 
MGEs are categorized as plasmids, transposons, integrons, gene cassettes, and phages 
(Gyles and Boerlin 2014). 
 
2.2.1.1 Plasmids 
Plasmids are circular extra-chromosomal DNA molecules with self-replication 
ability and can be found in almost all bacteria. Ranging from 2 kb to more than 100 kb, 
they carry spectrum of genes that encode nonessential functions such as drug resistance, 
virulence factors, fitness or adaptation (Smillie et al. 2010). Plasmids containing 
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antimicrobial resistance genes have been reported to be transferred from agricultural 
bacteria to human pathogens (Schuurmans et al. 2014). A formal classification of 
plasmid is based on incompatibility (Inc) groups (Novick 1987). Incompatibility 
grouping method is based on the introducing, by conjugation or transformation, of a 
plasmid of an “unknown” Inc group into a strain harbouring a plasmid of a “known” Inc 
group. If the resident plasmid is destabilized in the progeny, the incoming plasmid is 
assigned to its same Inc group (Datta and Hedges 1971). Plasmids with the same 
replication control are “incompatible”, whilst plasmids with different replication 
controls are “compatible”. Therefore, two plasmids belonging to the same Inc group 
cannot be procreated in the same cell line (Datta and Hughes 1983; Couturier et al. 
1988). These plasmids could carry different incompatibility (Inc) groups to improve 
bacterial adaptability. IncHI2, IncF, IncA/C and IncI1 harbouring plasmids are only a 
few examples of Inc groups that have recently been found in E. coli isolates from animal 
farms which transfer multiple resistance determinants such as penicillinases (blaTEM-1, 
blaTEM-135), ESBLs (blaSHV-12 and blaCTX-M-1) and plasmid-mediated AmpC β-lactamases 
(blaCMY-2) to render bacteria resistant to different antimicrobial classes (Martin et al. 
2012; Deng et al. 2015; Jones-Dias et al. 2015; Yang et al. 2015).  
 
2.2.1.2 Transposons 
Transposons or transposable elements (TE) are small DNA sequences that can 
translocate from one position to another on the genome and alter the cell's genome size 
(Schwarz and Chaslus-Dancla 2001). Similar to integrons, they must integrate into 
plasmids or chromosomal DNA but unlike plasmids they lack replication system. They 
can be found from a very small size (< 2.5 kb) with a simple organization called 
insertion sequence (IS) that can carry only one gene, to around 60 kb that often carry 
antimicrobial resistance genes. Insertion of transposons has no restriction which makes 
them very efficient at transferring antimicrobial resistance genes between bacteria 
species (Schwarz and Chaslus-Dancla 2001). Mobilisation of CTX-M genes via 
transposons onto plasmids has a key role in widespread dissemination and adaptation of 
CTX-M enzymes in pathogenic bacteria (Canton et al. 2012). Some families of 
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transposons such as Tn3, Tn5053 and Tn402-like transposons are more involved in 
movement of antimicrobial resistance genes among species and carry antimicrobial 
resistance genes as part of class 1 integrons (El Salabi et al. 2013). The majority of 
Metallo-β-lactamase encoding genes are reported to be carried in the form of gene 
cassettes on class 1 integrons and/or Tn402-type transposons (Marchiaro et al. 2010). 
 
2.2.1.3 Integrons and gene cassettes 
Integrons are known as genetic elements with an attachment site that have the 
ability to capture and incorporate antimicrobials resistance genes known as gene 
cassettes in a site-specific recombination manner and as result to enhance the expression 
of the genes conferring resistance to antimicrobials (Mazel 2006). Although they are 
generally known as mobile elements in a plasmid-mediated form, some large integrons 
were detected recently on the chromosome (El Salabi et al. 2013). Expressing a unique 
capacity to cluster resistance genes into complex operons, integrons promote resistance 
gene dissemination by horizontal gene transfer (Carattoli 2001). According to the 
homology of the integrase, the enzymes that mediate the recombination process, five 
classes of mobile integrons have been identified to date (El Salabi et al. 2013). Class 1 
represents the most common structure and plays an important role in disseminating of 
MBLs particularly the genes with high levels of resistance to carbapenems in 
Enterobacteriaceae such as blaNDM-1, blaVIM-1, blaVIM-2, blaIMP and blaDIM-1 (Yong et al. 
2009; Zhao et al. 2009). Class 2 integrons are embedded on large transposon called Tn7 
and are likely to confer resistance to six antimicrobials. Class 3 integrons are even less 
frequently observed than class 2 integrons and finally Class 4 and 5 are mainly related to 
trimethoprim resistance in V. cholerae. (Mazel 2006). The prevalence of Class 1 and 2 
integrons is high among gram-negative isolates in Europe and Middle East countries 
(Leverstein-van Hall et al. 2002; Al-Assil et al. 2013). Several recent studies reported 
the prevalence of class 1 and 2 integrons in multi-drug resistant E.coli isolates in 
humans (Lavakhamseh et al. 2015) as well as in food producing animals such as cattle 
(Bakhshi et al. 2014), pigs (Szmolka et al. 2015) and poultry (Cavicchio et al. 2015), 
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underlining the fact that plasmid-mediated integrons are one of the major elements of 
inter-species transfer of antimicrobial resistance. 
 
2.2.2 Vertical gene transfer 
The inheritance of genetic material via transmission of genes from ancestors to 
progeny during DNA replication is known as vertical gene transfer or vertical evolution 
(Kenneth Todar 2008). This is a very important event in spreading of new adaptive traits 
(e.g. antimicrobial resistance) resulting from genetic mutation or acquired to the 
bacterial population. The mutation is a very rare event in a single cell. For example, the 
rate for acquisition of resistance to streptomycin via gene mutation is 10-9 in E. coli.  
However, due to very fast growth rate of bacteria, under the selective environment of the 
antimicrobial, resistance is developed rapidly in a population (Kenneth Todar 2008). 
 
2.2.3 Horizontal gene transfer 
Lateral transfer of resistance genes from other bacteria or what so-called 
horizontal gene transfer is known as the major way of acquiring antimicrobial resistance 
(Binnewies et al. 2006). The dynamic structure of the bacterial genome is prone to 
constant modification by addition and deletion of genes in order to adapt to their 
environment (Dutta and Pan 2002). HGT is believed to be an evolutionary genetic 
adaptation mechanism against antimicrobials because, unlike other adaptive genetic 
changes like mutations, transferring of the mobile genetic elements can result in the 
acquisition of genes with entirely novel functions for the cell. For example, in case of 
plasmid-encoded β-lactamases, the recipient will acquire the ability to inactivate drugs 
(Culyba et al. 2015). 
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2.2.3.1 Transformation 
Transformation has been described as the ability of bacteria to alter their genetics 
by uptake and introduction of foreign homologous genetic materials (DNA or RNA) 
from the environment which subsequently enables bacteria to acquire new adaptation 
traits such as resistance to antimicrobials (Johnston et al. 2014). Because not all bacteria 
have such competency, special chemical and physical conditions are required (eg. 
electroporation) to facilitate the process. It has been proposed that DNA internalization 
during transformation is a transient twostep process known as competence (Johnston et 
al. 2014), consisting of an initial transfer from the surface to the cytoplasmic membrane 
followed by crossing of DNA through highly conserved cytoplasmic membrane 
channels as was confirmed in Helicobacter pylori (Stingl et al. 2010; Kruger and Stingl 
2011). It has been reported in in vitro study that administration of certain antimicrobials 
such as aminoglycosides and fluoroquinolones in sub-lethal concentrations can induce 
competence in S. pneumoniae (Prudhomme et al. 2006). Non-therapeutic dosage of 
antimicrobials can provide enough stress for such a reaction, especially in pathogens 
lacking the SOS response (an inducible DNA repair network). For instance, Legionella 
pneumophila is induced to competence for natural genetic transformation by 
fluoroquinolones and other DNA-damaging antimicrobials (Charpentier et al. 2011). 
 
2.2.3.2 Transduction 
Another mechanism of HGT is the transfer of genetic material by bacteriophages 
(Soucy et al. 2015). The process includes the integration of exogenous host genetic 
materials from chromosome DNA fragments to various mobile elements such as 
plasmids, islands, transposons and insertion elements, into a phage genome and transfer 
it to another organism recognized by the phage. Two methods of transduction have been 
demonstrated among bacteria: «Generalized» that happens during cell lysis with the 
incorporation of a random piece of the host DNA; and «Specialized», in which a 
prophage imprecisely excises itself from a host genome and incorporates some of the 
flanking host DNA. (Soucy et al. 2015). A good example of specialized transduction is λ 
in E. coli, when it can packaged into the bacteriophage and transferred to another 
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recipient cell (Huddleston 2014). Transduction is a major mechanism of horizontal gene 
transfer in nature. Bacterial genes of all types exist in up to 50% to 60% of 
bacteriophages (Dinsdale et al. 2008) showing their importance to serve as a reservoir 
for a spectrum of genes including antimicrobial resistance elements and to transfer them 
among bacteria. Recently, separate studies emphasised the role of bacteriophages in 
transfer of genes responsible for resistance to tetracycline (tetM) and gentamicin (ant2-
I) between the same and different enterococcal species (Yasmin et al. 2010; Mazaheri 
Nezhad Fard et al. 2011). However, compared to natural transformation and 
conjugation, the role of this mechanism in transferring antimicrobial resistance genes 
has been neglected for decades, although growing evidence demonstrates that 
antimicrobial treatment can increase the number of bacterial antimicrobial resistance 
genes within the phage genome, probably through activation of the SOS response (Modi 
et al. 2013).  
 
2.2.3.3 Conjugation 
Conjugation involves the transfer of DNA fragments (plasmids or conjugative 
transposons) in varied sizes by physical contact between a donor and a recipient cell via 
a conjugation pilus or pore (Soucy et al. 2015). The conjugative pilus is described as 
part of the Type IV secretion machinery (Bacon et al. 2000). Generally, the 
autonomously replicating plasmids or circular molecules of DNA that replicate from the 
host chromosome are considered as conjugative machinery. Some plasmids are 
conjugative in nature, meaning they harbor genes for the transfer machinery and are 
self-transmissible. In contrast, the non-conjugative plasmids are not able to be mobilized 
in the absence of a helper self-transmissible plasmid (Huddleston 2014). The fact that, in 
addition to plasmids, other mobile genetic elements such as conjugative transposons, 
integrons or integrating conjugative elements can be transferred by conjugative 
machinery reveals the complicated role of conjugation in horizontal gene transfer. 
Interestingly, these elements also enable the non-conjugative plasmids to be 
transferrable to other cells (Salyers et al. 1995). The role of the conjugative machinery 
in dissemination of antimicrobial resistance genes has been studied extensively. The 
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transferability of conjugative plasmids of incompatibility group IncL/M type carrying 
ESBL genes such as blaCTX-M-15, blaTEM-1, blaTEM-71, blaSHV-1 and blaPER-2 was reported in 
Serratia marcescens, an important pathogen in nosocomial infections (Batah et al. 
2015). The conjugal transfer of IncA/C plasmid harbouring antimicrobial resistance 
genes in E. coli has also been reported in pig farms where high-dose administration of 
chlortetracycline in the feed was carried out (Johnson et al. 2015).  
 
2.3 Antimicrobial use in swine production  
Compared to other food production species, antimicrobial use is even more 
substantial in the pig industry, due to intensive livestock farming conditions (Street and 
Gonyou 2008). The high density of animal in commercial herds promotes the risk of 
injuries and diseases. Such conditions increase the need for antimicrobials use as 
preventive, which are commonly administered as feed supplements (Callens et al. 2012). 
In addition, the ability of antimicrobials to suppress or inhibit the growth of certain 
microorganisms, made them a perfect choice to be used for improving the rate and 
efficiency of growth in pig farms (Cromwell 2002). The unfavorable impact of this 
practice is the dissemination of resistance among both pathogenic and commensal 
bacteria such as E. coli (van den Bogaard and Stobberingh 2000). In hog farms, animals 
receive in-feed antimicrobials in all stages of growth. The USDA has reported that 70 to 
80% of starter and grower diets for pig are antimicrobial supplemented compared to 50 
to 60% of finishers diets. However, records show that only 18% of all antimicrobials 
were used as growth promoters whereas 82% of cases were related to disease prevention 
and treatment (Cromwell 2002). It was also demonstrated that chlortetracycline was the 
most antimicrobial administered in all growth stages, followed by tylosin and 
oxytetracycline. Notably, the report underlined that 66.0% and 18.2% of total 
antimicrobials used in swine industry are classified as highly and critically important, 
respectively, according to (FDA/CVM) guidelines (Apley et al. 2012). 
In Canada, the story seems to be similar. In 2006, Alberta Agriculture, Food and 
Rural Development (AAFRD) reported a very high usage of in-feed antimicrobials in 
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Alberta pig farms (Rajic et al. 2006). Based on the records, 90.9% of grower farms 
added antimicrobial agents to animal feed compared to 80% of finishers. Combinations 
of chlortetracycline, sulfamethazine, and penicillin were the most frequent 
antimicrobials administered in weaners and growers/finishers. However, the report data 
were more encouraging for public health compared to US, as the frequency of critically 
important antimicrobials in human medicine (quinolones and 3rd generation 
cephalosporins) were apparently low (Rajic et al. 2006). Subsequently in 2013, Ontario 
Swine Veterinary-based Surveillance (OSVS) reported that 80.4% of pig farms in 
Ontario, Canada used antimicrobials. Interestingly, the administration of antimicrobials 
in viral (e.g., porcine circovirus infection and influenza) or non-infectious (e.g., injury) 
cases were greater than actual bacterial infections (e.g. Escherichia coli) because of 
misdiagnosis or in some cases to avoid secondary bacterial infections although the 
treatment failure was fairly high (70%). The most commonly used antimicrobials 
reported in this study were almost the same as in the preceding report, i.e. penicillin 
(34.9%) and tetracyclines (10.7%). However, a new 3rd generation cephalosporin, 
ceftiofur (7.8%) was now becoming one of the most frequent used antimicrobials in pig 
farms. This report also emphasised that in more than 20% of records the combination of 
more than 2 antimicrobials were used for treatment and the highest ranking in this list 
were the  combination of  penicillin with either tetracycline or ceftiofur. The use of 
multiple antimicrobials was also shown to be associated with increased probability of 
antimicrobial treatment failure. (Glass-Kaastra et al. 2013). The most recent report 
published by The Canadian Integrated Program for Antimicrobial Resistance 
Surveillance (CIPARS) also showed that β-lactams were the fourth most common class 
of antimicrobial sold in the animal industry in 2013. Based on the same report, 
fluoroquinolones, a group of antimicrobials that have been classified as of critical 
importance by WHO and are extremely regulated in use due to antimicrobial resistance 
concerns, have been used 11% more frequently in animals compared to 2012 (CIPARS 
2015). Considering the importance of growing AMR through antimicrobial use in 
animal production, the government of Canada has developed a collaborative Federal 
Action Plan in response to this threat. In order to improve the effectiveness of 
antimicrobial uses in farm animals, the framework has outlined two specific actions in 
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stewardship section: “1- To strengthen the promotion of the appropriate use of 
antimicrobials in human and veterinary medicine” and “2- To strengthen the regulatory 
framework on veterinary medicines and medicated feeds, including facilitating access to 
alternatives, and encourage the adoption of practices in order to reduce the use of 
antimicrobials” (PHAC 2015). Such frameworks would help governments to prevent the 
spread of infectious diseases, to reduce the need for treatment using antimicrobials, 
which in turn contributes to conserving the effectiveness of available treatment options. 
 
2.3.1  Association between antimicrobial use and antimicrobial 
resistance in pig farms 
Food animals are often exposed to antimicrobials either for treatment/prevention 
of infectious disease or in low concentration doses to promote growth. The use of 
antimicrobials as growth promotor and preventive (mostly as feed supplements) remains 
a concern in swine industry, as this practice provides the conditions which result in 
selective pressure for antimicrobial-resistant bacteria. The major controversy concerns 
the usage of antimicrobials that are identical to or closely resemble human drugs. The 
acquired resistance subsequently transfers via resistance genes and bacteria among other 
animals, animal products (e.g. meat), and the environment. There is also evidence that 
the antimicrobial resistance genes in commensal bacteria (e.g generic E. coli) may be 
transferred to zoonotic enteropathogens such as E. coli O157:H7 (Salyers et al. 2004). 
Among different bacteria acquiring antimicrobial resistance, the ESBL-producing 
zoonotic bacteria (e.g. E. coli) are of major concern as they can transfer resistance to 
some of the highly and critically important antimicrobials such as commonly-used 
extended-spectrum (third-generation) cephalosporins (i.e., ceftazidime, cefotaxime and 
ceftriaxone) as well as to β-lactam-lactamase inhibitor combinations (i.e., piperacillin 
tazobacatam, etc.) (McEwen and Fedorka-Cray 2002; CIPARS 2015).  
The association between antimicrobial use in farm animals and development of 
antimicrobial resistance seems to be a complex species-dependent process as some on-
farm and experimental studies failed to show such relationship in specific bacteria 
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(Dargatz et al. 2000; McEwen and Fedorka-Cray 2002). Nonetheless, antimicrobial use 
in animals apparently contributes to the spread of resistance among populations of 
bacteria by the selection process. A recent study on prevalence of antimicrobial 
resistance among E. coli isolates from food animals and consumption of in-feed 
antimicrobials among European farms showed a significant correlation between the two 
parameters for certain antimicrobial classes such as tetracyclines, fluoroquinolones and 
third-generation cephalosporins with Spearman’s rank correlations of 0.92, 0.85 and 
0.703 respectively (Chantziaras et al. 2014). Earlier, Kim et al. had also shown that 
resistance to antimicrobials (apramycin, carbadox, and chlortetracycline) increases 
among zoonotic enteropathogens (E. coli) isolates from growing piglets when these 
antimicrobials were used as feed additives. However, upon removal of apramycin, 
resistance in E. coli declined suggesting that resistance to antimicrobials in E. coli is a 
drug-dependent event (Kim et al. 2005). Another study on prevalence and patterns of 
antimicrobial resistance of fecal E. coli in farms carrying out administration of 
antimicrobials as growth promotor and preventive, revealed similar results. In this study 
72% of farms used antimicrobials as in-feed additives. Interestingly, 68% of E. coli 
isolates collected from these farms were resistant to at least one antimicrobial, more than 
3 time greater than what was observed in isolates categorized as being associated with 
"No in-feed medication". Further analysis showed that prevalence of MDR in farms 
using in-feed antimicrobials reaches to 80%, much greater than 52% in farms not using 
such antimicrobials (Akwar et al. 2008).  
The Canadian provincial and national reports reveal similar statistics but in 
greater scale. Based on the last CIPARS report in 2013, 65% of E. coli isolated from pig 
farms were resistant to at least one antimicrobial, higher than the prevalence of 25% in 
cattle/beef. At the same time, the prevalence of resistance to ceftriaxone in E. coli 
isolates was less than 4% in pig farms and neither carbapenem- nor fluoroquinolone-
resistant isolates were found. Although the report confirms the presence of multi-class 
resistant E. coli on farms, no clear statistics are provided (CIPARS 2015). The 
provincial report published by the Ministère de l'Agriculture, des Pêcheries et de 
l'Alimentation du Québec (MAPAQ), confirms that in the same period (2013), clinical 
E. coli isolates from pig farms were highly resistant to tetracycline, ampicillin, 
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trimethoprim, neomycin, and ceftiofur, with a prevalence of 90%, 72%, 50%, 29%, and 
19%, respectively, demonstrating an increase of 5-10% in resistance to almost all 
antimicrobials as compared to 2012. The report did not provide information about 
antimicrobial administration, although the increase observed in prevalence of resistance 
in one year (2012-2013) could be partly due to an increase in antimicrobial usage in pig 
farms, either for therapeutic purposes or as a growth promoter (MAPAQ 2014). 
 
2.3.2 Public health concerns 
The WHO has referred to antimicrobial resistance as one of the greatest threats 
to public health at present (WHO 2014). Antimicrobial resistance can be passed to 
humans from resistant bacteria (pathogenic and/or commensal) through mobile genetic 
elements, such as plasmids or transposons, by either food or direct contact with animals 
or release of animal waste into the environment (Silbergeld et al. 2008). In the swine 
industry, use of antimicrobials classified as highly important or critically important for 
human medicine by WHO, such as tetracyclines (chlortetracycline), potentially provide 
selective pressure for the maintenance or emergence of resistant bacteria in humans. The 
incidence of antimicrobial-resistant infection outbreaks in  European countries (Maguire 
et al. 1993; Molbak et al. 1999) involving strains originating from swine herds, 
convinced European Union (in 2006) to ban the use of antimicrobials as growth 
promoters in all food-producing animals (European Union 2005). In North American 
countries, the rules are less strict as both Canada and the United States implemented 
plans for a voluntary reduction in antimicrobial use for the purpose of growth promotion 
in food producing animals (United States Food and Drug Administration 2013; 
Health Canada 2014). However, to be aligned with WHO global action plan against 
AMR threat, the government of Canada stepped forward and developed a Federal 
Action Plan in order to limit and control the impact of AMR on public health through 
deliverable actions in three areas: surveillance, stewardship, and innovation (PHAC 
2015). The action plan is specifically focuses on improvement of the veterinary usage of 
antimicrobials by modernization of the regulatory frameworks for medicated feeds, by 
supporting the industry to validate the commercially available alternatives to in-feed 
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antibiotics and by straightening the control over the importation of veterinary active 
pharmaceutical ingredients (PHAC 2015). Although these action plans are at the starting 
point, optimistically after implementation, some farms might start raising antimicrobial-
free animals which would be a major step to avoid an apocalyptic outbreak of multi-
drug resistant infections.  
 
2.4 Antimicrobial resistance in E. coli 
E. coli is the cause of various bacterial infections and at the same time is the 
most prevalent commensal inhabitant of the gastrointestinal tracts in both humans and 
animals (Guenther et al. 2011; Stedt et al. 2014). These two characteristics together with 
that the ability of  E. coli to easily adapt to its environment with genetic flexibility, make 
this species a primary candidate for the acquisition of a great number of antimicrobial 
resistance mechanisms. Hence, it is not surprising that E. coli is frequently used as an 
indicator bacterium for addressing the circulation of antimicrobial resistance in different 
environments and host species which often demonstrate MDR (Guenther et al. 2011; 
Stedt et al. 2014). In addition, due to similarities in physiology and sharing identical 
genetic determinants of resistance with similar mechanisms of genetic dissemination, E. 
coli has been shown to be capable of exchanging resistance genes with other members 
of Enterobacteriaceae (Mann et al. 2011). Currently, E. coli is known as an important 
reservoir of resistance genes to “critically important antimicrobials” in human medicine, 
including β-lactams (cephalosporins), fluoroquinolones, aminoglycosides and 
sulfonamides (trimethoprim–sulfamethoxazole - SXT) (Pitout 2012). In 2010, over 20% 
of E. coli causing urinary infection in the United States were resistant to SXT, hence this 
drug will no longer be acceptable for treatment of urinary tract infections (Sanchez et al. 
2011). As with SXT, incidence of fluoroquinolone (ciprofloxacin) resistance seems to 
be higher in urinary E. coli isolates from hospitals than the community settings (Fasugba 
et al. 2015).  
The transmission of antimicrobial-resistant bacteria to humans through livestock 
products has become a concern to public health since it has been shown that they reduce 
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the efficacy of antimicrobial drugs in humans (Swann et al. 1969). The emergence and 
dissemination of resistant E.coli in pig farms, as one of the most commonly human food 
sources, has specially received attention from relevant international organizations 
including the World Health Organization (WHO) and World Organisation for Animal 
Health (OIE) (Dehaumont 2004; Orand 2012). The resistance patterns and their 
frequencies are considerably varied in pig originated E. coli isolates which is believed to 
be associated with antimicrobial uses in farms (European Food Safety Authority 2014). 
A recent report on faecal E.coli isolates from Irish pig farms revealed a strong 
correlation between high frequencies of resistance to tetracycline, 
trimethoprim/sulphamethoxazole and streptomycin and consumption of in-feed 
antibiotics. Besides, the use of trimethoprim/sulphonamide was found to be associated 
with the occurrence of resistance to other antimicrobials (Gibbons et al. 2016). In North 
America, the association between extensive use of both narrow-spectrum and broad-
spectrum antimicrobials used as in-feed medication, and resistance in fecal E. coli in 
pigs was mentioned in several reports (Dunlop et al. 1998; Kim et al. 2005; Bunner et al. 
2007). Also, the use of antimicrobials in weaner and finisher pigs was shown to 
contribute to the selection of resistance among fecal E.coli not only “within” but also 
“between” classes of antimicrobials (Akwar et al. 2008). Considering these studies and 
the increasing number of other reports warning about the situation of veterinary 
antimicrobial usage and prevalence of antimicrobial-resistant E.coli isolates from food-
producing animals, necessitate more decent research to better understand the 
contributing factors such as bacterial properties (virulence factors and other genetic 
determinants) that affect the occurrence of antimicrobial resistance.  
 
2.4.1 Extended spectrum cephalosporin (ESC) -resistance in E. coli  
Among antimicrobial classes, resistance to β-lactams in E. coli, especially the 
third generation extended spectrum cephalosporins (ESCs), is of a major concern to 
public health not only because this group of drugs is used to treat serious community-
onset or hospital-acquired infections caused by E. coli but also the ESC-resistant isolates 
are often resistant to other families of antimicrobials (Livermore 2008). Resistance to 
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ESCs is commonly emerging in E. coli via production of plasmid-mediated ESBLs (e.g. 
CTX-M types) and/or AmpC β-lactamases (e.g. CMY types).  
The CTX-M family of ESBLs have emerged as the most prevalent ESBLs 
enzymes in E. coli causing bacteremia and intra-abdominal infections in human (Canton 
et al. 2012). In Europe, CTX-M producing E. coli are also the most frequently detected 
ESBL in livestock and has been recognized as the causative agent in animal infections 
such as bovine mastitis (Timofte et al. 2014). The most common CTX-M types reported 
in food-producing animals (particularly in pigs) are CTX-M-14 and CTX-M-15 (Horton 
et al. 2011; Tamang et al. 2013). Insertion sequences such as IS10, IS26, and IS903 have 
been observed flanking the ORF region of blaCTX-M genes (Arduino et al. 2002). The 
blaCTX-M genes are carried on plasmids belonging to different incompatibility groups, 
including IncK, IncHI2, IncHI1, IncN, IncFIB, IncF or IncI1 (Girlich et al. 2007; Liao et 
al. 2015). In pigs, blaCTX-M-1 carried on IncN plasmids was found to be identical to that 
isolated from farm workers which confirmed the within-farm transmission between 
human and porcine commensal E. coli (Moodley and Guardabassi 2009).  
Plasmid-mediated AmpC β-lactamases are the second determinant, although less 
commonly encountered, with a broader spectrum of resistance compare to ESBLs. They 
confer resistance to 3rd generation cephalosporins (e.g. ceftiofur, ceftriaxone) in E. coli 
isolates from food animal farms (Lutz et al. 2011). In many gram negative bacteria, 
AmpC β-lactamase genes are chromosomal, although in E. coli these are poorly 
expressed and are mainly acquired by plasmids (Jacoby 2009). CMY-2 β-lactamases are 
the most common AmpC-type β-lactamases that are widely distributed via plasmids and 
have recently been recognized among animal farms in North American (Daniels et al. 
2007), Asian (Ewers et al. 2012) and European countries (Batchelor et al. 2005) with a 
frequency ranging from 2% to 31% . The majority of the blaCMY-2 plasmids identified in 
E. coli and Salmonella spp. in the United States belong to IncA/C and I1 (Carattoli 
2009) and less frequently to other incompatibility groups such as IncF, K and ColE 
(Mata et al. 2012). IncA/C plasmids often carry the qnrA1 gene conferring resistance to 
fluoroquinolones and have been characterized as the most multi-resistant plasmids in 
bovine originated E. coli (Martin et al. 2012). IncI1 plasmids were also reported to be 
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the predominant plasmids carrying blaCMY-2 in human E. coli isolates (Sidjabat et al. 
2014).  
The high prevalence of ESBLs and AmpC-producing E. coli isolates in the food 
animal industry demonstrates the risk of their diffusion in the human food chain and 
underlines the need to develop appropriate strategies to limit the spread of multidrug-
resistant bacteria from food-producing animals to the community. 
 
2.4.2 Antimicrobial resistance in E. coli and its association with 
virulence genes 
Mobile genetic elements (plasmids, transposons, and integrons) are the core for 
epidemiological studies of antimicrobial resistance traits. However, AMR genes are not 
the only sequences carrying by mobile genetic elements. It is probable that virulence 
genetic determinants on the same genetic platform as antimicrobial resistance genes co-
mobilize under antimicrobial selective pressure so the virulent strains will become stable 
by acquiring resistance properties (Da Silva and Mendonca 2012). 
Among E. coli pathotypes that may transfer from animals and contaminated 
human foods, E. coli O157:H7 (EHEC pathotype) is one of the most threatening 
serotypes to human health. Shiga toxin (stx1, stx2)-producing E. coli O157:H7 from 
feedlot beef cattle revealed resistance to ciprofloxacin indicating that the use of in-feed 
fluoroquinolones may trigger the development of resistance in E. coli O157 in food-
producing animals (Galland et al. 2001; Manna et al. 2006). In another study, 50% of E. 
coli O157 isolated from bovine, caprine and ovine milk possessed virulence genes (stx1, 
stx2, eae and ehxA) and all of them were found to be resistant to ampicillin and 
streptomycin (Solomakos et al. 2009). Presence of some virulence genes alone or in 
combinations seems to be correlated with antimicrobial resistance. In a study on E. coli 
isolated from meat, the prevalence of resistance to multiple antimicrobials was much 
higher in strains were carrying both astA and iucD genes compared to strains harboring 
only the iucD. The strains with the pap gene were more resistant to several 
antimicrobials than those lacking the pap (Badri et al. 2009).   
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Ngeleka and colleagues have reported that virulent EPEC and ETEC E. coli 
isolated from piglets (both diarrheic and non-diarrheic) expressed high levels of 
resistance to gentamicin, neomycin, and sulphametoxazol-trimethoprim (Ngeleka et al. 
2003). This observation agrees with more recent similar studies reporting the correlation 
between resistance to ceftiofur and presence of faeG and aidA in E. coli isolated from 
diseased pigs (Wang et al. 2010) as well as the association between multi-drug 
resistance to certain antimicrobials (cefoxitin, gentamicin, kanamycin, streptomycin, 
tetracycline, and ceftiofur) and APEC-associated virulence genes (cvaC, iss, iutA, and 
traT) in avian-source E. coli (Johnson et al. 2012).  
Genetically, a strong association between the resistance gene for tetracycline 
(tetA) and ETEC virulence genes (estA, paa) and between the apramycin resistance gene 
(aac(3)IV) and faeG were observed in pig-originated E. coli strains. It was also 
noteworthy that the difference observed in prevalence of antimicrobial resistance among 
isolates from ETEC and non-ETEC sick animals was assumed as a proof for existence 
of linkages between resistance and virulence genes (Boerlin et al. 2005). The linkage 
hypothesis was used again in another similar study on E. coli isolated from healthy pigs 
where a strong positive association between fedA and two gentamicin resistance genes 
aadA1 and aadA2 was believed to reveal their co-localization on the same mobile 
genetic elements (e.g., plasmids, transposons) (Lay et al. 2012).  
The co-mobilization of AMR and virulence genes is still a controversial 
phenomenon, although accumulating evidence indicates that in certain strains there is a 
correlation between virulence and antimicrobial resistance. Hence, elucidating the 
genetic mechanisms regulating such hypothetical linkage will be necessary in order to 
help us to understand the interplay of resistance and virulence at the genetic level with 
the aim to improve our management of infectious diseases 
 
3 Alternatives to antimicrobials as growth promoters 
Antimicrobials have played a major role in the growth and development of the 
swine production for more than 50 years. Their efficiency in increasing growth rate, 
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improving feed utilization and reducing mortality from clinical disease is well 
documented (Cromwell 2002). The emergence of multidrug resistant bacteria is 
increasing, which is a particular concern on livestock farms. Many countries have 
banned or are banning the use of antimicrobials in swine diets as a growth promoter 
(van der Fels-Klerx et al. 2011). As a result, intensive studies have been focused on the 
development of alternatives to antimicrobials to maintain swine health and performance. 
There are a number of commonly used non-therapeutic alternatives to antimicrobial 
growth promoters in swine production. 
Probiotics are widely used live microbial supplements which improve the host's 
health by modifying the intestinal microflora (Fuller 1989). Bacillus, yeasts, and lactic 
acid-producing bacteria are the three categories of organisms that are commonly 
referred to as probiotics (Heo et al. 2013). The anti-diarrhea potential of probiotics has 
been stressed in the animal industry and specifically in weaning piglets due to the 
emergence of antimicrobial-resistant microbes (Lalles et al. 2007). Probiotics provide 
beneficial effects via different mechanisms. They compete with pathogenic 
microorganisms for binding sites in the intestinal mucosa.  Lactobacillus spp. has been 
shown to reduce the adhesion of pathogenic E. coli ETEC K88 to piglet ileal mucus by 
approximately 50% (Blomberg et al. 1993). Probiotics can also increase nutrient 
availability and inhibition of pathogen growth by production of organic acids 
(Vondruskova et al. 2010).  
Prebiotics are selectively ingredients which cannot be digested by host but are 
specifically fermented by the intestinal microbiota and can change both the composition 
and (or) activity of the gastrointestinal microbiota (Gibson and Roberfroid 1995). To be 
qualified as a prebiotic, the ingredient should be resistant to hydrolysis and gastric 
acidity, be fermentable by the intestinal microbiota and could selectively promote 
growth and activity of well-being related intestinal bacteria. Thus, only two groups of 
fructo-oligosaccharides (FOS) and transgalacto-oligosaccharides (TOS) are categorized 
as prebiotics (Roberfroid 2007).Prebiotics can especially support the growth and/or 
activities of probiotic microorganisms in the gastrointestinal tract, such as 
Bifidobacteria, Lactobacilli and Eubacteria (Rayes et al. 2009). The evaluation of 
dietary TOS addition on swine nutrient digestibility revealed an increase in beneficial 
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species in the ileal and fecal bacteria population and an improvement in ileal short-chain 
fatty acid (SCFA) production, an indicator of intestinal fermentation (Smiricky-Tjardes 
et al. 2003).  
Bacteriocins are another alternatives to traditional antibiotics. They are a 
subgroup of antimicrobial peptides produced by certain bacteria and play as a specific 
immunity mechanism against other bacterial species (Cotter et al. 2013). Certain 
properties of bacteriocins make them a very viable alternative to antimicrobials such as 
their in vitro potency against clinically important pathogens such as Escherichia coli,  
Streptococcus pneumoniae and Clostridium difficile (Piper et al. 2009) as well as their 
low toxicity for the treated host either human or animal (Haste et al. 2012). To control 
foodborne pathogenic bacteria (e.g E.coli) in livestock, a variety of bacteriocin have 
been tested (Diez-Gonzalez 2007). However, among all bacteriocins, colicins hold a 
great deal of promise. Colicins are a class of bacteriocins produced by and effective 
against E. coli and closely related bacteria. It was shown that the daily addition of 
colicin E7-producing E. coli to cattle feed could reduce the fecal shedding of E.coli 
serotype O157:H7 (Schamberger et al. 2004). It has been also indicated that colicins are 
effective against E. coli ETEC strains responsible for postweaning diarrhea and edema 
disease in swine (Stahl et al. 2004) and dietary inclusion of colicin E1 would help to 
prevent postweaning diarrhea caused by F18-positive E. coli (Cutler et al. 2007).  
Organic acids such as citric, fumaric, lactic and formic acids, are also 
considered as dietary supplements in the swine industry to improve growth performance 
and health (Tsiloyiannis et al. 2001). Several benefits were observed for dietary 
supplementation of organic acids including, bactericidal effects due to reduction in pH 
and the ability to penetrate bacterial wall and destroy some specific microorganisms 
(Pettigrew 2006), improving enzymatic digestion and nutrient absorption, and increasing 
the performance of weaned and growing piglets (Vondruskova et al. 2010). The impact 
of organic acids on reduction of the intestine E. coli ETEC K88 population and reducing 
the severity of pig post-weaning diarrhea have been discussed previously (Tsiloyiannis 
et al. 2001). Another meta-analysis study also confirmed the positive effect of organic 
acids and their salts on improvement of growth and feed efficiency in piglets (Partanen 
and Mroz 1999). 
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Zinc is an abundant trace element in the body and is involved in a variety of 
general cellular functions, including replication, transcription and maintaining the 
epithelial barrier integrity (Vondruskova et al. 2010). Dietary supplementation of zinc in 
the form of zinc oxide was shown to be beneficial not only for the stability of the 
intestinal microbiota (Hahn and Baker 1993) but also by expressing antimicrobial 
activities to inhibit the growth of some pathogenic bacteria (Sawai 2003) in weaned 
piglets. In high dose, feeding zinc to weaned piglets has been also demonstrated to 
reduce pig post-weaning diarrhea incidence (Stensland et al. 2015). It was shown that 
zinc oxide protects the intestinal epithelia through two major pathways; it maintains the 
integrity of the cell membrane, reducing damage via translocation of redox-active metal 
ions (Srivastava et al. 1995) and by involvement in protein expression associated with 
glutathione metabolism and oxidative stress (Wang et al. 2008). On the other hand, the 
zinc oxide antimicrobial mechanism of action is believed to be partly due to its ability to 
bind to bacterial fimbriae and interfere with bacterial adhesion, specifically of 
pathogenic species such as E. coli ETEC (Jin and Zhao 2000). Recently, it was also 
shown that feed supplementation with zinc increases the proportion of multidrug 
resistant E. coli and clonal diversity of E .coli population in piglets (Bednorz et al. 
2013). 
Copper (like Zinc) is another essential trace elements that perform several 
biological functions. It is increasingly used, as copper sulfate (CuSO4), as an alternative 
to in-feed antibiotics in weaned piglets for prevention of diarrheal disease (Yazdankhah 
et al. 2014; Agga et al. 2015). Although its mechanism of action is not clear, it has been 
shown that in presence of copper sulfate, gut microbiota are altered to reduce 
fermentation loss of nutrients and to suppress gut pathogens (Hojberg et al. 2005). 
However, over feed supplementation with copper activates several mechanisms of metal 
tolerance in bacteria that might promote the spread of antimicrobial resistance via co-
selection not only at the farm level, but also in the environment (Seiler and Berendonk 
2012). 
Other feed alternatives such as enzymes, herbs, plants extracts and 
neutraceuticals like clay minerals, egg yolk antibodies, essential oils,  eucalyptus oil-
medium chain fatty acids and rare earth elements are also used as feed additives in pork 
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industry with the aim to maintain swine health and performance (McEwen and Fedorka-
Cray 2002; Verstegen and Williams 2002; Thacker 2013). 
 
3.1 Clay minerals 
One of the alternatives to antimicrobials growth promoters that has been 
suggested as a feed additive for use in swine production is the clay (Trckova et al. 2009; 
Song et al. 2012; Subramaniam and Kim 2015). Clays are crystalline, hydrated 
aluminosilicate molecules composed of alkali and alkaline earth cations along with 
small amounts of various other elements. Clay minerals are formed by a net of stratified 
tetrahedral and octahedral layers and channels capable of trapping a wide variety of 
molecules. As a result of this structure, clay minerals are considered as a simple and 
effective tool for the prevention of the negative effects of toxic compounds. They have 
molecules of silicon, aluminium and oxygen. The layers can be inter-connected by 
hydrogen bonds or a group of cations, and this space is called an interlayer. A common 
feature of clay minerals is a high adsorption capacity determined by their stratified 
structure. The natural extracted clays (bentonites, zeolite, kaolin) are a mixture of 
various clays differing in chemical composition. The best-known are montmorillonite 
(MMT), smectite, illite, kaolinite, biotite and clinoptilolite (Vondruskova et al. 2010; 
Subramaniam and Kim 2015). 
 
3.1.1 Clay minerals as animal food supplements  
Administration of clays as a feed additive has been shown to improve weight 
gain and feed conversion in pigs (Papaioannou et al. 2004; Trckova et al. 2009; Duan et 
al. 2013). One of the most likely explanations for the improvement in performance is the 
fact that supplementation of the diet with clay minerals has been shown to increase 
nutrient digestibility (Shurson et al. 1984; Subramaniam and Kim 2015). The 
supplementation of a diet with 1% to 3% of clay minerals is generally recommended 
(Vondruskova et al. 2010). Several studies have described the decontamination 
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properties of clays with respect to mycotoxins (Lindemann et al. 1993; Phillips 1999; 
Marroquin-Cardona et al. 2009), heavy metals (Xu et al. 2004; Yu et al. 2008), and other 
toxins (Knezevic and Tadic 1994).  
One of the known clay minerals, clinoptilolite is a natural zeolite which is mined 
from sedimentary deposits. Zeolites have diverse applications based on their unique 
adsorption, cation-exchange, dehydration–rehydration, and catalytic properties 
(Mumpton 1999; Papaioannou et al. 2005). Clinoptilolite is authorized by the European 
Union and registered as a technological additive in feed stuffs for all animal species at 
max 20,000 mg/kg complete animal feed (E- 568) (EFSA 2013). In Canada according to 
Veterinary Drugs Directorate (VDD) and Canadian Food Inspection Agency (CFIA) 
recommendation, using zeolites as animal feed additive are permitted however they 
should not exceed 2% of the complete feed (HC 2012). Also, it is considered as a GRAS 
(Generally Regarded as Safe), as listed by the Food and Drug Administration (FDA). 
Recently, use of clinoptilolite in animal nutrition has been increased mainly to 
improve performance and health (Katsoulos et al. 2006) and also is considered as an 
alternative to antimicrobials in prevention of diarrhea in weaned piglets (Papaioannou et 
al. 2004). It has been reported that the performance of pigs fed 2 % clinoptilolite in 
comparison with a control group after weaning until market weight showed a 5.3% 
improvement in weight gain for pigs fed clinoptilolite, the response being greater in 
younger pigs than older pigs. Also, it has been shown that weight gain increased by 14.3 
% and feed conversion by 2.9 % as a result of feeding 2 % clinoptilolite to growing pigs 
(Subramaniam and Kim 2015). There is evidence that oral administration of 
clinoptilolite can decrease the rate of passage of food through the intestine and improve 
average body weight gain and feed conversion and nutrient utilization in pigs 
(Papaioannou et al. 2004; Papaioannou et al. 2005; Leung et al. 2007). Clinoptilolite has 
been widely used in swine diets to protect against mycotoxins (Schell et al. 1993).  
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3.1.2 Antimicrobial activity of clay minerals 
It has been reported that clays alter the microbial composition of the 
gastrointestinal tract resulting in a more favorable gut microflora (Subramaniam and 
Kim 2015). The ability of clay minerals to reduce the number of pathogenic bacteria in 
the intestinal tract has been demonstrated in vivo in pigs (Trckova et al. 2009) and in 
vitro (Hu et al. 2002; Haydel et al. 2008). Haydel et al. (2002), in an in vitro study, 
reported that clay mineral (CsAg02) induced a bactericidal activity against pathogenic 
E. coli, extended-spectrum β-lactamase (ESBL)-producing E. coli, S. enterica serovar 
Typhimurium, Pseudomonas aeruginosa, and Mycobacterium marinum and a combined 
bacteriostatic/bactericidal effect against Staphylococcus aureus, penicillin-resistant S. 
aureus (PRSA), methicillin-resistant S. aureus (MRSA), and Mycobacterium smegmatis 
(Haydel et al. 2008). 
 Additionally, it has been shown that administration of clinoptilolite as a feed 
supplement resulted in a reduction in total flora colony counts in the proximal and distal 
intestine in chickens (Olver 1983; Mallek et al. 2012). Likewise, it has been reported 
that feed supplementation with clinoptilolite reduced total viable counts of E. coli in the 
cecal contents of broiler chicks (Wu et al. 2013). The ability of clay minerals to allow 
adsorption of pathogens and enterotoxins to the surface layer or into the interlayer sheets 
to degrade them in the intestinal tract has been shown in vivo study (Trckova et al. 
2009). However, little is known of the mechanism of action of clinoptilolite.  
 
3.1.3 Effect of clay minerals on horizontal gene transfer 
Yoshida et al. (2004) demonstrated that clay minerals induce bacterial mutation 
and promote genetic variability of bacteria. Where bacteria were cultured in Luria-
Bertani medium with and without caly minerals. Chromosomal DNA was extracted 
from both group and underwent Random amplified polymorphic DNA PCR and band 
pattern were compared. By comparison of amplified DNA they reported that clay 
minerals induce mutation in bacteria and may play roles in microbial evolution (Yoshida 
et al. 2004) and that chromosomal and plasmid DNA bound to clay minerals are more 
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resistant to degradation by DNase I than free DNA (Romanowski et al. 1991; Khanna 
and Stotzky 1992; Paget et al. 1992; Romanowski et al. 1992). Several in vitro studies 
have shown that clay minerals promote direct horizontal transfer of AMR genes in 
different bacterial species. For instance, Rodríguez-Beltrán et al. (2013), who described 
that clay minerals (e.g. sepiolite) increase direct horizontal gene transfer between 
bacterial species, due to plasmid transfer in certain conditions such as presence of 
septiolite (final concentration of 100 µg/ml) and increased friction forces, the latter of 
which may have been provided by peristalsis in the intestine of the animal receiving 
continuously clay mineral as a food additive. This phenomenon may be exacerbated by 
the use of antimicrobials as growth promoters. Moreover, it has been shown that clay 
minerals montmorillonite and kaolinite increased the frequency of transformation in 
competent Bacillus subtilis cells (Richaume et al. 1989; Romanowski et al. 1993; 
Lotareva and Prozorov 2000; Rodriguez-Beltran et al. 2013). Influence of clay minerals 
on horizontal transfer of AMR genes is concentration dependence and previous in vitro 
studies demonstrated that higher concentrations of clay minerals resulted in a decrease 
in the number of transformed cells, in other words, a discount in HGT (Richaume et al. 
1989; Lotareva and Prozorov 2000).  
  
 
 
 
 
 
 
 
 
 
Chapter 2: Rationales and Objectives 
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Rationale 
Emergence of resistance to clinically important antimicrobials such as 
cephalosporins (ceftiofur, ceftriaxone, etc) through widespread use of antimicrobials in 
animal production is a major public health concern. E. coli pathotypes (e.g. ETEC, 
STEC, EPEC and ExPEC) cause diseases in pigs and often carry antimicrobial 
resistance genes. In pigs, antimicrobials are used in feed primarily to treat disease and 
thus reduce mortality and morbidity but also for promoting growth and for disease 
prevention. Furthermore, administration of in-feed antimicrobials in pigs has been 
associated with increased resistance of fecal E. coli within and between classes of 
antimicrobials.  
Ceftiofur is a critically important antimicrobial, being in the same general class 
as ceftriaxone which is important in human medicine for treating serious infections 
especially for use in children. It has been hypothesised that the widespread use of 
ceftiofur on animal farms has resulted in food-borne ceftriaxone-resistant enteric 
bacteria. To maintain the efficacy of this clinically important antimicrobial, it is 
important to know the frequency of ESC-resistant bacteria in livestock and to 
understand the mechanisms involved in their selection and persistance. As ceftiofur is 
extensively used in swine production, ceftiofur-resistant E.coli isolates from pigs are an 
appropriate subject for further investigation of the evolution with time of ceftiofur-
resistant E. coli isolates from when ceftiofur resistance was first reported. 
In addition, certain supplements are routinely used in animal feed to improve 
growth. For instance, the clay mineral clinoptilolite has been used in an attempt to 
improve performance and health but also as an alternative to the use of antimicrobials or 
together with antimicrobials for prevention of diarrhea in weaned piglets. However, 
little is known about the mechanism of action of clinoptilolite. Some in vitro studies 
have shown that clay minerals induce bacterial mutation and promote genetic variability 
of bacteria, and clays protect DNA degradation by DNAase I. Moreover, several in vitro 
studies reported that clay minerals promote direct horizontal transfer of AMR genes in 
different bacterial species. These data suggest that clay minerals may modulate the 
prevalence of AMR and virulence genes of E.coli in the animal gut. In addition, clay 
minerals may effect on certain E. coli clones and plasmids. 
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Hypothesis 
Feed supplements influence the prevalence of virulence and antimicrobial 
resistance genes of E. coli in the intestine of pigs and could affect the fecal excretion of 
E. coli possessing these genes.  
 
Objectives 
The primary objective of this study was to study the temporal characterization of 
virulence genes and antimicrobial resistance in E. coli from pig fecal samples and the 
effect of a feed supplement. 
In particular, the specific objectives of this research are: 
 
1- To examine the dynamic of AMR phenotype, virulence and AMR gene profiles 
in E. coli isolates from pigs receiving a diet containing chlortetracycline and 
penicillin G at therapeutic doses following weaning on a commercial farm and to 
investigate the effect of simultaneous feeding of the clay mineral, clinoptilolite, 
on this dynamic. 
 
2- To elucidate the mechanisms leading to an increase of the prevalence of blaCMY-2 
conferring resistance to ceftiofur in a nursery barn in pigs with no ceftiofur use 
but which received a feed medicated with chlortetracycline and penicillin G, and 
to investigate the effect of feed supplementation with a clay mineral on this 
phenomenon. 
 
3- To study the temporal characterization of clinical ceftiofur-resistant E.coli 
isolates from diseased pigs in Quebec-Canada from 1997 to 2012. 
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Abstract 
The aim of this study was to examine changes in antimicrobial resistance (AMR) 
phenotype and virulence and AMR gene profiles in E. coli from pigs receiving in-feed 
antimicrobial medication following weaning and the effect of feed supplementation with 
a clay mineral, clinoptilolite, on this dynamic. Eighty E .coli strains isolated from fecal 
samples of pigs receiving a diet containing chlortetracycline and penicillin, with or 
without 2% clinoptilolite, were examined for antimicrobial resistance to 15 
antimicrobial agents. Overall, an increased resistance to 10 antimicrobials was observed 
with time. Supplementation with clinoptilolite was associated with an early increase but 
later decrease in blaCMY-2, in isolates, as shown by DNA probe. Concurrently, a later 
increase in the frequency of blaCMY-2 and the virulence genes iucD and tsh was observed 
in the control pig isolates, being significantly greater than in the supplemented pigs at 
day 28. Our results suggest that, in the long term, supplementation with clinoptilolite 
could decrease the prevalence of E. coli carrying certain antimicrobial resistance and 
virulence genes.   
 
 
 
 
 
 
 
 
 
Keywords: Pig; E. coli; virulence gene; antimicrobial resistance; clay mineral 
(clinoptilolite). 
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Introduction 
Antimicrobial use in animal production has been monitored over the past two 
decades because of potential adverse effects on animal and human health related to 
antimicrobial resistance. Administration of antimicrobials in animal production began 
early after their initial discovery, primarily for treatment of diseases, but also for 
promoting growth and for disease prevention. The latter is particularly important 
because animals are commonly housed at high densities that can facilitate the spread of 
disease. Nevertheless, there are disadvantages associated with antimicrobial use in 
animal production. For instance, administration of antimicrobials may select, or co-
select for the presence of AMR genes in the commensal or pathogenic bacterial 
populations in animals and lead to a breakdown in the treatment of associated diseases 
or transfer of resistance pathogenic bacteria to humans by contaminated meat. AMR 
genes may also be transferred to human pathogens and lead to problems in the treatment 
of disease in human patients (Johnston 2001, Wegener 2003). In light of these 
disadvantages, animal feeds maybe supplemented with other feed additives as 
alternatives for or a complement to, the use of antimicrobials. For example, the clay 
mineral clinoptilolite has been used in an attempt to improve performance and health but 
also as an alternative to the use of antimicrobials or together with antimicrobials for 
prevention of diarrhoea in weaned piglets (Papaioannou, Kyriakis et al. 2004). However, 
little is known of the mechanism of action of clinoptilolite. It has been demonstrated that 
clay minerals induce bacterial mutation and promote genetic variability of bacteria 
(Yoshida, Naka et al. 2004), chromosomal and plasmid DNA bound to clay minerals 
being more resistant to degradation by DNase I than free DNA (Romanowski, Lorenz et 
al. 1991). Some in vitro studies have shown that clay minerals promote direct horizontal 
transfer of AMR genes in different bacterial species (Lotareva and Prozorov 2000, 
Rodriguez-Beltran, Rodriguez-Rojas et al. 2013). These data suggest that clay minerals 
may modulate the prevalence of AMR and virulence genes of bacteria in the animal gut.  
In weaning pigs, antimicrobials are used in feed primarily as a medication to 
prevent disease and thus reduce mortality and morbidity (Cromwell 2002). Among the 
most frequently used in-feed antimicrobials are penicillin and tetracycline, often in 
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combination (Akwar, Poppe et al. 2008). Use of in-feed antimicrobials in pigs has been 
associated with increased resistance of fecal E. coli within and between classes of 
antimicrobials (Kim, Gray et al. 2005, Akwar, Poppe et al. 2008). The main objective of 
the present study was to examine the dynamic of AMR phenotype and virulence profiles 
in E.coli and AMR gene profiles in these isolates from pigs receiving a diet containing 
chlortetracycline and penicillin in therapeutic doses following weaning on a commercial 
farm and to investigate the effect of simultaneous feeding of the clay mineral, 
clinoptilolite, on this dynamic. 
 
Materials and methods 
 
Antimicrobial medication regime 
Pigs from a commercial crossbred genetic line were weaned at 21 days of age 
and transferred to pens in the nursery barn. Pigs received a standard commercial diet, 
three different rations (1, 2 and 3) being given continuously in feeders during the 28 
days of the trial. The feed contained the following antimicrobials: chlortetracycline 
(Aureomycin® 220 G) in therapeutic doses as prescribed for protection of respiratory 
problems and penicillin G (Pen-P 110) at a metaphylactic dose as prescribed to prevent 
Streptococcus suis infections. Antimicrobials were used in feed as follows: 
chlortetracycline (1100 g/ton) from day 0 to day 7; chlortetracycline (660 g/ton), 
penicillin G (198.6 g/ton) and IVOMEC from day 8 to day 14; and chlortetracycline 
(660 g/ton) and penicillin G (198.6 g/ton) from day 15 to day 28. On days 3 and 5 after 
weaning, all pigs received a circovirus (Circumvent® PCV) and mycoplasma (Myco 
Silencer® Once) vaccine, respectively. 
 
Trial design, collection and preparation of samples 
This study was conducted on 168 pigs. At day 0 (first day of placement in the 
nursery), the pigs were randomly divided into 2 groups: control (C) and supplemented 
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(S). Feeding and housing conditions were identical for the two groups, except for the 
addition of 2% clinoptilolite to the feed of the supplemented group. The control group 
received a standard commercial feed (basal diet) and the supplemented group received 
the basal commercial diet with 2% clinoptilolite. Both groups were housed in the same 
room, each group allocated into 3 different pens, 28 pigs being placed in each pen, so 
that the average pen weights were similar. 
Twelve pigs were tagged in each group to permit individual follow-up. Samples 
were collected at days 0, 2, 7, 14, and 28 after weaning, either directly from the rectum 
of the tagged pigs using a cotton swab or by pooling faeces from five sites on the floor 
of the pens as described by the Canadian Integrated Program for Antimicrobial 
Resistance Surveillance (CIPARS) (CIPARS 2008). On each sampling day, 8 samples 
were collected per group and were shipped on ice to the laboratory for further analysis. 
The method used for sample preparation was a modification of the CIPARS protocol 
(CIPARS 2008). Briefly, floor fecal samples were diluted to 1/10 (weight-for-weight) in 
buffered peptone water and 200 µl of diluted fecal samples and rectal swabs were 
inoculated into 5 ml Luria Bertani broth (LB – Difco, USA) and incubated overnight at 
37°C. DNA templates were prepared from the processed samples by boiled cell lysis for 
examination by PCR, as described previously by Maluta et al. (Maluta, Fairbrother et al. 
2014). 
Processed fecal samples (a total of 80 samples consisting of 60 floor samples and 
20 rectal samples) were serially diluted in peptone water to 10-5, from which a last 
dilution was made in peptone water containing 1% tween 80 to obtain a 10-7 diluted 
subsample (approximately 102 CFU/ml) (Sharpe and Peterkin 1988). A volume of 2 ml 
of this final dilution was filtered through a hydrophobic grid membrane filter (HGMF) 
using a Spreadfilter (Filtaflex, Almonte, Ontario, Canada). Filters were placed onto 
MacConkey agar plates and incubated overnight at 37°C to obtain HGMF master filters 
bearing predominantly E. coli lactose-positive colonies. 
 
Bacterial isolation and identification 
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A total of 80 presumptive E.coli isolates were randomly selected from HGMF 
master filters to represent the different sampling days (except for day 2) and the two 
groups (n=40 for each of the groups supplemented or not with clinoptilolite). Isolates 
were identified as E. coli by biochemical tests (Simmons Citrate Agar, mobility and 
indole) and by PCR for the presence of uidA E.coli housekeeping gene, which encodes 
Beta-glucuronidase (Table 1 in the supplemental material). 
 
Antimicrobial susceptibility testing  
The selected E. coli strains (n=80) were examined for susceptibility to the same 
15 antimicrobial agents examined in the CIPARS surveillance program in Canada 
(CIPARS 2008) using the disk-diffusion (Kirby-Bauer) assay. Bacterial strains grown 
overnight on blood agar were mixed in tubes containing 10 ml of sterile water to reach a 
turbidity of 0.5 McFarland Standard. The contents of the tubes were placed onto 
Mueller-Hinton agar plates using a sterile swab. The plates were incubated at 37°C for 
24 h, and the diameters of the zones of complete inhibition were measured. The strains 
were recorded as susceptible, intermediate, or resistant according to the zone diameter 
interpretative standards recommended by Clinical and Laboratory Standards Institute 
(CLSI) in 2010 (CLSI 2010) for most of the antimicrobials and in 2008 for ceftiofur 
(CLSI 2008). The following antimicrobial disks were used; amikacin (30µg), kanamycin 
(30µg), gentamicin (10µg), streptomycin (10µg), ceftriaxone (30µg), ceftiofur (30µg), 
cefoxitin (30µg), ciprofloxacin (5µg), nalidixic acid (30µg), trimethoprim-
sulfamethoxazole (23.75µg), sulfisoxazole (250µg), ampicillin (10µg), 
amoxicillin/Clavulanic acid (30µg), chloramphenicol (30µg), and tetracycline (30µg). 
 
PCR for determination of virulence and AMR genes 
Boiled cell lysates from the samples and the 80 selected E. coli strains were 
tested by multiplex PCR to determine the presence of the virulence genes which define 
the E. coli pathotypes commonly found in animals: Enterotoxigenic E. coli (eltB, estA, 
estB), Enteropathogenic E. coli (eae), Shiga toxin-producing E. coli (stxA, stx2A) and 
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Extraintestinal pathogenic E. coli (cnf, papC, iucD, and tsh). PCR procedures for 
detection of these genes were performed according to the protocol of the Reference 
Laboratory for Escherichia coli (EcL- Faculté de Médecine Vétérinaire de L'Université 
de Montréal) available in the animal pathogenic zoonotic Escherichia coli website 
(http://apzec.ca/en/Protocols). The presence of the AMR genes blaTEM, blaCMY-2, tetA, 
and aadA1 was determined by PCR using primers and conditions as shown in Table 1 in 
the supplemental material. 
 
Phylogenetic analysis 
Phylogenetic grouping was carried out for the 80 selected E. coli strains using a 
multiplex PCR-based assay as described by Clermont et al. (Clermont, Bonacorsi et al. 
2000). Based on the presence or absence of two genes (chuA and yjaA) and an 
anonymous DNA fragment (TSPE4.C2), strains were classified into four main E.coli 
phylogenetic groups (A, B1, B2, or D). 
 
Detection of AMR and virulence genes in an extended collection of E. coli isolates  
A HGMF Interpreter (Filtaflex, Almonte, Ontario, Canada) was used to count 
presumptive E. coli colonies on HGMF master filters, which were then replicated using 
a HGMF Replicator (Filtaflex, Almonte, Ontario, Canada), placed onto MacConkey 
agar plates, and incubated overnight at 37°C to obtain HGMF replicates. The positive 
and negative control strains used in the hybridization process were also filtered and 
replicated as described above. To generate DNA hybridization probes to detect each of 
the virulence or antimicrobial resistance genes, templates were prepared from overnight 
LB cultures of the appropriate control strains. Digoxigenin (DIG) alkaline phosphatase 
labelled probes were generated by using the specific primers (Table 1 in the 
supplemental material and (http://apzec.ca/en/Protocols) and a PCR DIG Probe 
Synthesis Kit (Roche Diagnostics) following instructions. The bacterial colonies on the 
HGMF replicates were pre-treated as described by Todd et al. (Todd, Szabo et al. 1999). 
Briefly, the HGMFs were incubated in pre-treatment solution (45 ml of 10 mM Na2PO4 
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[pH 6.0] [1.42 g/liter], 9 ml of 1 M NaHCO3, 135 ml of Lugalvan G35 detergent), then 
in 3 ml of lysis solution (150 mM NaOH in 70% ethanol) at 37°C for 30 min. HGMFs 
were then heated in a microwave oven for 30s, and gently shaken for 60 min at 37°C in 
0.01% proteinase K solution [Sigma Chemical Co., St. Louis, Mo.] in 2X SSC [1X SSC 
is 0.15 M sodium chloride plus 0.15 M sodium citrate] supplemented with 0.1% sodium 
dodecyl sulfate [SDS]). 
The DNA was cross-linked to the HGMFs by exposure to UV light. HGMFs 
containing cross-linked DNA were hybridized with DIG-labeled probes for the detection 
of the appropriate virulence or antimicrobial resistance genes. The procedure was 
carried out at 68°C using 20 ng /ml of denatured specific probe in hybridization solution 
(100 mg of herring sperm DNA [Sigma] per ml in 6X SSC supplemented with 0.5% 
SDS). 
DIG-labeled DNA probes were detected, after hybridization to target nucleic 
acids, by enzyme-linked immunoassay using an antibody-conjugate (anti-digoxigenin 
alkaline phosphatase conjugate, anti-DIG-AP) according to the instructions for the DIG 
Nucleic Acid Detection Kit (Roche Diagnostics). The presence of specific genes was 
revealed colorimetrically with the alkaline phosphatase substrate, 5-bromo-chloro-3-
indolyl phosphate (BCIP), and nitroblue tetrazolium salt (NBT). A total of 7232 
presumptive E.coli isolates were examined for the presence of selected genes. 
 
Statistical analysis 
Statistical analysis was carried out using SAS v.9.3 and JMPv.7 (SAS Institute, 
Cary, NC, USA). The Chi-square test (95% confidence intervals) was used to compare 
the effect of feed ingredient and time on the prevalence of AMR (genotypic and 
phenotypic) and virulence genes. Fisher’s exact test was also used to examine the 
differences among groups constrained across days. Odds ratios (OR) (95% confidence 
intervals) based on HGMF results calculated with SAS were used to evaluate the 
associations between genes. For each comparison, a P value of <0.05 was considered to 
denote significant differences. 
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Results 
 
Evolution of antimicrobial resistance in fecally shed E. coli from healthy pigs after 
weaning 
Overall, the most frequently observed resistance in the randomly selected E.coli 
strains (n=40 for each of the groups supplemented or not with clinoptilolite) was to 
tetracycline (92.5%), ampicillin (83.7%), sulfisoxazole (80%), trimethoprim-
sulfamethoxazole (77.5%), streptomycin (77.5%), amoxicillin/clavulanic acid (65%), 
chloramphenicol (40%), kanamycin (22.5%), ceftriaxone (20%), ceftiofur (20%) and 
cefoxitin (20%), gentamicin (18.75%)  (data not shown). Furthermore, thirty-three AMR 
patterns were distinguished among E.coli strains and only 3 strains (3.75%) were 
susceptible to all antimicrobials tested, whereas 70 (87.5%) were classified as multi-
drug resistant (MDR) as described by Magiorakos et al., a strain being MDR if it is non-
susceptible to at least 1 antimicrobial agent in 3 or more antimicrobial defined 
categories (Magiorakos, Srinivasan et al. 2012) (Table 1). 
At weaning, resistance to streptomycin, trimethoprim-sulfamethoxazole, 
sulfisoxazole, ampicillin, amoxicillin/clavulanic acid, chloramphenicol, and tetracycline 
was observed in up to 60% of the strains (Fig. 1). The resistance prevalence increased 
significantly from day 0 to day 7 for most of these antimicrobials, remaining high until 
the end of the study or decreasing slightly in the case of streptomycin, sulfisoxazole, and 
trimethoprim-sulfamethoxazole. On the other hand, resistance remained low for 
kanamycin, gentamicin, ciprofloxacin and nalidixic acid (Fig. 1). All strains were 
susceptible to amikacin. No significant difference was observed between control and 
supplemented groups for any of the antimicrobials (supplementary Fig. 1). In contrast, 
no strains resistant to ceftiofur, ceftriaxone, or cefoxitin were observed at weaning, and 
the prevalence of resistance to these antimicrobials increased from 7 days after weaning, 
the increase being significant at day 28. Interestingly, the resistance to these 
cephalosporins was only observed in the supplemented pigs at days 7 and 14, being 
significantly different to the control group (P<0.05) (Fig. 2). On the other hand, in the 
control group, resistance to these cephalosporins was only observed at day 28, the 
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prevalence being similar to that observed in the supplemented group. One AMR pattern 
was predominant in extended-spectrum cephalosporin (ESC)-resistant E.coli strains in 
both groups, with co-resistance to streptomycin, cefoxitin, trimethoprim-
sulfamethoxazole, sulfisoxazole, amoxicillin/clavulanic acid, ampicillin, 
chloramphenicol, and tetracycline. Nevertheless, five AMR patterns were observed in 
ESC-resistant E. coli strains, all being classified as MDR, all being non-susceptible to at 
least 1 agent in 5 or more antimicrobial categories (Table 1). 
 
Presence of blaCMY-2 gene in fecal samples 
Since AMR gene blaCMY-2 is a candidate for conferring resistance to clinically 
important cephalosporins such as ceftriaxone, ceftiofur and cefoxitin, DNA templates 
from the processed fecal samples from the weaned pigs were examined by PCR for the 
presence of this gene. The proportion of samples positive for the blaCMY-2 gene in the 
supplemented group rapidly increased from day 2, reaching 100% at days 7 and 14, and 
decreasing at day 28 (Fig. 3). In contrast, no samples positive for blaCMY-2 were 
observed in the control group until day 14, a gradual increase in the proportion of 
positive samples being observed at day 28. The proportion of positive samples was 
significantly higher in the supplemented group than in the control group at days 2, 7, 
and 14 (P<0.05); furthermore, as an increase in frequency of resistance to 
amoxicillin/clavulanic acid, ampicillin, tetracycline and streptomycin was observed with 
time in the randomly selected E. coli strains, fecal samples were examined by PCR for 
the presence of the AMR genes: blaTEM, aadA and tetA. Results revealed an overall high 
prevalence of these genes in samples that was not affected by either the supplementation 
or time (data not shown). 
 
Distribution of E. coli virulence genes in fecal samples 
DNA templates from the processed fecal samples from post weaning pigs were 
tested by multiplex PCR for the presence of virulence genes defining the E. coli 
pathotypes commonly found in animals (http://apzec.ca/en/Protocols). Overall, the 
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proportion of samples positive for the ExPEC virulence genes iucD, tsh and papC was 
high, greater than 90% for all groups, no significant differences being observed with 
respect to the supplementation or the time after weaning. The proportion of samples 
positive for eae increased with time after weaning, from 37% to 75%, no significant 
differences being observed with respect to the supplementation. The proportion of 
samples positive for estB varied considerably between groups whereas cnf was rarely 
detected. In contrast, estA , eltB, StxA, and Stx2A were not detected in any sample (data 
not shown). 
 
Prevalence of blaCMY-2 and ExPEC genes iucD, tsh, papC, and cnf in E. coli  
To further investigate the effect of time after weaning and supplementation with 
clinoptilolite on the presence of blaCMY-2 and the ExPEC virulence genes in fecally shed 
E. coli, we initially examined the 80 randomly selected E.coli strains previously 
examined for antimicrobial susceptibility. As observed for resistance to ceftiofur, 
ceftriaxone, and cefoxitin, frequency of the blaCMY-2 gene was significantly higher in the 
supplemented group than the control group at days 7 and 14 after weaning (P<0.05) 
(Table 2), correlation between the cephalosporin resistance and presence of blaCMY-2 
being 100%. In addition, the frequencies of ExPEC virulence genes iucD and tsh were 
higher in the control group than the supplemented group at day 28.  
In order to confirm these trends and to further investigate the relation between 
the presence of blaCMY-2, iucD, and tsh in isolates, we examined a more extensive 
collection of 7232 presumptive E.coli isolates obtained from the fecal samples by 
HGMF, using DNA probe colony hybridization. In the supplemented group, the 
proportion of isolates with the blaCMY-2 gene increased at day 7, being significantly 
higher (P<0.05) than in the control group, and thereafter decreased. On the other hand, 
in the control group, the proportion of isolates with the blaCMY-2 gene increased later, at 
day 14, being significantly greater (P<0.05) than in the supplemented group at both days 
14 and 28 after weaning. In addition, an increase in the proportion of isolates positive 
for iucD or tsh was also observed on days 14 and 28 for the control group but not the 
supplemented group, being significantly greater (P<0.05) than in the supplemented 
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group at day 28 after weaning. Most of the isolates possessed only one of the genes 
iucD, tsh, and blaCMY-2, although about one third of the blaCMY-2-positive isolates from 
the control group at days 14 and 28 also possessed iucD or tsh, or both of these genes 
(Table 3). Odds ratio using the data of HGMF DNA probe hybridization confirmed the 
positive association between the blaCMY-2 and iucD genes [OR (95%CI) =3.75 (2.67-
5.27)], blaCMY-2 and tsh genes [OR (95%CI) =3.95 (2.63-5.93)] and iucD and tsh genes 
[OR (95%CI) =5.05 (3.22-7.91)]. 
 
Distribution of blaCMY-2 -positive E. coli among phylogenetic groups 
In order to gain some insight into whether the effect of clinoptilolite on blaCMY-2-
positive isolates may be clonal, we determined the phylogenetic group of each of the 
blaCMY-2-positive strains among the 80 randomly selected E. coli strains previously 
examined for antimicrobial susceptibility. In the supplemented group, all blaCMY-2-
positive E. coli strains belonged to phylotype A at days 7 (n= 4) and 14 (n=3) after 
weaning and 3 out of 4 blaCMY-2-positive E. coli strains belonged to phylotype A at day 
28 . On the other hand, in the control group, blaCMY-2-positive E. coli strains, found only 
at day 28 (n=5), belonged to phylotypes B1 (n= 3), D (n=1) and A (n=1 ) which 
indicates they belong to different clones than the blaCMY-2-positive E. coli strains of the 
supplemented group (Fig. 4). 
 
Discussion 
Emergence of multidrug resistance in bacteria is one of the most important 
problems in animal and human medicine. In the present study an increased in frequency 
of resistance to streptomycin, ceftriaxone, ceftiofur, cefoxitin, trimethoprim-
sulfamethoxazole, sulfisoxazole, ampicillin, amoxicillin/clavulanic acid, 
chloramphenicol, and tetracycline in E. coli strains from pigs with time could be a result 
of continuous administration of chlortetracycline and penicillin G in the feed. These 
results are in good agreement with the data of Akwar et al. (2008) and Kim et al. (2005), 
who showed that use of antimicrobials in feed in pigs, may exert a selection pressure 
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resulting in increased resistance of fecal E. coli within and between classes of 
antimicrobials (Kim, Gray et al. 2005, Akwar, Poppe et al. 2008). Indeed, Looft et al. 
(2012) found that use of chlortetracycline, penicillin, and sulfamethazine (known as 
ASP250) may increase the prevalence of resistance genes not only for the used 
antimicrobial but also for antimicrobials of other classes that were not administered, 
likely due to co-selection. For instance, they found an increased frequency of the 
following genes associated with feeding of ASP250: the aph(3”)-Ib,aph(6’)-Ic gene 
conferring resistance to streptomycin, the ImrA gene related to lincomycin resistance; 
the emrD, mdfA, mdtH, bcr multi-drug resistance efflux pump genes conferring 
resistance to chloramphenicol, tetracycline, deoxycholate, fosfomycin, florfenicol, and 
sulfathiazole; and the acrAmulti-drug resistance efflux pump gene responsible for 
resistance to many antimicrobial classes including phenicols, aminoglycosides, 
macrolides, and β-lactams (Looft, Johnson et al. 2012). Funk et al. (2006),  in a 
phenotypic resistance study, also found that inclusion of chlortetracycline in the pig diet 
has an effect on resistance to multiple antimicrobials, including ampicillin, ceftriaxone 
and tetracycline, in the gram negative fecal flora of swine (Funk, Lejeune et al. 2006). 
Interestingly, in our study, whereas prevalence of resistance to antimicrobials in the 
same classes as the medicated feed, such as tetracycline and ampicillin, increased and 
remained high throughout the study, during which time pigs continued to be medicated, 
prevalence of resistance to antimicrobials of other classes, such as streptomycin, 
trimethoprim-sulfamethoxazole and sulfisoxazole,  initially increased and then 
decreased with time. An exception was chloramphenicol, for which prevalence of 
resistance increased and remained high until the end of the study. 
  Identification of risk factors for development of AMR in food animals is 
complex, as it has been established that antimicrobial administration and selection or co-
selection pressure may not be the only factors increasing AMR with time in farm 
conditions. Hence, other mechanisms such as vertical transmission of resistant E. coli, 
horizontal gene transfer between bacteria, adaptation, and maintenance of some sets of 
resistant strains could also have been responsible for the development of AMR with 
time on the studied farm (Blahna, Zalewski et al. 2006, Nilsson, Borjesson et al. 2014, 
Mazurek, Bok et al. 2015). On the other hand, in agreement with a previous study on a 
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cattle farm, in the present study the pigs in the control and supplemented groups were 
housed separately from each other, with no contact between pigs in the different groups. 
Nevertheless, animal to animal (some nose to nose and body contact) resistant strain 
transmission within each group could be a possible factor to increase AMR with time 
(Sharma, Munns et al. 2008). In addition, it has been reported that E. coli originating 
from fecal material, and contaminated food or water may be considered a possible 
source in cattle and that the feedlot environment is a critical source of new strains 
(Hoyle, Yates et al. 2005). Hence, it is possible that the farm conditions could play an 
important role in resistance dissemination over time in the present study. 
It is interesting to note in our study that resistance to all antimicrobials except the 
cephalosporins and ciprofloxacin was present in pigs at weaning, before they received 
the medicated feed. The latter antimicrobials are not used in pigs in Canada, with the 
exception of injectable ceftiofur (CIPARS 2008). Although the number of tested strains 
for antimicrobial susceptibility was relatively low, the finding of resistance to ceftiofur, 
which was first observed at day 7 and continued to increase in prevalence through to day 
28, was unexpected, as ceftiofur was not used in this batch of pigs. We confirmed a 
positive association between ceftiofur-resistance and the presence of blaCMY-2 gene in 
E.coli isolated from healthy pigs. This is in accordance with previous investigations on 
the prevalence of blaCMY-2-positive isolates in different animal species (Diarra, 
Silversides et al. 2007, Mataseje, Baudry et al. 2010). It is possible that the use of 
ceftiofur in previous batches of pigs, along with inadequate pen sanitation, allowed the 
blaCMY-2 genes to persist in the environment. Indeed, we recovered blaCMY-2-positive 
isolates from the pens before introduction of the pigs of this batch (results not shown). 
In addition, the resistance to ceftiofur in the piglets could also be associated with the 
microflora of the sows and the fact that resistance to ceftiofur was not observed before 
day 7 might be due to the low level of this phenotype in piglets initially and effect of 
selection pressure over time. The usage of chlortetracycline may have resulted in 
subsequent expansion of the blaCMY-2 gene. For instance, in a recent 26 day 
metagenomic study in cattle, administration of chlortetracycline led to exacerbation of 
the number of blaCMY-2 gene copies/gram of feces following ceftiofur therapy (Kanwar, 
Scott et al. 2014). Moreover, in our study, resistance to chloramphenicol increased up to 
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50%, even though this antimicrobial has not been used in pig production in Canada 
since the 1980s and florfenicol was not used in this batch. This is in agreement with 
Harada et al (2006), who showed that co-selection with other approved antimicrobials in 
pig production is a possibility for persistence of chloramphenicol resistant E. coli 
(Harada, Asai et al. 2006). Diarra et al. (2007) showed that, in the absence of 
antimicrobial selection pressure, certain resistance genes can be conserved due to a link 
with the genes encoding resistance to other antimicrobials that are registered for use in 
animal production (Diarra, Silversides et al. 2007). In our study, almost all ESC-
resistant E.coli strains were co-resistant to streptomycin, trimethoprim-
sulfamethoxazole, sulfisoxazole, amoxicillin/clavulanic acid, ampicillin, 
chloramphenicol, and tetracycline. The association on the same plasmid of the blaCMY-2 
gene and genes conferring resistance to other antimicrobials, such as aminoglycosides, 
sulphonamides, phenicols and tetracyclines has been described by Doublet (Doublet, 
Carattoli et al. 2004), and co-transmission of resistance to non-β-lactam antimicrobials 
is often associated with CMY-2 (Blanc, Cortes et al. 2008). 
The present investigation is, to our knowledge, the first to provide insights 
regarding the effect of a clay mineral, clinoptilolite, as a feed ingredient, on the level of 
fecal excretion of ESC-resistant E. coli in vivo in pigs in farm conditions. We have 
demonstrated that feeding of clinoptilolite was associated with an early temporary 
increase in the proportion of fecally excreted E. coli carrying the gene responsible for 
ESC-resistance, blaCMY-2. On the other hand, a delayed increase in the proportion of 
fecally excreted E. coli carrying blaCMY-2, or one of the virulence genes iucD and tsh, 
was observed in pigs which did not receive clinoptilolite in the feed, the proportion of 
these isolates being significantly higher than in the group having received clinoptilolite. 
The initial temporary increase in frequency of isolates carrying blaCMY-2 in the 
supplemented group is compatible with data from Rodriguez-Beltran et al. (2013)  who 
reported that clay minerals (e.g. sepiolite) promote direct horizontal gene transfer (HGT) 
between bacterial species in in vitro conditions, which may be exacerbated by the use of 
antimicrobials as growth promoters. In addition, these authors showed that the 
promotion of HGT was due to plasmid transfer in certain conditions such as presence of 
septiolite (final concentration of 100 µg/ml) and increased friction forces, the latter of 
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which may have been provided by peristalsis in the intestine of the pigs receiving 
continuously clay mineral as a food additive (Rodriguez-Beltran, Rodriguez-Rojas et al. 
2013). On the other hand, the subsequent significant decrease in the frequency of 
isolates carrying blaCMY-2, gene, and the lack of increase in the frequency of isolates 
carrying the plasmid-encoded virulence genes iucD and tsh in the supplemented group 
could be related to accumulation of clinoptilolite in the gastrointestinal tract of pigs over 
time after weaning which may lead to a decline in the HGT. For instance, previous in 
vitro studies demonstrated that higher concentrations of clay minerals result in a 
decrease in the number of transformed cells, in other words, a reduction in HGT 
(Richaume, Angle et al. 1989, Lotareva and Prozorov 2000). Alternatively, the later 
decrease in frequency of isolates carrying blaCMY-2 observed in the supplemented group 
could be due to a direct or indirect antimicrobial effect of clinoptilolite or an interaction 
between clinoptilolite and chlortetracycline or penicillin G. The ability of clay minerals 
to reduce the number of pathogenic bacteria has been reported in vivo and in vitro 
(Haydel, Remenih et al. 2008, Vondruskova, Slamova et al. 2010). Likewise, Wu et al. 
(2013) found that the total number of Lactobacillus acidophilus bacteria was 
significantly increased from days 22 to 42 in broiler chickens fed with clinoptilolite and 
also they showed that small intestinal and cecal PH values in the treatment group were 
significantly lower than those in the control group (Wu, Wang et al. 2013). Since 
probiotics containing L. acidophilus may inhibit growth of pathogenic bacteria by 
production of organic acids and antibiotic-like compounds (Lordelo, Marinho et al. 
2007, Vondruskova, Slamova et al. 2010), an increase in L. acidophilus numbers due to 
the presence of clinoptilolite in the current study may have led to the later decrease in 
the proportion of blaCMY-2, iucD, and tsh-positive isolates. Although the potential 
interaction of clay minerals and antimicrobials is controversial, nevertheless, a potential 
interaction between clinoptilolite and some antimicrobials has been demonstrated. For 
instance, in in vitro conditions, chlortetracycline, tylosin, and metronidazole can be 
absorbed strongly to clinoptilolite or other clay minerals. The interference is probably 
related to polarity of the antimicrobial molecules, since no interaction was confirmed 
with sulfamethoxazole and β-lactams, which are highly polar compounds (Papaioannou, 
Katsoulos et al. 2005, Allaire, Del Castillo et al. 2006). 
 77 
The finding that the phylotype of blaCMY-2-positive strains differed in the 
supplemented and control groups led us to speculate that the clinoptilolite 
supplementation may result in predominance of certain clones, that is, those of 
phylotype A. On the other hand, we observed a positive association between blaCMY-2 
and iucD, blaCMY-2 and tsh, and iucD and tsh. The association between the iucD and tsh 
genes has been described previously, both genes being present on the pAPEC-1 plasmid 
of E. coli O78:K80:H9 and on pAPEC-02-ColV plasmid (Mellata, Touchman et al. 
2009). Similarly, iucD and blaCMY-2were found on the same plasmid, pCVM29188_10, 
isolated from S. Kentucky and transferable to S. Kentucky, S. enteric serovar Newport, 
and E. coli (Fricke, McDermott et al. 2009). Taken together, our results indicate that 
clinoptilolite may also have a selection effect on specific plasmids. 
In conclusion, our results reveal an increased level of resistance, lasting at least 4 
weeks, to several antimicrobials in E. coli from pigs, both within and between classes 
with respect to antimicrobials used for medicated feeding of these pigs following 
weaning. Our results also show that feed supplementation with clinoptilolite decreases 
the proportion of fecally shed E. coli possessing certain virulence and antimicrobial 
resistance genes, at least in the first month after weaning. Since in farm conditions, 
various factors may contribute, further studies involving different farms and a longer 
time after weaning will be required to confirm our findings over the long term. Future 
experiments should also more thoroughly investigate the relative role of bacterial clones 
and plasmids in the circulation of blaCMY-2 gene in pigs and their environment over time 
after weaning, and the effect of feed supplementation with clinoptilolite on this 
circulation.  
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Tables and figures 
 
Table 1. Antimicrobial resistance patterns for 80 E. coli strains based on the number of 
antimicrobials to which each strain was resistant. 
No. of  
antimicrobials 
AMR patterna 
No. of strains with 
AMR pattern (%)  
  0  Susceptible  3 (3.75)  
  1  TET  3 (3.75)  
NAL  1(1.25)  
STR  1 (1.25)  
  2  STR, TET 1 (1.25)  
  3  SXT, FIS, TET 1 (1.25)  
AMP, CHL, TET 1 (1.25)  
AMP, AMC, TET 1 (1.25)  
  4  SXT, FIS, CHL, TET 1 (1.25)  
SXT, FIS, AMP, AMC 1 (1.25)  
SXT, FIS, AMP, TET  2 (2.5)  
AMP, AMC, CHL, TET 2 (2.5)  
STR, SXT, FIS, TET  1 (1.25)  
  5  KAN, STR, SXT, FIS, TET  1 (1.25)  
STR, SXT, FIS,AMP, TET  3 (3.75)  
KAN , FIS,AMP, AMC, TET  1 (1.25)  
STR, AMP, AMC, CHL, TET  2 (2.5)  
STR, FIS, AMP, AMC, TET 1 (1.25)  
  6  
   
STR, SXT, FIS, AMP, AMC, TET  7 (8.75)  
STR, SXT, FIS,AMP, CHL, TET  3 (3.75)  
GEN, STR, SXT, FIS,AMP, TET  2 (2.5)  
CRO,TIO, FOX,AMP, AMC, TETb 1 (1.25)  
  7  
   
   
   
   
KAN, STR, SXT, FIS,AMP, AMC, TET  2 (2.5)  
GEN, KAN, STR, SXT, FIS; AMP,TET 3 (3.75)  
STR, SXT, FIS, AMP, AMC, CHL, TET  9 (11.25)  
KAN, STR, SXT, FIS,AMP, CHL, TET  1 (1.25)  
GEN, STR, SXT, FIS, AMP, AMC, TET  1 (1.25)  
  8  GEN, KAN, STR, SXT, FIS, AMP, AMC, TET  7 (8.75)  
  9  
   
   
KAN, STR,CIP, NAL, SXT,FIS,AMP, CHL, TET 1  (1.25)  
GEN, KAN, STR,NAL, SXT,FIS,AMP, AMC, TET 1 (1.25)  
STR, CRO, TIO, FOX, SXT, FIS, AMP, AMC, TET b 1 (1.25)  
  10  STR, CRO, TIO, FOX, SXT, FIS, AMP, AMC, CHL, TET b 12 (15)  
  11  
   
STR, CRO,TIO, FOX,NAL, SXT, FIS,AMP, AMC, CHL, TETb 1 (1.25)  
GEN, KAN, STR, CRO,TIO, FOX, SXT, FIS,AMP, AMC, TETb 1 (1.25)  
Total 33  80 
aAbbreviations for antimicrobials are as follows: amikacin (AMK), kanamycin (KAN), 
gentamicin (GEN), streptomycin (STR), ceftriaxone (CRO), ceftiofur (TIO), cefoxitin 
(FOX), ciprofloxacin (CIP), nalidixicacid (NAL), trimethoprim-sulfamethoxazole 
(SXT), sulfisoxazole (FIS), ampicillin (AMP), amoxicillin/clavulanicacid (AMC), 
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chloramphenicol (CHL), tetracycline (TET). b Five AMR patterns in ESC-resistant E. 
coli strains. 
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Table 2. Recovery and distribution of E. coli positive strains for blaCMY-2 and ExPEC virulence genes in fecal samples from weaned 
pigs as detected by PCR. 
Day of 
samplinga 
Groupb 
No. of tested 
strainsc 
 No. of positive strains for AMR and virulence genes (%)  
bla
CMY-2
d iucDe tshe papCe cnfe 
Day 0  
C 10  0  1(10)  1(10)  1(10)  1(10)  
S 10  0  1(10)  0  0  1(10)  
Day 7  
C 10  0  3(30)  0  1(10)  0  
S 10  4(40)*  1(10)  0  0  1(10)  
Day 14  
C 10  0  0  0  0  0  
S 10  3(30)*  0  0  0  0  
Day 28  
C 10  5(50)  3(30)  3(30)  1(10)  1(10)  
S 10  4(40)  1(10)  1(10)  0  0  
Total  80  16(20)  10(12.5)  5(6.25)  3(3.75)  4(5)  
a Sampling days after starting supplement with clinoptilolite 
b Animals receiving feed supplemented (S) or not (C) with clinoptilolite 
c Number of strains tested by PCR 
d Antimicrobial resistance gene (conferring resistance to β-lactam antibiotics) 
e ExPEC, extraintestinal pathogenic E. coli, opportunistic agent that may cause extraintestinal infections. 
*Value is significantly different to that of the supplemented or control group on the same day using the Fisher’s exact test (P<0.05). 
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Table 3. Prevalence of iucD, tsh and blaCMY-2 genes in fecal isolates from weaned pigs receiving or not clinoptilolite in the feed, as 
detected by the HGMF method 
Day of 
samplinga 
Groupb 
No. of tested 
isolates c 
No. of isolates positive for antimicrobial and virulence gene combinations (%)  
bla
CMY-2
d iucDe tshe blaCMY-2:iucD blaCMY-2:tsh blaCMY-2:iucD:tsh iucD:tsh 
Day0 
C  477  0 4(0.8)  2(0.4)  0 0 0 0 
S 403  0 14(3.5)  6(1.5)  0 0 0 1(0.2)  
Day2 
C  817  24(2.9)  0 4(0.5)  0 1(0.1)  0 0 
S 819  14(1.7)  4(0.5)  11(1.3)  0 0 0 0 
Day7 
C  774  18(2.3)  26(3.4)  3(0.4)  2(0.3)  0 0 0 
S 790  122(15.4)* 16(2)  10(1.3)  1(0.1)  1(0.1)  0 0 
Day14 
C  737  50(6.8)* 47(6.4)  31(4.2)  8(1.1)  11(1.5)  3(0.4)  15(2)  
S 787  33(4.2)  35(4.4)  29(3.7)  5(0.6)  0 2(0.3)  0 
Day28 
C  627  38(6.1)*  36(5.7)* 19(3)*  12(1.9)  7(1.1)  3(0.5)  0 
S 1001  33(3.3)  16(1.6)  2(0.2)  8(0.8)  1(0.09)  0 0 
Total 7232 343 198 117 36 21 8 16 
a Sampling days after starting supplement with clinoptilolite 
b Animals receiving feed supplemented (S) or not (C) with clinoptilolite 
c Number of tested isolates by HGMF DNA probe hybridization. 
d Antimicrobial resistance gene (conferring resistance to β-lactam antibiotics) 
e ExPEC, Extraintestinal pathogenic E. coli, opportunistic agent that may cause extraintestinal infections 
* Value is significantly different to that of the supplemented or control group on the same day using the Chi-Square test (P<0.05). 
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Supplementary Table 1. List of primers used in the PCR and HGMF DNA probe hybridization, PCR conditions, and control strains. 
Product or 
antimicrobial 
Gene Primera 
Amplicon 
size (bp) 
Annealing 
temperature  
Control 
strain 
Reference 
β- glucuronidase uidA 
for5’GCGTCTGTTGACTGGCAGGTGGTGG  
rev5’GTTGCCCGCTTCGAAACCAATGCCT 
530 65°C  ECL3482 (Walk et al., 2009) 
Tetracycline tetA 
for 5’GTGAAACCCAACATACCCC 
rev5’GAAGGCAAGCAGGATGTAG 
888 55°C ECL3482 
(Maynard et al., 
2003) 
Ampicillin blaTEM 
for 5’GAGTATTCAACATTTTCGT  
rev 5’ACCAATGCTTAATCAGTGA 
857 50°C ECL3482 
(Maynard et al., 
2003) 
Ceftiofur blaCMY-2 
for 5’GACAGCCTCTTTCTCCACA  
rev 5’TGGAACGAAGGCTACGTA 
1000 50°C  ECL3482 (Zhao et al., 2001) 
Streptomycin 
Spectinomycin 
aadA1 
for 5’CATCATGAGGGAAGCGGTG  
rev5’GACTACCTTGGTGATCTCG 
786 50°C  ECL3482 (Gow et al., 2008) 
a The other primers used in the PCR and HGMF technique are available at http://apzec.ca/en/Protocols
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Figure 1. Effect of time on resistance profiles of 80 E. coli strains from weaned pigs. The percentage of resistance to most 
antimicrobials increased over time.  
Asterisks indicate antimicrobials for which there is a significant association between days and frequency of resistance using the 
Chi-Square test (P<0.05).
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Figure 2. Effect of dietary supplementation with clinoptilolite on the frequency of 
ceftiofur, ceftriaxone and cefoxitin in 80 E. coli strains isolated from weaned pigs over 
time.  
Asterisks indicate antimicrobials for which there is a significant association between group 
and frequency of resistance on each day of sampling using the Fisher’s exact test (P<0.05). 
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Figure 3. Trends in the presence of blaCMY-2 gene in 80 fecal samples from weaned pigs 
over time, as detected by PCR.  
Asterisks indicate days on which the frequency of the blaCMY-2 gene was significantly 
higher in the supplemented group than in the control group using the Chi-Square test 
(P<0.05). 
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Figure 4. Association between presence of blaCMY-2 and phylogenetic grouping in 80 E. 
coli strains isolated from weaned pigs overtime. 
Animals receiving (S) or not (C) clinoptilolite 
a Number of blaCMY-2-positive strains 
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Supplementary Figure. 1. Effect of dietary supplementation of clinoptilolite on the frequency of AMR in 80 E. coli strains from 
weaned pigs. 
 No significant difference was observed between the control and supplemented groups for any of the antimicrobials. Resistance to 
ceftriaxone, ceftiofur and cefoxitin was two times greater in the supplemented group than in the control group; however the 
difference was not statistically significant (Chi-square test, P=0.09). 
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Abstract 
 Aims: To investigate the mechanisms leading to an increase in the prevalence of 
blaCMY-2 conferring resistance to ceftiofur in pigs receiving a feed medicated with 
chlortetracycline and penicillin and to examine the effect of supplementation with a clay 
mineral on this phenomenon. 
Methods and Results: In 138 blaCMY-2-positive E. coli isolates from feces of pigs 
receiving feed supplemented or not with 2% clinoptilolite, from day 2 to day 28 after 
weaning, isolates from the two groups differed significantly with respect to their 
phylogenetic group: phylotype A predominated in the supplemented group whereas 
phylotypes B1 and D predominated in the control group, as determined by PCR. In 36 
representative isolates, pulsed-field gel electrophoresis and antimicrobial susceptibility 
testing revealed that the blaCMY-2-positive E.coli isolates were polyclonal with diverse 
antimicrobial resistance patterns and blaCMY-2-carrying plasmids of incompatibility (Inc) 
groups, I1, A/C and ColE were observed in transformants as detected by PCR. 
Enterobacter cloacae possessing blaCMY-2-carrying IncA/C plasmids were found in the 
pens before introduction of this batch of pigs. The blaCMY-2 -positive E. coli isolates were 
more clonally diverse in the control group than the supplemented group. 
Conclusions: The blaCMY-2 gene appears to have spread both horizontally and clonally in 
this batch of pigs and may have spread from previous batches of pigs via plasmids carried 
by E. cloacae and expanded in animals of the present batch in the presence of the selection 
pressure due to administration of chlortetracycline and penicillin in the feed. Feed 
supplementation may have an effect on clonal diversity of blaCMY-2 -positive isolates. 
Significance and Impact of Study: Implementation of improved hygiene measures, 
decreased administration of certain antimicrobials on farm, and feed supplementation with 
certain ingredients may limit antimicrobial resistance spread between and within batches of 
animals. 
Keywords: Pigs, E.coli, blaCMY-2-positive plasmid, antimicrobial resistance, clay mineral 
(clinoptilolite) 
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Introduction 
The emergence of Escherichia coli resistant to extended-spectrum cephalosporins 
(ESCs) is of great concern because third generation cephalosporins such as ceftriaxone and 
ceftiofur are clinically important β-lactam antimicrobials in human and animal medicine. 
Plasmid-mediated AmpC beta-lactamases, including CMY-2, confer resistance to 
cephalosporins, the latter being encoded by the blaCMY-2 gene (Dunne et al. 2000; Martin et 
al. 2012). Antimicrobial use during animal production can result in the emergence of 
antimicrobial resistance (AMR) in bacteria which are shed into the environment where 
they may persist for long periods (Chantziaras et al. 2014). CMY-2-encoding genes are 
located commonly on transferable elements (integrons, transposons, insertion sequences) 
carried by plasmids that facilitate the horizontal spread of resistance and most AmpC beta-
lactamase producing strains may carry resistance genes for other antimicrobials. Hence, 
certain resistance genes can be conserved due to a link with the genes encoding resistance 
to antimicrobials that are registered for use in animal production (Dunne et al. 2000; Allen 
and Poppe 2002; Funk et al. 2006; Singer and Hofacre 2006). Although the E.coli 
phylotypes are often different between isolates from humans and animals (Johnson et al. 
2008), common replicon types of plasmids encoding beta-lactamase genes were observed 
in E. coli isolates from humans and food producing animals (Carattoli 2009). Moreover, 
IncA/C plasmids with fingerprint similarities of greater than 90% have been found to 
circulate in E. coli from human and animal sources (Mulvey et al. 2009). Furthermore, 
transmission of CMY-2 AmpC beta-lactamase plasmids between E. coli and Salmonella 
among humans and animals has been reported (Winokur et al. 2001). Plasmids bearing 
both virulence and resistance genes may also be spread in a pathogenic bacteria population 
and the virulence traits will be selected due to antimicrobial selective pressure (Martinez 
and Baquero 2002). Further research is needed to understand mechanisms contributing to 
the circulation and persistence of antimicrobial resistance determinants among both 
commensal and pathogenic enteric bacteria on-farm and worldwide. 
On one commercial farm, we observed the appearance of a high level of resistance 
to ESCs (e.g. ceftiofur, ceftriaxone) in E. coli in a batch of weaned pigs which were fed a 
diet containing chlortetracycline and penicillin G in therapeutic doses for protection of 
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respiratory problems and to prevent Streptococcus suis infections but which had not been 
treated with other antimicrobials, including ceftiofur. Supplementation of the feed of pigs 
in this batch with the clay mineral clinoptilolite decreased the proportion of E. coli 
possessing blaCMY-2, the gene responsible for ESC-resistance, excreted in the feces, at least 
in the first month after weaning (Jahanbakhsh et al. 2015). We hypothesized that both 
bacterial clones and plasmids were involved in the spread of blaCMY−2 gene in pigs and feed 
supplementation with clinoptilolite may have an effect on certain of these E. coli clones 
and plasmids. Thus, the main objective of the present study was to characterize the blaCMY-
2 isolates from this batch of pigs in order to elucidate the mechanisms leading to an 
increase in the prevalence of blaCMY-2 conferring resistance to ceftiofur in pigs which had 
not been treated with this antimicrobial and to investigate the effect of feed 
supplementation with a clay mineral on this phenomenon. 
 
Materials and methods 
 
E. coli isolation and identification 
In our previous on farm experiment, pigs from one batch in the nursery had been 
randomly divided into 2 groups following weaning: control (C) and supplemented (S). The 
control group received a standard commercial feed containing chlortetracycline and 
penicillin G and the supplemented group had received the same feed but also containing 
2% clinoptilolite. None of the pigs had been treated with other antimicrobials, including 
ceftiofur, during the experiment (Jahanbakhsh et al. 2015). Four hundred and eight blaCMY-
2-positive isolates, either alone (n=343) or in combination with iucD and tsh ExPEC-
associated virulence genes (n=65) had been detected in 7232 E. coli isolates examined by 
hydrophobic grid membrane filter (HGMF) method. For the present study, 138 of the 408 
blaCMY-2-positive isolates from the previous study were selected to represent sampling days 
and groups. Hence, 138 blaCMY-2-positive E. coli isolates (2 or 3 isolates per sample) were 
selected from the control (n=66) and supplemented (n=72) groups at days 2, 7, 14, and 28 
after weaning. No blaCMY-2-positive E. coli isolate had been detected at day 0. In addition, 
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101 blaCMY-2-negative E. coli isolates were recovered from the control (n=53) and 
supplemented (n=48) groups representing all sampling days (0, 2, 7, 14 and 28). Isolates 
were identified as E. coli by biochemical tests (Simmons Citrate Agar, mobility and 
indole) and by PCR for the presence of uidA E.coli housekeeping gene, which encodes 
beta-glucuronidase (Walk et al. 2009). However, E.coli phylotype D isolates were negative 
for uidA gene, and were thus confirmed by API 20E kit system (BioMerieux, Canada). In 
addition, uidA-negative isolates were further identified as E. coli by sequencing of the 
housekeeping gene adk, from the E. coli MLST scheme as described by Maheux et al. 
(Maheux et al. 2014). 
  
PCR for determination of blaCMY-2 and ExPEC-associated virulence genes 
A loop from the confluent growth or individual colonies on MacConkey agar plates 
were inoculated into 5 mL Luria Bertani (LB – Difco, USA) broth and incubated overnight 
at 37°C. DNA templates were prepared from the samples by boiled cell lysis for 
examination by PCR, as described previously by Maluta et al.  (Maluta et al. 2014). 
The presence of the blaCMY-2 gene was confirmed in boiled cell lysates from the 138 
representative blaCMY-2-positive E. coli isolates by PCR as described by Zhao et al. (Zhao 
et al. 2001). Likewise, all these isolates were tested by multiplex PCR to determine the 
presence of ExPEC-associated virulence genes (cnf, papC, iucD, and tsh). PCR procedures 
for detection of these genes were performed according to the protocol of the Reference 
Laboratory for Escherichia coli (EcL- Faculté de Médecine Vétérinaire de L'Université de 
Montréal) available in the animal pathogenic zoonotic Escherichia coli website 
(http://apzec.ca/en/Protocols)   
 
Phylogenetic grouping 
Phylogenetic grouping was performed for the blaCMY-2-positive E. coli isolates 
(n=138) using a multiplex PCR-based assay as described by Clermont et al. (Clermont et 
al. 2000). Based on the presence or absence of two genes (chuA and yjaA) and an 
anonymous DNA fragment (TSPE4.C2), isolates were classified into four main E.coli 
phylogenetic groups (A, B1, B2, or D). 
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Antimicrobial susceptibility testing 
  A subset of 25% (n=36) of 138 blaCMY-2-positive isolates representing criteria 
described above along with consideration of phylotypes and ExPEC-associated virulence 
genes were selected, and tested for antimicrobial susceptibility. These isolates, from 
control (n=17) and supplemented (n=19) groups from each sampling day except day 0, 
were examined for susceptibility to the same 15 antimicrobial agents examined in the 
CIPARS surveillance program in Canada (CIPARS 2008) using the disk-diffusion (Kirby-
Bauer) assay as described previously (Jahanbakhsh et al. 2015). The isolates were recorded 
as susceptible, intermediate, or resistant according to the zone diameter interpretative 
standards recommended by Clinical and Laboratory Standards Institute (CLSI) in 2010 
(CLSI 2010) for most of the antimicrobials and in 2008 for ceftiofur (CLSI 2008). The 
following antimicrobial disks were used; amikacin (AMK, 30µg), kanamycin (KAN, 
30µg), gentamicin (GEN, 10µg), streptomycin (STR, 10µg), ceftriaxone (CRO, 30µg), 
ceftiofur (TIO, 30µg), cefoxitin (FOX, 30µg), ciprofloxacin (CIP, 5µg), nalidixic acid 
(NAL, 30µg), trimethoprim-sulfamethoxazole (SXT, 23.75µg), sulfisoxazole (FIS, 250µg), 
ampicillin (AMP, 10µg), amoxicillin/clavulanic acid (AMC, 30µg), chloramphenicol 
(CHL, 30µg), and tetracycline (TET, 30µg). 
 
O Serotyping 
The O serotyping was determined for blaCMY-2-positive E. coli isolates (n=36) by 
standard agglutination methods (Edwards and Ewing 1972) for 86 O serogroups associated 
with swine disease. O antisera were produced at the EcL (Faculté de médecine vétérinaire, 
Université de Montré al, Saint-Hyacinthe, Quebec, Canada) according to standard methods 
(Edwards and Ewing 1972). 
 
PFGE analysis 
The blaCMY-2-positive E. coli isolates (n=36) were analyzed by PFGE using XbaI 
restriction enzyme as described by PulseNet (Ribot et al. 2006). PFGE Profiles were 
analyzed using the BioNumerics 6.6 (Applied Maths, Sint-Martens-Latem, Belgium). 
Dendrograms were generated by the unweighted pair-group method using arithmetic 
averages, based on the Dice similarity coefficient (optimization 1%; tolerance 1.2%). The 
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definition of isolates and clones was based on that previously described by Bednorz et al. 
Accordingly each E. coli colony as recovered after initial screening on MacConkey agar 
plates was considered to be an individual isolate. A clone was defined as an E. coli group 
of isolates with a similar PFGE pattern differing by a maximum of one band. Hence, two 
clones differed by more than one band (Bednorz et al. 2013). 
 
Plasmid characterization  
Plasmids were extracted from wild type blaCMY-2-positive E. coli isolates (n=36) 
using the Qiagen Plasmid Mini in accordance with manufacturer’s instructions (Qiagen, 
Inc., Mississauga, ON). Transformations were performed by electroporation in 
MicroPulser with E. coli ElectroMAX DH10B™ as the recipient in accordance with 
manufacturer’s instructions (Invitrogen, Carlsbad, CA). As previously described by Martin 
et al., (2012) transformants were selected on Mueller Hinton agar (BD, Franklin Lakes, 
NJ) supplemented with 8 µg/ml ceftiofur (Pfizer Animal health, Canada) (Martin et al. 
2012). We analyzed up to five transformants per transformation experiment, whenever 
available. Transformants were examined by PCR to confirm the presence of blaCMY-2 gene 
and by antimicrobial susceptibility testing (described above). Plasmid incompatibility 
grouping was carried out using PCR replicon typing as previously described  for 21 
Incompatibility (Inc) groups (Carattoli et al. 2005; Garcia-Fernandez et al. 2009). 
Detection of class 1 and 2-integrons in plasmids was performed by PCR as previously 
described (Ruiz del Castillo et al. 2013). 
 
Conjugation mating experiments 
In order to ascertain whether blaCMY-2-positive isolates were present in the pen 
environment, pooled environmental swabs were taken from the walls and floors of pens 
before the introduction of the weaned pigs. Inoculation of environmental swabs on 
ceftiofur-supplemented MacConkey agar yielded only Enterobacter cloacae (E. cloacae) 
isolates (n=15). E. cloacae isolates were identified by API 20E kit system (BioMerieux, 
Canada). As purification of the blaCMY-2-positive plasmid from E. cloacae isolates was not 
possible by transformation (electroporation) using electrocompetent E coli DH10B, 
conjugation was done using competent E. coli DH5α (Invitrogen).   
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E. cloacae was mated to competent E. coli DH5α by the broth-mating method (Usui et al. 
2012). Briefly, overnight cultures of donor (20 µl) and recipient (20 µl) bacteria were 
mixed with 160 µl of fresh LB broth and incubated at 37ºC overnight. Transconjugants 
were selected on Mueller Hinton agar supplemented with 50 µg/ml nalidixic acid (Sigma-
Aldrich, St. Louis, MO) and 8 µg/ml ceftiofur (Pfizer Animal health, Canada). 
 
Statistical analysis 
Statistical analysis was carried out using JMPv.10 (SAS Institute, Cary, NC, USA). 
The Chi-square test (95% confidence intervals) was used to compare the effect of feed 
ingredient and time on the prevalence of phylotypes and AMR (phenotypic). Fisher’s exact 
test was also used to examine the differences among groups constrained across days. Odds 
ratios (OR) (95% confidence intervals) were used to evaluate the associations between 
phylotypes and ExPEC- associated virulence genes. Statistical significance for each 
comparison was deemed at P value of <0.05. 
 
Results 
 
Phylogenetic grouping and association of ExPEC-associated virulence genes and 
phylotypes 
The blaCMY-2-positive E. coli isolates belonged to phylotypes A, B1, and D (Table 
1, Fig. 1) whereas the blaCMY-2-negative E. coli isolates belonged only to phylotypes A and 
B1 (Fig. 1). In the supplemented group, all blaCMY-2-positive E. coli isolates belonged to 
phylotype A and D at days 2, 7, 14 and phylotype B1 was only found at day 28 (Fig. 2). On 
the other hand, in the control group, blaCMY-2-positive E. coli isolates belonged to 
phylotypes A, B1 and D at all sampling days. Interestingly, in the blaCMY-2-positive E. coli, 
the frequency of phylotype A was significantly higher in the supplemented group than in 
the control group at all sampling days, whereas phylotypes B1 and D were significantly 
more frequently found in the control group than in the supplemented group (Fig. 2). On the 
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other hand, among the blaCMY-2-negative E. coli isolates, the frequency of phylotypes did 
not differ in the control and supplemented groups (Fig. 1).  
The iucD gene was the most commonly detected ExPEC-associated virulence gene 
and was significantly more frequent in the control group than in the supplemented group 
(data not shown). Likewise, some association between prevalence of virulence genes and 
phylotype in blaCMY-2-positive E. coli isolates was observed, almost all isolates positive for 
ExPEC-associated virulence genes belonging to phylotype B1 (Table 1). A positive 
association was found between phylotype B1 and ExPEC-associated virulence genes in 
blaCMY-2-positive E. coli isolates, whereas the presence of ExPEC-associated virulence 
genes showed negative association with phylotypes A and D (Table 1). The most common 
virulence gene combinations in B1 isolates were iucD alone (55%) and tsh alone (22%). 
 
PFGE and O serogroup of blaCMY-2-positive E.coli  
Relatedness of each DNA fingerprint was clustered using BioNumerics software 
and isolates were divided into 7 clusters (I to VII) at ≥90% similarity, two of these clusters 
being singletons (II and VII). All phylotype A isolates belonged to serogroup O101 and to 
PFGE cluster I, consisting of 2 distinct clones. Phylotype D isolates were O83 and 
demonstrated a unique clone. Indistinguishable fingerprints were present in isolates from 
different sampling days indicating the persistence of clones during the course of study. On 
the other hand, Phylotype B1 isolates were non-typable, except for one O64 isolate, and 
exhibited more heterogeneity than those of phylotypes A and D, being grouped into four 
distinct clusters (IV, V, VI and VII) with four distinct clones. 
In general, phylotype A isolates tended to cluster in the supplemented group, 
whereas phylotype B1 isolates tended to cluster in the control group which indicates the 
blaCMY-2-positive E. coli isolates belong to different clones in the control and supplemented 
groups and are more clonally related in the supplemented group (Fig. 3).   
 
Antimicrobial susceptibility profiles of blaCMY-2-positive E. coli isolates 
Overall, all isolates were resistance to ceftiofur, ceftriaxone, cefoxitin, ampicillin, 
amoxicillin/clavulanic acid, tetracycline, and followed by sulfisoxazole (94.4%), 
trimethoprim-sulfamethoxazole (94.4%), streptomycin (91.6%), chloramphenicol (44.4%), 
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kanamycin (37.1%), gentamicin (37.1%), and nalidixic acid (2.8%). All isolates were 
susceptible to amikacin and ciprofloxacin. Furthermore, seven AMR patterns were 
distinguished among blaCMY-2 -positive E. coli isolates, all being classified as multi-drug 
resistant (MDR) as described by Magiorakos et al., an isolate being MDR if it is non-
susceptible to at least one antimicrobial agent in three or more defined antimicrobial 
categories (Magiorakos et al. 2012). The predominant AMR patterns in ESC-resistant 
E.coli isolates were STR, CRO, TIO, FOX, SXT, FIS, AMP, AMC, CHL, TET (Pattern 3; 
n=14) which was observed in phylotype A and B1 isolates and GEN, KAN, STR, CRO, 
TIO, FOX, SXT, FIS, AMP, AMC, TET (Pattern 1; n=12) found in phylotype D isolates, 
indicating that AMR patterns differed in relation to phylotypes (Fig. 3). The two 
predominant AMR patterns were found in both control and supplemented groups from day 
2 to day 28 after weaning. No significant difference was observed between control and 
supplemented groups for any of the antimicrobials (supplementary Fig. 1). 
 
Characterization of plasmids harboring blaCMY-2 
PCR-based replicon typing of the transformants revealed that IncI1 was the most 
prevalent replicon in blaCMY-2-positive plasmids from transformants, being present in 86% 
(31/36) of isolates (Fig. 3), and followed by two IncA/C, two ColE and one non-typeable 
blaCMY-2-positive plasmids. Multiple replicon types of transferable blaCMY-2-positive 
plasmids were not observed in any transformants. Interestingly, IncA/C blaCMY-2-carrying 
plasmids were only observed in phylotype B1 isolates in the control group at day 28 in 
cluster IV. Moreover, ColE blaCMY-2-positive plasmid was observed only in phylotype A at 
days 2 and 7 in clusters II and III in both groups. 
Antimicrobial susceptibility testing showed that transfer of resistance to 
antimicrobials other than beta-lactams was observed in the transformants with IncA/C 
plasmids, with co-resistance to streptomycin, sulfisoxazole, chloramphenicol and 
tetracycline. However, it should be mentioned that as DH10B is resistant to streptomycin, 
this drug could not be evaluated in the transformation experiments. All of the 
transformants with IncI1 and ColE plasmids were resistant to all of the beta-lactam 
antimicrobials but susceptible to all the non-beta-lactam antimicrobials tested (Fig. 3). 
Class 1 and 2-integrons were not detected in any blaCMY-2-positive plasmids. In addition, 
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all transformed plasmids were negative for the presence of the ExPEC-associated virulence 
genes (data not shown). As IncA/C blaCMY-2-positive plasmids were only found in 
transformants from isolates of the control group at day 28, all of the blaCMY-2-positive E. 
coli wild type isolates were examined for the presence of IncA/C and IncI1 plasmids. All 
isolates were positive for the presence of IncI1 plasmid. On the other hand, IncA/C 
plasmids were detected only in those blaCMY-2-positive E. coli wild type isolates resistant to 
chloramphenicol, both in the control and supplemented groups from day 2 to day 28. 
Frequency of the presence of IncA/C plasmids was two times greater in the supplemented 
group than in the control group, although the difference was not statistically significant 
(Chi-square test, P=0.08). Also, the frequency of IncA/C plasmid in the blaCMY-2-positive 
E. coli wild type isolates increased, although not significantly, over the course of the study, 
even though IncA/C blaCMY-2-positive plasmids were not detected in any transformants 
before day 28 (Fig. 3). In contrast, IncI1 and IncA/C plasmids were not found in any of 20 
blaCMY-2-negative E. coli wild type isolates examined (data not shown). 
 
Spread of blaCMY-2 between batches of weaned pigs  
E. cloacae isolated from environmental swabs were blaCMY-2-positive, resistant to 
ceftiofur and MDR, showing a unique AMR pattern similar to that observed in blaCMY-2-
positive E. coli isolates, the only difference being resistance to kanamycin in the E. 
cloacae isolates (wild type) (Table 2). Transconjugants carrying IncA/C plasmid from E. 
cloacae showed a unique AMR pattern similar to that observed in IncA/C plasmid from E. 
coli isolates. However, it should be noted that E. coli DH5α is resistant to nalidixic acid so 
this drug could not be evaluated in the conjugation experiments. Nevertheless, the two 
patterns differed in resistance to kanamycin and trimethoprim-sulfamethoxazole as they are 
underlined in AMR pattern from E. cloacae and class 1-integron was detected in IncA/C 
plasmids from E. cloacae (Table 2). 
 
Spread of blaCMY-2-positive E. coli within a batch of pigs following weaning 
As shown in a schematic representation of the circulation of blaCMY-2-positive E. 
coli isolates with respect to time after weaning and supplementation of feed with 
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clinoptilolite (Fig. 4), blaCMY-2-positive isolates of phylotype A: cluster III and phylotype 
D: cluster I were first observed at day 2 after weaning in both the control and 
supplemented groups, which had been housed in separate pens. Isolates of these two 
clusters remained in both groups until day 28. Phylotype D showed no changes in clonal 
type over time, whereas phylotype A revealed a new clone at day 7 in cluster II, although 
the predominant clone of phylotype A was in cluster III over time.  However, the 
proportion of blaCMY-2-positive E. coli isolates was greatest at day 7 in the supplemented 
group, consisting of phylotypes A and D, whereas the proportion of blaCMY-2-positive E. 
coli isolates was greatest at day 28 in the control group, consisting of phylotypes A, B1 and 
D. For isolates of phylotype B1, there was relationship between sampling day and clonal 
type, as at day 7 a new clone was detected in the control group in cluster VI. Likewise, at 
day 28, new clones of phylotype B1 were found and grouped in cluster IV in the control 
group and in a singleton, cluster VII, in the supplemented group. Thus, overall, the blaCMY-
2-positive E. coli isolates were more clonally related in the supplemented group than the 
control group.  
 
Discussion 
The purpose of this study was to elucidate the mechanisms leading to an increase in 
the prevalence of blaCMY-2 conferring resistance to ceftiofur in pigs which had not been 
treated with this antimicrobial and to investigate the effect of supplementation with a clay 
mineral on this phenomenon. The first step was to study the clonal relatedness of blaCMY-2-
positive E. coli isolates resistant to ESCs with respect to PFGE type, phylotype and O 
serotype. Clonal analysis by PFGE showed diversity among the blaCMY-2-positive E. coli 
isolates and revealed 7 distinct clones among the 36 blaCMY-2-positive E. coli isolates 
tested. This is in good agreement with previous studies which showed CMY-2-producing 
E. coli from livestock to be highly polyclonal (Daniels et al. 2007; Hiki et al. 2013; Guo et 
al. 2014). On the other hand, a recent study in a pig farrowing farm based on MLST and 
PFGE analysis suggested the clonal spread of blaCMY-2-positive E. coli isolates. Although 
they found different clones on the farm, one clone predominated, being found in (7/13) 
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tested isolates (Deng et al. 2015). Further, Schmidt et al (2013) reported that clonal spread 
of blaCMY-2 -positive E. coli strains was observed more than horizontal gene transfer of 
IncA/C plasmids between E. coli strains in cattle feedlot. Nonetheless they found diverse 
clones but some clones predominated (Schmidt et al. 2013).  
Moreover, PFGE patterns with 100% similarity between at least 2 isolates were 
observed. This suggests that blaCMY-2 spreads both horizontally and clonally in this study, 
and some clones are more common than others. Although the number of tested isolates for 
clonal analysis by PFGE was relatively low, taken together, the phylotyping and PFGE 
results show that the blaCMY-2 -positive E. coli isolates were more clonally diverse in the 
control group than the supplemented group. On the other hand, Bednorz et al. (2013) 
showed higher diversity of multi-resistant E.coli in zinc supplemented  pigs compared to 
the control group (Bednorz et al. 2013). Nevertheless, our results suggest that feed 
supplementation may have an effect on clonal diversity of blaCMY-2 -positive isolates, an 
aspect which warrants further investigation. Further, blaCMY-2-positive E. coli genotypes 
were diverse and influenced by sampling time within both groups in our study, possibly as 
a result of continuous administration of chlortetracycline and penicillin G in the feed. This 
is in accordance with a previous study which demonstrated a clear effect of treatment and 
time on genetic diversity of resistant E.coli in fecal samples from cattle (Alexander et al. 
2009). In the present study, the blaCMY-2-positive E. coli isolates were classified into three 
phylotypes A, B1 and D, as also observed by Guo et al. (2014) in food producing animals 
(Guo et al. 2014). It has been previously reported that phylotype D E.coli is associated with 
disease in humans such as urinary tract infections (Johnson et al. 2005; Jakobsen et al. 
2010). However, although phylotype D/cluster I and phylotype A/cluster III were present 
in similar proportions in the control and supplemented groups at day 2, from day 7 
phylotype A was predominant in isolates from the supplemented group and the majority of 
blaCMY-2-positive E. coli isolates in the control group belonged to phylotypes B1 and D. 
Our findings revealed that certain clones became predominant. The phylotype A clone 
predominated in the supplemented group, whereas the phylotype B1 clones which often 
possess the ExPEC-associated virulence gene iucD, predominated with time, especially in 
the control group. This finding could support the conjecture of Mathers et al. (2015) that 
some ExPEC virulence genes such as sat, iutA, malX, usp, iha, hra, and ompT may play a 
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part in the fitness and adaptation of ST131 E. coli isolates (Mathers et al. 2015). 
Furthermore, it has been reported most commensal E. coli strains belong to phylogenetic 
group A (Clermont et al. 2000), thus they can be favourable. In the current study, the 
phylotype A isolates, which were mostly negative for tested virulence-associated genes, 
predominated in the supplemented group. We speculate this might be related to the positive 
effect of clay mineral on the establishment of favourable bacteria in the intestine, as 
described by Chalvatzi et al, who showed that a more favourable microbiota was found in 
clay mineral supplemented groups in comparison with control groups in a 18 week-study 
on laying pullets (Chalvatzi et al. 2016). 
In the present study, blaCMY-2 was located on three types of plasmids in 
transformants: IncI1, IncA/C and IncColE. Several studies have shown that IncI1 and 
IncA/C are the most common blaCMY-2-positive plasmids in humans and animals 
worldwide (Carattoli 2009; Mataseje et al. 2010; Martin et al. 2012; Hiki et al. 2013). As 
observed in a previous study in broilers (Agerso et al., 2014), we found a high frequency of 
IncI1 carrying blaCMY-2 plasmids in transformants on all sampling days in the present study. 
Similarly, as previously observed, we found that IncI1 plasmids carrying blaCMY-2 confered 
resistance only to beta-lactam antimicrobials, including ceftiofur, ceftriaxone, cefoxitin, 
ampicillin, amoxicillin/clavulanic acid (Folster et al. 2011; Martin et al. 2012; Hiki et al. 
2013). The high frequency of IncI1 blaCMY-2-positive plasmids and resistance to ESCs in 
the absence of ceftiofur use could be a result of continuous administration of penicillin G 
in the feed. Similarly, Cameron-Veas et al. (2015) reported that the administration of 
amoxicillin resulted in an increase in the frequency of cephalosporin resistant-E. coli in 
pigs (Cameron-Veas et al. 2015) and Agerso et al. (2014) showed that use of 
aminopenicillins influenced the persistence and spread of ESC-producing E. coli in broiler 
production (Agerso et al. 2014). Interestingly, all isolates in clusters I and III showed the 
same plasmid profile, whereas for the B1 clusters, V and VI, and even in the same identical 
clone (in cluster VI), only some of the isolates were IncA/C positive, suggesting a 
transmission of the plasmid within the clone. In the case of clusters I and III, the plasmids 
may be strongly associated with the clones. Similarly, Yamamoto et al. (2014) 
demonstrated a correlation between plasmid profiles, PFGE profile and farms in multi-
antibiotic resistant E.coli isolated from beef cattle (Yamamoto et al. 2014). IncA/C 
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plasmids, which are known to be multi-resistance plasmids (Mulvey et al. 2009; Martin et 
al. 2012; Hiki et al. 2013), were detected in the blaCMY-2-positive E. coli wild type isolates 
from both the control and supplemented groups from day 2. However, as IncA/C blaCMY-2-
positive plasmids were not observed in any transformants before day 28, we cannot say if 
these IncA/C plasmids were positive for blaCMY-2. In our study, the frequency of E. coli 
carrying IncA/C plasmid increased to 54%, possibly a result of continuous high-dose 
administration of chlortetracycline in the feed. Similarly, Johnson et al. (2015) showed that 
high-dose administration of chlortetracycline (350 g/ton) significantly increased the 
prevalence of E.coli carrying IncA/C plasmid in pig feces (Johnson et al. 2015). All 
blaCMY-2-positive E. coli were resistant to tetracycline. Hence, such blaCMY-2 -positive E. 
coli isolates which also carry gene(s) that confer resistance to tetracycline would probably 
survive and persist in the presence of the selection pressure due to administration of 
chlortetracycline. It has been shown that E. coli can carry multiple plasmids (Johnson et al. 
2008; Abraham et al. 2014; Yamamoto et al. 2014)(unpublished data). Therefore, in the 
present study, despite the high frequency of the blaCMY-2 encoding IncI1 plasmid which 
only conferred resistance to beta-lactam antimicrobials, coexistence of multiple resistance 
plasmids harboring tetracycline-resistance genes with the IncI1 plasmid could explain the 
circulation of the blaCMY-2 gene and ESC-resistance. 
  Our results have also demonstrated that a possible source of the blaCMY-2  gene for a 
new batch of weaned pigs could be the presence of this gene in the pen environment before 
animal arrival. This might be due to use of ceftiofur in previous production batches, 
combined with inadequate pen sanitation, allowing the blaCMY-2 gene to persist in the 
environment. We recovered blaCMY-2-positive E. cloacae isolates, carrying blaCMY-2 
encoding IncA/C plasmids, from the pens before introduction of the pigs of this batch. In 
addition, we confirmed the transferability of IncA/C plasmid harbouring blaCMY-2 from E. 
cloacae to E. coli DH5α in vitro by conjugation, being a natural horizontal gene transfer 
between bacteria which thus could have occurred on this pig farm. Also, transfer of AmpC 
beta-lactamase plasmids and AMR genes between E. coli and Salmonella among humans 
and animals has been documented (Winokur et al. 2001; Blake et al. 2003). Alternatively, 
as transmission between sows and piglets has been shown, sow therapy with ceftiofur may 
lead to expansion of resistant E. coli isolates in piglets. The inability to detect resistance to 
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ceftiofur at day 0 in this batch could be due to the low level of this phenotype in piglets 
initially and effect of selection pressure of antimicrobials over time (Thompson et al. 2008; 
Schierack et al. 2009; Volkova et al. 2012). It should be noted that in the current study the 
most frequently observed  blaCMY-2 encoding plasmid was IncI1, whereas only IncA/C 
blaCMY-2 encoding plasmids were detected in E. cloacae isolates from the pens prior to 
introduction of the pigs. It is possible that the plasmid-borne blaCMY-2 gene was mobilized 
from IncA/C to IncI1. Yassine et al. (2015) showed the critical role of IS1294b (IS91 
family) in the mobilization of the blaCMY-2 gene from IncA/C to IncI1 in 
Enterobacteriaceae and its contribution to the evolution of diverse incompatibility group 
plasmids (Yassine et al. 2015). 
Seven AMR patterns were found among blaCMY-2-positive E. coli isolates, all being 
multidrug resistant. Particular AMR patterns were observed in certain clones, phylotype D 
showing a unique AMR pattern, just as some associations between phylotypes and 
antimicrobial resistance have been demonstrated previously (Mosquito et al. 2015; Massot 
et al. 2016). Similar AMR patterns were obtained in a previous study with a similar panel 
of  antimicrobial agents evaluated in human and animal sources (Mulvey et al. 2009). 
PFGE profiles correlated well with phylotypes, O serotypes and AMR pattern. A similar 
correlation between antibiotic resistance, O serogroup and PFGE profile has been seen in 
ceftiofur-resistant E. coli isolates from dairy calves (Donaldson et al. 2006).  Several 
studies have suggested that virulent clonal groups belong to phylogenetic group B2 and, to 
a lesser extent, to group D, which are more related to human clinical isolates, while 
commensal strains and strains derived from veterinary species belong to groups A and B1 
(Clermont et al. 2000; Boerlin et al. 2005). In present study, Phylotype A predominated in 
blaCMY-2-positive E. coli isolates, followed by phlotype B1 and D, whereas in comparison, 
ExPEC-associated virulence genes studied here were mostly harboured in phylotype B1 
and most phylotypes A and D isolates were negative for ExPEC-associated virulence 
genes. In contrast,  Tan et al. (2012) showed that isolates of phylogenetic groups B2 and D 
contained more ExPEC virulence genes in E.coli isolated from pigs (Tan et al. 2012). On 
the other hand, the  study of E. coli isolates from diseased pigs showed  that the presence 
of virulence genes did not differ among the four phylogenetic groups (Wang et al. 2010). 
The association between virulence genes and phylotypes has remained unclear in animals. 
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In conclusion, our results reveal that the sub-population of blaCMY-2-positive E.coli 
resistant to ESCs which expanded in a batch of weaned pigs not treated with this 
antimicrobial belonged to several different clones with diverse AMR patterns and 
possessed one or more blaCMY-2-carrying plasmids of the Inc groups I1, A/C, and ColE. 
Our results suggest that the blaCMY-2 gene spread both horizontally and clonally in these 
pigs. The blaCMY-2 gene may have spread from previous batches of pigs via IncA/C 
plasmids carried by E. cloacae and capable of resisting disinfection measures used in the 
pen environment and expanded in animals of the present batch by means of multiple 
resistance IncI1, IncA/C and IncColE plasmids carried by E. coli, in the presence of the 
selection pressure due to administration of chlortetracycline and penicillin G in the feed. 
Phylotyping and PFGE results showed that the blaCMY-2 -positive E. coli isolates were more 
clonally diverse in the control group than the group supplemented with the clay mineral 
clinoptilolite, suggesting that feed supplementation may have an effect on clonal diversity 
of blaCMY-2 -positive isolates, an aspect which warrants further investigation. Taken 
together, our results suggest that implementation of improved hygiene measures, decreased 
administration of certain antimicrobials on farm, and feed supplementation with certain 
ingredients may limit antimicrobial resistance spread between and within batches of 
animals. 
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Tables and figures 
 
Table 1. Association of ExPEC-associated virulence genes and phylogenetic groups in 
blaCMY-2 positive isolates. 
Category  
No. of bla
CMY-2
a positive 
isolates  
No. of isolates for phylogenetic 
grouping (%)  
A  B1  D  
With ExPEC virulence geneb  38  3(7.9) 33(86.8) 2(5.2)  
Without ExPEC virulence gene  100  54(54) 9(9)  37(37)  
P value  <0.0001 <0.0001 0.0002 
ORc (95% CI)  
0.07     
(0.02-0.25) 
66.73 
(20.8-231.6) 
0.09 
(0.02-0.41) 
Total  138 57  42  39  
a Antimicrobial resistance gene (conferring resistance to β-lactam antibiotics) 
b Extraintestinal pathogenic E.coli genes (iucD, tsh, papC) 
c Odds ratio (OR) above 1 represents positive associations, and below 1 represents negative 
associations. A total of 138 blaCMY-2-positive E. coli isolates were examined. 
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Table 2. A summary of antimicrobial resistance pattern in E. cloacae isolated from pens before introduction of pigs and E. coli 
isolated from pigs and in IncA/C blaCMY-2-positive plasmids from both bacterial species. 
 
Bacterial 
species 
  AMR patterna (wild type)   AMR pattern  for IncA/C plasmids (transformants or conjugants)   
Class 1-
integron 
E.coli   STR,CRO,TIO,FOX, SXT,FIS,AMP,AMC,CHL,TET   STRb,CRO,TIO,FOX,FIS,AMP,AMC,CHL,TET   - 
E. cloacae   KANd,STR,CRO,TIO,FOX,SXT,FIS,AMP,AMC,CHL,TET   KANe,STR,CRO,TIO,FOX,NALc,SXT,FIS,AMP,AMC,CHL,TET   + 
a Abbreviations for antimicrobials are as follows: kanamycin (KAN), streptomycin (STR), ceftriaxone (CRO), ceftiofur (TIO), 
cefoxitin (FOX), nalidixic acid (NAL), trimethoprim-sulfamethoxazole (SXT), sulfisoxazole (FIS), ampicillin (AMP), 
amoxicillin/clavulanicacid (AMC), chloramphenicol (CHL), tetracycline (TET). 
b Electrocompetent E coli DH10B is resistant to streptomycin so this drug could not be evaluated in the transformation experiments. 
c E. coli DH5α is resistant to nalidixic acid so this drug could not be evaluated in the conjugation experiments. 
d AMR patterns from E. coli and E. cloacae differ in resistance to KAN (wild type). 
e IncA/C plasmids AMR patterns from E. coli and E. cloacae differ in resistance to KAN and SXT (transformants and conjugants). 
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Figure 1. The frequency of blaCMY-2-positive (n=138) (A) and blaCMY-2-negative (n=101) 
(B) E. coli isolates among phylogenetic groups.  
In A, asterisks indicate that, regardless of time, the frequency of the phylotype A was 
significantly higher in the supplemented group than in the control group and the frequency 
of the phylotypes B1 and D were significantly higher in the control group than in the 
supplemented group using the Fisher’s exact test (P<0.05). In B, there was no difference in 
frequency of blaCMY-2-negative strains among phylogenetic groups. In addition, phylotype 
D was not detected in blaCMY-2-negative isolates. 
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Figure 2. Distribution of 138 blaCMY-2 -positive E. coli isolates among phylogenetic groups in relation to time after weaning and 
supplementation with clinoptilolite.  
Phylotype A predominated in the supplemented group. Phylotypes B1and D predominated in the control group. The value is 
significantly different to that of the supplemented or control group on the same day using the Fisher’s exact test (P<0.05), with 
except for phylotype D where significant differences were only observed on day 14.  
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Figure 3. Cluster analysis of 36 blaCMY-2 positive E. coli isolates based on PFGE patterns 
obtained by digestion of bacterial genomic DNA with XbaI.  
The dendrogram was generated using the Dice coefficient and unweighted-pair group 
method. Using a similarity index of ≥90%, E. coli isolates are separated into 7 PFGE 
clusters (I to VII). Abbreviations for antimicrobials are as follows: kanamycin (KAN), 
gentamicin (GEN), streptomycin (STR), ceftriaxone (CRO), ceftiofur (TIO), cefoxitin 
(FOX), nalidixicacid (NAL), trimethoprim-sulfamethoxazole (SXT), sulfisoxazole (FIS), 
ampicillin (AMP), amoxicillin/clavulanicacid (AMC), chloramphenicol (CHL), 
tetracycline (TET). Black fields with “+” indicate the presence of ExPEC-associated 
virulence genes (iucD, tsh and papC) or the resistance to described antimicrobial agents. 
NT-non typable. C-control group and S-supplemented group.  
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Figure 4. Schematic representation of circulation of blaCMY-2-positive E. coli in the control 
and supplemented groups, with respect to the frequency of blaCMY-2-positive isolates and 
phylogenetic grouping in relation to PFGE cluster/clone over time after weaning.  
Size of each pie is based on the frequency of blaCMY-2-positive isolates as detected by 
hydrophobic grid membrane filter (HGMF) method in an extended collection of E. coli 
isolates from our initial study (Jahanbakhsh et al. 2015) and proportion of phylotypes in 
each pie is in regardto phylogenetic grouping of 138 blaCMY-2-positive E. coli isolates in 
each group and sampling day. Also, E. cloacae with IncA/C blaCMY-2-positive plasmid was 
detected in both groups from pens before introduction of pigs. Symbols indicate as follows: 
 clones from cluster I with IncI1 plasmid,  clones from cluster II with IncColE 
plasmid,  clones from cluster III with IncI1 or IncColE plasmids,  clones from cluster 
IV with IncA/C plasmid,  clones from cluster V with IncI1 plasmid,  clones from 
cluster VI with IncI1 plasmid and  clones from cluster VII with IncI1 plasmid. 
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Supplementary Figure 1. Effect of dietary of supplementation clinoptilolite on the frequency of AMR in 36 E. coli isolates from 
weaned pigs.  
No significant difference was observed between the control and supplemented groups for any of the antimicrobials. Resistance to 
chloramphenicol was two times more in supplemented group than in the control group however the difference was not statistically 
significant (Chi-square test, P=0.08) 
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Abstract 
The aim of this study was to investigate the evolution with time of ceftiofur-
resistant E. coli clinical isolates from pigs in Québec, Canada, between 1997 and 2012 
with respect to E. coli pathotypes, clones, and antimicrobial resistance. Eighty-five 
ceftiofur-resistant E. coli isolates were obtained from the OIE (World Organisation for 
Animal Health) Reference Laboratory for Escherichia coli (EcL). The most prevalent 
pathovirotypes were enterotoxigenic E. coli (ETEC):F4 (40%), extraintestinal pathogenic 
E. coli (ExPEC) (16.5%) and shiga toxin-producing E. coli (STEC):F18 (8.2%). 
Susceptibility testing for 15 antimicrobial agents revealed a high prevalence of resistance 
to 13 antimicrobials, all isolates being multidrug-resistant. blaCMY-2 (96.5%) was the most 
frequently detected β-lactamase gene, followed by blaTEM (49.4%) and blaCTX-M (3.5%). 
Pulsed-field gel electrophoresis (PFGE) applied to 45 E. coli isolates revealed that 
resistance to ceftiofur is spread both horizontally and clonally. In addition, the emergence 
of extended-spectrum β-lactamase (ESBL)-producing E. coli isolates carrying-blaCTX-M 
was observed in 2011 and 2012 in distinct clones. The most predominant plasmid 
incompatibility (Inc) groups were IncFIB, IncI1, IncA/C and IncFIC. Resistance to 
gentamicin, kanamycin, chloramphenicol, and the frequency of blaTEM and IncA/C 
significantly decreased over the study time, whereas the frequency of IncI1 and multidrug-
resistance to seven antimicrobial categories significantly increased over time. Our findings 
reveal that extended-spectrum cephalosporins (ESCs)-resistant porcine E. coli isolates in 
Québec belong to several different clones with diverse antimicrobial resistance patterns 
and plasmids. Furthermore, blaCMY-2 was the major β-lactamase gene in these isolates. 
From 2011, we report the emergence of blaCTX-M in distinct clones. 
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Introduction 
The emergence and prevalence of extended-spectrum cephalosporins (ESCs)-
resistant Escherichia coli in food-producing animals is a global public health concern. 
Cephalosporins are used in both animals and humans to treat various bacterial infections. 
Ceftiofur, a third-generation cephalosporin, is used in pigs to treat respiratory disease, 
lameness and enteric disease, the regulation of use varying from country to country 
(Deckert et al. 2010). Third-generation cephalosporins are considered to be a critically 
important class of antimicrobial as they are of very high importance to human medicine 
(WHO 2011). For example, the third-generation cephalosporin ceftriaxone is one of the 
drugs of choice to treat invasive pediatric salmonellosis (Fey et al. 2000). Resistance to 
ceftiofur in food-producing animals is a potential public health issue because ceftiofur 
resistance determinants also confer cross-resistance to ceftriaxone and other third-
generation cephalosporins. Ceftiofur has been used therapeutically in food-producing 
animals since 1989 and ceftiofur resistance mediated via the blaCMY-2 gene was first 
reported in 1998 (Daniels et al. 2009). Since 1997, prevalence of ceftiofur-resistance in E. 
coli isolates from clinically ill pigs has increased in Quebec, reaching about 22% in 2014 
(MAPAQ 2015). In Enterobacteriaceae, ESC-resistance has been associated with 
production of AmpC β-lactamases (e.g. CMY-2) and ESBLs (e.g. CTX-M and some OXA) 
encoded by genes on transferable plasmids. The CTX-M and CMY families of β- 
lactamase producing gram negative bacteria are a major public health threat due to the 
limited therapeutic options to treat infections with these bacteria as a result of co-
association of resistance to that of other classes of antimicrobials, including 
aminoglycosides, sulphonamides, phenicols and tetracyclines, giving rise to multidrug-
resistant (MDR) strains (Mathers et al. 2015).  
During the past decade, ESC-resistance has been reported among clinical isolates of 
Enterobacteriaceae from humans and animals in Canada (Mulvey et al. 2009; Mataseje et 
al. 2010). The objective of this study was to investigate the evolution with time of 
ceftiofur-resistant E.coli isolates from diseased pigs on different farms in Quebec, Canada 
from 1997 to 2012 with respect to E. coli pathotypes, clones, plasmid types, and 
antimicrobial resistance. 
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Materials and methods 
 
Source of isolates  
A total of 85 ceftiofur-resistant E. coli isolated from clinically diseased pigs from 
1997 to 2012 were obtained from the strain collection of the OIE (World Organisation for 
Animal Health) Reference Laboratory for Escherichia coli (EcL) (EcL- Faculté de 
Médecine Vétérinaire de L'Université de Montréal). Isolates from possible cases of E. coli 
infection from the routine bacteriology diagnostic laboratories were submitted to the EcL 
for further analysis. Pathogenic isolates based on virulence gene determination were tested 
by the disk-diffusion (Kirby-Bauer) assay for antimicrobial resistance and those resistant to 
ceftiofur were selected for this study. The ceftiofur-resistant E. coli isolates were mainly 
recovered from pigs with diarrhea, respiratory problems, or oedema disease from 85 
separate samples from 74 different cases on 41 distinct farms (Table 1 in the supplemental 
material). For DNA preparation, individual colonies on MacConkey agar plates were 
inoculated into 5 ml Luria Bertani (LB-Difco, USA) broth and incubated overnight at 
37°C. DNA templates were prepared from E.coli isolates by boiled cell lysis for 
examination by PCR, as described previously (Maluta et al. 2014). 
 
Detection of virulence genes and determination of pathotypes  
The data of virulence genotyping were extracted from the EcL collection (1997-
2007) and APZEC database (2008-2012) (http://www.apzec.ca). Briefly, the virulence 
gene typing was carried out at the EcL by PCR or colony hybridization using radioactively 
labeled (
32
P) DNA probes for virulence genes which define the E. coli pathotypes 
commonly found in pigs: enterotoxigenic E. coli (ETEC) (eltB, estA, and estB), 
enteropathogenic E. coli (EPEC) (eae), shiga toxin-producing E. coli (STEC) (stxA, stx2A) 
and extraintestinal pathogenic E. coli (ExPEC) (cnf, papC, iucD, and tsh) and for the genes 
faeG, fedA, fanC, fasA, f41, paa, aidA, astA, which permit the identification of extended 
pathovirotypes. PCR and colony hybridization procedures for detection of these genes 
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were performed according to the protocol of the EcL available in the APZEC website 
(http://apzec.ca/en/Protocols), and Table 2 in the supplemental material, and as described 
previously (Harel et al. 1991).  
 
Antimicrobial susceptibility testing 
E. coli isolates were examined for susceptibility to the same 15 antimicrobial 
agents examined in the CIPARS surveillance program in Canada (CIPARS 2008) using the 
disk-diffusion (Kirby-Bauer) assay as previously described (Jahanbakhsh et al. 2015). E. 
coli isolates were considered multidrug-resistant based on the definitions described by 
Magiorakos et al., an isolate being MDR if it is non-susceptible to at least 1 antimicrobial 
agent in 3 or more antimicrobial defined categories (Magiorakos et al. 2012). Furthermore, 
different levels of MDR were defined as follows; MDR4: non-susceptible to at least 1 
agent in only 4 antimicrobial categories, MDR5: non-susceptible to at least 1 agent in only 
5 antimicrobial categories, etc.  
 CTX-M-positive isolates were confirmed for ESBL production in the Minimum 
Inhibitory Concentration (MIC) method (CLSI- M100-S22) using V2AGNF and ESB1F 
plates in the Sensititre System (CLSI 2012). 
 
β-lactamase genotyping 
Isolates were screened for the presence of the blaCMY-2, blaTEM, blaCTX-M, blaSHV and 
blaOXA-1 genes by multiplex PCR, as described previously (Poirel et al. 2011; Mataseje et 
al. 2012). Isolates that were PCR positive for blaCTX-M were examined for the presence of 
blaCTX-M-15 , because of its importance in human medicine, using the primers CTX-M-15-F 
(5’-CACACGTGGAATTTAGGGA-3’) and CTX-M-15-15-R (5’-
GCCGTCTAAGGCGATAAAC-3’) as described (Doi et al. 2009).  
  
Plasmid replicon typing and determination of class 1 and 2-integrons 
Plasmid incompatibility (Inc) grouping was conducted using PCR replicon typing 
as described by Carattoli et al.  for 18 Incompatibility (Inc) groups (Carattoli et al. 2005). 
A multiplex PCR assay targeting class 1 and 2-integrons (int1 and int2) was performed to 
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investigate the presence of integrons using previously described primers and conditions 
(Ruiz del Castillo et al. 2013). 
 
Phylogenetic grouping 
Phylogenetic grouping was performed using a multiplex PCR-based assay as 
described by Clermont et al. (Clermont et al. 2000).  
 
O serotyping 
 O serotyping was determined by standard agglutination methods (Edwards and 
Ewing 1972) for 86 O serogroups associated with swine disease. O antisera were produced 
at the EcL according to standard methods (Edwards and Ewing 1972). 
 
Pulsed-Field Gel Electrophoresis (PFGE) 
E. coli isolates were analyzed for genetic relationships by PFGE using restriction 
enzyme XbaI as described by PulseNet (Ribot et al. 2006). PFGE patterns were analyzed 
using the BioNumerics 6.6 (Applied Maths, Sint-Martens-Latem, Belgium). Dendrograms 
were generated by the unweighted pair-group method using arithmetic averages, based on 
the Dice similarity coefficient (optimization 1%; tolerance 1.2%).  
 
Statistical analysis 
Statistical analysis was carried out using JMPv.10 (SAS Institute, Cary, NC, USA). 
The Chi-square test or Fisher’s exact test, as appropriate, was used to compare the 
significance of differences in prevalence of traits (genetic and phenotypic) with respect to 
different factors (e.g. study time, pathovirotypes). Odds ratios (OR) (95% confidence 
intervals) were used to evaluate the associations between traits. Statistical significance for 
each comparison was considered at a P value of <0.05. 
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Results 
 
E. coli pathovirotype, O serogroup, and phylogenetic group 
The most prevalent pathovirotype among 85 ceftiofur-resistant E. coli isolates from 
diseased pigs was ETEC:F4 (40%) (Fig 1). ETEC:F4 isolated before 2006 were mostly of 
virotype LT:STa:STb:F4 encoded by the eltB, estA, estB, and faeG  virulence genes 
respectively, whereas those isolates from 2006 or afterwards were mostly LT:STb:F4, 
based on the presence of the appropriate virulence genes. Most ETEC:F4 isolates were 
O149 and belonged to phylotype A. Five STEC:F18 isolates (8.2%) and two 
ETEC:STEC:F18 isolates were found, all belonging to O147 and phylotype A. Isolates 
possessing a combination of virulence genes defining two pathotypes were considered to 
belong to both pathotypes. The remaining isolates were ExPEC (16.5%), EPEC (7%), or of 
other E.coli pathotypes (e.g. ETEC, ETEC:F5) or  non-typeable, being heterogeneous with 
respect to O serogroup and phylotype. Two of the ExPEC isolates demonstrated the 
virotype PapC:CNF and phylotype B2, but were of different O serotypes, O88 and O4 
(Fig. 1). 
Isolates from cases of diarrhea were most commonly ETEC:F4 (48.8%), whereas 
those from oedema disease were mainly STEC:F18 (66.6%) and those from respiratory 
disease mostly ExPEC (50%) (Table 3 in supplemental material). 
 
Antimicrobial resistance profiles and distribution of β-lactamase genes and class 1 
and 2-integrons 
Overall, the most frequently observed resistance in ESC-resistant E. coli was to 
ceftiofur (100%), ceftriaxone (100%), ampicillin (100%), cefoxitin (96.5%), 
amoxicillin/clavulanic acid (96.5%), streptomycin (89.4%), tetracycline (89.4%), 
sulfisoxazole (82.3%), trimethoprim-sulfamethoxazole (68.2%), chloramphenicol (58.8%), 
kanamycin (50.6%), gentamicin (40%), and nalidixic acid (4.7%).  All isolates were 
susceptible to amikacin and ciprofloxacin (data not shown). Furthermore, 22 antimicrobial 
resistance (AMR) patterns were distinguished, all being classified as MDR. 
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The predominant AMR patterns were GEN, KAN, STR, CRO, TIO, FOX, SXT, FIS, 
AMP, AMC, CHL, TET (n=17, from 1997 to 2011) and STR, CRO, TIO, FOX, SXT, FIS, 
AMP, AMC, TET (n=8 from 2006 to 2011), being found in the nursery and preweaning 
phases of pig production and different farms (Fig. 1).  Moreover, two previously 
undetected AMR patterns with respect to resistance to β-lactam antibiotics were found as 
follows, KAN, STR, CRO, TIO, SXT, FIS, AMP, TET (n=1, 2011) and STR, CRO, TIO, 
SXT, FIS, AMP, CHL, TET (n=2, 2012), in isolates from pigs in the nursery phase and 
from different farms (Fig. 1 and Fig. 5). The latter three isolates were found to be ESBL 
producers. 
blaCMY-2 was the most frequently detected β-lactamase gene in ESC-resistant E.coli 
isolates (96.5%), followed by blaTEM (49.4%) and blaCTX-M (3.5%) (Table 1, Fig. 1). 
Notably, the three ESBL-producing isolates were blaCTX-M-positive but negative for 
blaCMY-2. Nevertheless, they were not the blaCTX-M-15 variant. In addition, the frequency of 
the presence of blaTEM decreased significantly over the course of the study. Furthermore, 
blaSHV and blaOXA-1 were not detected in any ESC-resistant E. coli isolates (Fig. 2). The 
most prevalent β-lactamase genes were blaCMY2 alone (48.2 %) and blaCMY2:blaTEM in 
combination (48.2 %) (Table 1), the frequency of the combination blaCMY-2:blaTEM 
decreasing with time from 81.8% in 1997-2002 to 35.2% in 2008-2012 (P value=0.0089 
using Fisher’s Exact test). Class 1-integrons were more frequently observed than class 2-
integrons (Table 1) and there was no difference in frequency of class 1 and 2-integrons 
over time. Five isolates had both classes of integrons simultaneously. The presence of class 
1-integrons was significantly associated with resistance to gentamycin, kanamycin, 
streptomycin, trimethoprim-sulfamethoxazole, sulfisoxazole, chloramphenicol and 
tetracycline. In addition, no significant differences in resistance to antimicrobial agents and 
the frequency of class 1 and 2-integrons were found in relation to pathovirotypes (data not 
shown). There was no significant difference in the proportion of class 1 and 2-integrons 
among β-lactamase gene profiles (Table 1). 
Different levels of multidrug resistance were observed, MDR8 (48%) being the 
most frequent, followed by MDR7 (26%). Interestingly, the frequency of MDR8 revealed a 
tendency to decrease over the time of the study, accompanied by a significant increase in 
the frequency of MDR7 (Fig. 3). Notably, the frequency of resistance to gentamicin 
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significantly decreased with time among ESC-resistant E.coli, from 81.8% in 1997-2002 to 
40% in 2003-2008 (P value=0.0158 using Fisher’s Exact test) and 26.5% in 2008-2012 (P 
value=0.0018 using Fisher’s Exact test). In addition, resistance to kanamycin and 
chloramphenicol significantly decreased similarly to the gentamicin pattern over the study 
time. Likewise, the frequency of resistance to both gentamicin and  chloramphenicol 
significantly differed with respect to production phase, as it was significantly higher in the 
nursery phase than the preweaning phase (P value = 0. 0135) (Fig.1). 
  
Detection of plasmid replicon types  
Plasmid replicon typing identified 15 different plasmid types, all isolates except 
one carrying one or more plasmids. The most predominant Inc groups were IncFIB 
(81.2%), IncI1 (57.6%), IncA/C (49.4%) and IncFIC (41.2%) (Table 1), forty-nine replicon 
type patterns being observed (Fig. 1). Over the course of the study, the frequency of the 
presence of IncA/C in isolates significantly decreased, whereas the proportion of IncI1 in 
isolates significantly increased, and there were no significant differences in the frequency 
of IncFIB and IncFIC (Fig. 4). The frequency of IncA/C significantly differed between 
blaCMY-2 and blaCMY-2:blaTEM carrying E. coli isolates, 29.7% and 73.2%, respectively 
(Table 1). The presence of IncA/C demonstrated a positive association with resistance to 
gentamicin, kanamycin, streptomycin, trimethoprim-sulfamethoxazole, sulfisoxazole, 
chloramphenicol, tetracycline, MDR8, and the presence of blaTEM and Int1, although there 
was a negative association with MDR7 (Table 3). In contrast, IncA/C was not detected in 
blaCTX-M positive E. coli isolates. The frequency of IncFIB, IncI1 and IncFIC did not differ 
among β-lactamase gene combinations (Table 1).  
Furthermore, a positive association between IncFIB and IncA/C was observed [OR 
(95%CI) =3.67 (1.07-12.54), P=0.0302], whereas the presence of IncI1 showed negative 
association with IncA/C [OR (95% CI) =0.14 (0.055-.38), P<0.0001]. The presence of 
IncFIC and IncFIB was highly associated with ETEC:F4 isolates whereas a negative 
association between IncFIC and ExPEC and EPEC was seen. In addition, a positive or 
negative association between various other pathovirotypes and Inc plasmids was observed 
(Table 2). The presence of IncFIB positively associated with resistance to kanamycin, 
streptomycin, trimethoprim-sulfamethoxazole, tetracycline, MDR8 and blaTEM. The 
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presence of IncI1 demonstrated negative association with resistance to gentamicin and 
MDR8 (Table 3).  
 
Clustering analysis of ESC-resistant E. coli isolates based on tested genes 
Clustering analysis based on tested genes revealed 74 unique patterns (Fig. 1). 
Isolates were divided into 32 clusters at 70% similarity and seven of these clusters were 
singletons. Approximately 32% of isolates were grouped in the major cluster, which 
represents ETEC:F4, O149 isolates belonging to phylotype A. Gene clustering analysis 
separated ESC-resistant E. coli isolates according to O serogroup, most O149 strains being 
differentiated from the other detected O serogroups (Fig. 1). 
 
 PFGE analysis of ESC-resistant E. coli isolates  
In order to study the epidemiological genetic relationships of the ESC-resistant 
E.coli, 45 representative isolates were further analyzed by XbaI-PFGE. PFGE revealed 36 
unique patterns each representing a clone and isolates were grouped into 15 clusters (I to 
XV) at 75% similarity, five of these clusters containing a single isolate (Fig. 5). Moreover, 
45% (n=20) of isolates were grouped in the major cluster III at 75% similarity which 
represented ETEC:F4. In addition, isolates in the major cluster at similarity ≥ 90% were 
grouped in 4 subclusters, III-1, III-2, III-3 and III-4. Isolates of the subcluster III-1 
possessed the faeG, paa, eltB, estA, estB, astA gene pattern (virotype LT:STa:STb:F4) 
except for isolate EC37 which was negative for astA  whereas isolates in subclusters III-2, 
III-3 and III-4 possessed the faeG, paa, eltB, estB, astA  gene pattern, all being negative for 
estA (virotype LT:STb:F4).   
There was a correlation between clonal type and time of isolation, as closely related 
clusters (Similarity ≥ 90%) were separated by years, subcluster III-1 being found from 
2001 to 2006, subcluster III-2 in 2006 and 2007, III-3 from 2006 to 2011, and III-4 from 
2009 to 2012. Identical clones, with a few exceptions, revealed close relationships by 
presenting similar features with respect to virulence and β-lactamase genes, phenotypic 
AMR patterns, replicon types, class 1 and 2-integrons, phylotypes and O serogroups (Fig. 
5). IncA/C was mostly found prior to 2006 in III-1 isolates, such as EC37 from farm 16. 
IncA/C re-emerged in three III-4 isolates from the same farm in 2009, 2011, and 2012.  
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Cluster III contained isolates from different farms and years. Indistinguishable 
PFGE patterns were present in isolates from multiple farms and years, such as the isolates 
in subclusters III-1 (EC7, EC22 and EC37), and III-2 (EC43, EC49) and cluster XI (EC73, 
EC84). Also, isolates EC60 and EC63 belonging to an identical clone were found in 
different years in the same farm and for isolates (EC19 and EC20) and (EC36 and EC40), 
each pair revealed an identical pattern in the same year from different farms, indicating a 
circulation of clones between farms. Further, an indistinguishable PFGE pattern was found 
from 2001 to 2006 (isolates EC7, EC22, EC23 and EC37) indicating the persistence of the 
clone with time.   
The three blaCTX-M carrying isolates (EC67, EC77 and EC82) were ETEC:F4, all 
belonging to O149 and phylotype A, but were not clonally related and originated from 
different farms.  
 
Discussion 
In this study, clonal analysis by PFGE showed high diversity among ESC-resistant 
clinical E. coli isolates from pigs although half of the isolates belonged to a single cluster. 
Similarly, our previous study on healthy pigs on a commercial farm showed that ESC-
resistant E.coli isolates belonged to several different clones with diverse AMR patterns, 
certain clones being predominant (submitted article). This is also in good agreement with 
previous studies which showed ESC-resistant E. coli from cattle were highly polyclonal 
(Donaldson et al. 2006; Daniels et al. 2007). 
Our finding that identical ETEC:F4 clones were found in different years on the 
same farm suggest persistence of certain clones between batches. In addition, some clones 
were observed from multiple farms which suggested potential circulation among the farms. 
Also, these clones may have originated from a single source (e.g. same breeding pig farm), 
as observed by Agerso et al, (2014) who reported that the same E. coli clones possessing 
blaCMY-2 were found in imported grandparents and in all levels of the Danish broiler 
production, indicating spread of ESC-producing E. coli clones and plasmids from imported 
parent animals to broilers and to broiler meat (Agerso et al. 2014). In our study, 
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transmission may have occurred because of imported and exported pigs, and also by the 
movement of water and wild animals and/or through contaminated food (Yamamoto et al. 
2014). It is interesting to note that presently only 44% of farms in Quebec are «farrow-to-
fattening», that is, on a single site, as compared to 33% fattening and 23% farrowing farms 
which together constitute multisite farms. Transport of pigs between these sites would 
result in a more widespread spreading of clones (Lacroix and Morin 2015). Likewise, in 
line with previous studies, E. coli may be transmitted from farm to farm by vehicles such 
as transport trucks and visitors on farms (truck drivers, veterinarians, producers, 
technicians) or by farm workers (Lim et al. 2010; Abraham et al. 2015). 
 Heterogeneity among ESC-resistant isolates was found, suggesting that their 
spread is not only due to the dispersion of successful E. coli clones, and horizontal gene 
transfer may be contributing to the emergence of ESC-resistance in pigs, as has been 
suggested by others (de Been et al. 2014). A notable finding was that, among ETEC:F4, 
O149 E. coli isolates, the more virulent clones with the virotype LT:STa:STb:F4 were 
mostly seen prior to 2006 (subcluster III-1) whereas from 2006 to 2012 most clones 
displayed the virotype LT:STb:F4 (subclusters III-2,3,4). In accordance with previous 
studies, the changes observed in O149 clones with time probably reflect the changes in the 
pathogenic population, in that an overall predominance of LT:STa:STb:F4 isolates was 
found in early 2000s (Noamani et al. 2003; Fairbrother et al. 2005). 
Interestingly, the plasmid IncA/C was mostly seen prior to 2006 in ETEC:F4 O149 
clones of subcluster III-1 although it re-emerged in 2009-2012 clones (III-4) on one 
particular farm. The presence of IncA/C was significantly associated with resistance to 
gentamicin, kanamycin, streptomycin, trimethoprim-sulfamethoxazole, sulfisoxazole, 
chloramphenicol, tetracycline, as described previously (Doublet et al. 2012). Also, IncA/C 
plasmid-carrying blaTEM and Int1 and genes conferring resistance to the above mentioned 
antimicrobials have been demonstrated (Fernandez-Alarcon et al. 2011). The decrease in 
resistance to gentamicin, kanamycin and chloramphenicol in ESC-resistant E. coli could be 
a result of less administration of these antimicrobials in pig production. The ban on the use 
of chloramphenicol in food animals in Canada since the 1980s could contribute to the 
decrease in resistance to chloramphenicol over time. Similarly, based on anecdotal 
evidence from local authorities and veterinarians, a tendency to less prescribing of 
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gentamicin has recently been seen. On the other hand, kanamycin is not used in pig 
production in Canada. The emergence and prevalence of antimicrobial resistance in 
bacteria are likely to be linked to administration of antimicrobials in animals through 
cross-resistance or co-resistance (Harada and Asai 2010). It can also be associated with 
disinfectant use and administration of metals like copper and zinc as feed additives 
(Bednorz et al. 2013).  
In the present study, we observed a relationship between certain pathotypes and Inc 
plasmid types. Our finding that ETEC:F4 was positively associated with IncFIB and 
IncFIC but negatively with IncB/O and IncP confirms the observations in a recent study of 
pig isolates in Australia (Abraham et al. 2014). In addition, ExPEC showed a positive 
association with the presence of IncB/O and negative association with the presence of 
IncI1 and IncFIC groups. Johnson et al. described a similar trend in human ExPEC strains 
(Johnson et al. 2008). Future studies will further examine the relative role of pathogenic 
clones and the various plasmids in the circulation of the blaCMY-2 gene.  
This study demonstrated the recent emergence of multidrug-resistant CTX-M-
producing ETEC:F4 E. coli isolates in pigs in 2011 and 2012. It seems that the spread of 
blaCTX-M may have occurred by horizontal transmission as blaCTX-M was detected in distinct 
clones. To our knowledge, this is the first report of blaCTX-M-positive, ESLB-producing 
pathogenic E. coli isolates from pigs in Quebec, Canada.  
Three distinct phylotype B2 clones were detected among ESC-resistant E.coli 
which were ExPEC O4 and O88 and ETEC O98. E. coli  of phylotype B2 and D, 
possessing virulence factors PapC and CNF and serogroup O4 is associated with disease 
such as urinary tract infections in humans (Johnson et al. 2005) suggesting a zoonotic 
potential. Similarly, a recent Australian study reported human associated zoonotic clones 
in pigs and cattle (Abraham et al. 2015). The results we observed in this study are based on 
our collection that includes 91% pathogenic E.coli from clinical cases. However, the 
discussed patterns could be different in commensal E.coli as was reported by Boerlin et al 
(2005) who showed that AMR differs significantly between pathogenic and commensal E. 
coli isolates (Boerlin et al. 2005). 
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In conclusion, our findings reveal that ESC-resistance was mostly associated with 
the blaCMY-2 gene and that the blaCTX-M gene has recently emerged. ESC-resistant E. coli 
belonged to several different clones with diverse AMR patterns and often carried plasmids 
of several Inc groups. However, there was no persistent and predominant clone over the 
study time. Further, we confirmed that some clonal ESC-resistant isolates were present at 
multiple farms in the same and different years. Our results suggest that the blaCMY-2 gene 
spreads both horizontally and clonally in this study and the spread of blaCTX-M gene may 
have occurred by horizontal transmission. Resistance to gentamicin, kanamycin, 
chloramphenicol, and the frequency of blaTEM and IncA/C plasmid significantly decreased 
over the period of time. In contrast, IncI1 and MDR7 significantly increased over the study 
time. To our knowledge, this is the first study describing characteristics of ESC-resistant 
E.coli isolated over a long period. In addition, we believe this to be the first report of 
blaCTX-M positive, ESLB-producing pathogenic E. coli strains from pigs in Canada. Our 
findings underline the importance of monitoring E. coli isolates from pigs for the presence 
of blaCTX-M gene in the future since they could be transmitted to humans via the food chain 
or by direct contact. Widespread occurrence of antimicrobial resistance plasmids in ESC-
resistant E. coli from pigs is a concern for animal and public health and warrants further 
attention. 
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Tables and figures 
Table 1. Distribution of plasmid Inc groups and Integrons in relation to selected β-lactamase genes in ESC-resistant E. coli isolated 
from pig in Quebec, Canada from 1997-2012  
Selected β-lactamase 
gene combinations 
No. of positive 
isolates (%) 
No. of positive isolates for (%)  
Plasmid Inc groups     Integron classes  
FIB  I1  A/C  FIC     1  2  
blaCMY-2a 41(48.2)  29 (70.7)  22 (53.6)  12 (29.7)  16 (39)     26 (63.4)  5 (12.2)  
blaCTX-M  2 (2.3) 2 (100)  2 (100)  0  2 (100)     2 (100)  1 (50)  
blaCMY-2:blaTEM  41 (48.2) 37 (90.2)  24 (58.5)  30 (73.2)  16 (39)     33 (80.5)  5 (12.2)  
blaCTX-M :blaTEM 1 (1.2) 1 (100)  1 (100)  0  1 (100)     1 (100)  0  
Total  85 (100)  69 (81.2)  49 (57.6)  42 (49.4)  35 (41.2)     62 (72.9)  11 (12.9)  
a Overall the frequency of blaCMY-2 gene was 96% (41+41/85) and the frequency of blaTEM gene was 49.4% (41+1/85) 
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Table 2. Statistically significant association between pathovirotypes and major Inc groups. 
E. coli pathovirotype Associated Inc groups ORc 95%CIb P valuea 
ETEC:F4 FIB NApd NA 0.0003 
FIC 43.5 12.15-155.71 <0.0001 
B/O 0.072 0.009-0.58 0.0022 
P 0.28 0.07-1.08 0.0448 
STEC:F18 FIB 0.13 0.02-0.68 0.0068 
A/C NAn NA 0.0063 
EXPEC I1 0.23 0.06-0.81 0.016 
FIC NAn NA 0.0006 
B/O 4.57 1.3-16 0.0118 
N 19.5 4.92 <0.0001 
ETEC:F5 I1 NAp NA 0.0179 
EPEC I1 NAn NA 0.0168 
A/C NAp NA 0.0382 
FIC NAn NA 0.0865 
a Only statistically significant (P<0.05) associations are reported using Fisher’s Exact test . A 
total of 85 isolates were examined. 
b95%CI-95% confidence interval 
c Odds ratio (OR) above 1 represents positive associations, and below 1 represents negative 
associations. 
d Na: statistically highly significant positive (NAp) or negative (NAn) associations but 
calculation of odds ratios not applicable. 
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Table 3. Statistically significant association between major Inc groups, and antimicrobial 
resistance phenotypes and determinants 
Major Inc groups Associated traits  ORc 95%CIb P valuea 
FIB Kanamycin 10.25 2.15-48.65 0.0007 
  Streptomycin 4.26 0.99-18.22 0.0376 
  Trimethoprim-sulfamethoxazole 5.09 1.61-16.11 0.0034 
  Tetracycline 7.38 1.71-31.86 0.0029 
  MDR8 3.46 1.01-11.82 0.039 
  blaTEM 3.67 1.07-12.54 0.0302 
I1 Gentamicin 0.32 0.12-0.78 0.0121 
  MDR8 0.4 0.16-0.97 0.041 
A/C Gentamicin 37.57 9.64-146.4 <0.0001 
  Kanamycin 9.3 3.47-24.96 <0.0001 
  Streptomycin 9.37 1.11-78.64 0.0151 
  Trimethoprim-sulfamethoxazole 3.36 1.26-8.94 0.0128 
  Sulfisoxazole 5.03 1.3-19.41 0.0121 
  Chloramphenicol 11.53 4.07-32.65 <0.0001 
  Tetracycline 9.37 1.11-78.64 0.0151 
  MDR7 0.14 0.04-0.48 0.0007 
  MDR8 9.3 3.46-24.94 <0.0001 
  blaTEM 6.45 2.51-16.60 <0.0001 
  Int1 2.96 1.06-8.21 0.0331 
FIC Tetracycline 6.47 0.77-54.35 0.0364 
P Streptomycin NAd NA 0.0457 
a Only statistically significant (P<0.05) associations are reported using Fisher’s Exact test . A 
total of 85 isolates were examined. 
b 95%CI-95% confidence interval 
c Odds ratio (OR) above 1 represents positive associations, and below 1 represents negative 
associations. 
d Na: statistically highly significant positive associations but calculation of odds ratios not 
applicable. 
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Supplementary Table 1. Descriptive information of 85 ceftiofur-resistant clinical E. coli 
isolated from pig in Quebec-Canada from 1997-2012 
 
Characteristics  
Number  
(% of total) 
Production phase (age)     
Preweaning (0-21 days)  25 (29)  
Nursery (22-89 days)  52 (61)  
Growing-finishing (90-240 days)  5 (6)  
Unknown  3 (4)  
 
Sample origin     
Intestinal  79 (93)  
Extera-intestinal  6 (7) 
 
Clinical sign     
Diarrhea  41 (48)  
Oedema  3 (4)  
Respiratory problem  14 (16)  
Other clinical signs  11 (13)  
Unknown  16 (19)  
 
Three categories of study time (1997-2012)  
   
1997-2002  11 (12.9) 
2003-2007  40 (47.1) 
2008-2012  34 (40) 
 
Farm (n=41)  
Total No. of samples and isolates=85 
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Supplementary Table 2. List of primers used in the PCR and colony hybridization by DNA probe, PCR conditions, and control 
strains. 
Virulence 
factor 
Gene Primer a (5’        3’) 
Amplicon 
size (bp) 
Annealing 
temperature  
Control 
strain 
Reference 
F6 fasA 
For ATGAGAATGAAAAAATCCGCA   
Rev   CGAATAGTCATTACTGCACT 
333 60°C  ECL2316 [1] 
F5 fanC 
 
For   TGCGACTACCAATGCTTCTG 
Rev   TATCCACCATTAGACGGAGC 
450 60°C ECL13316 [2] 
F18 fedA 
 
For  GTGAAAAGACTAGTGTTTATTTC 
Rev  CTTGTAAGTAACCGCGTAAGC 
510 60°C ECL1033 [3] 
F41 f41 
 
For   GAGGGACTTTC TCTTTTAG 
Rev  AGT CCA TTC CAT TTA TAG GC 
431 60°C ECL13316 [2] 
AIDA aidA 
 
For  ACAGTATCATATGGAGCCA 
Rev TGTGCGCCAGAACTATTA 
585 60°C ECL1033 [4] 
Paa paa 
 
For  ATGAGGAACATAATGGCAGG 
Rev  TCTGGTCAGGTCGTCAATAC 
360 60°C ECL7805 [5] 
EAST1 astA 
 
For  TCGGATGCCATCAACACAGT 
Rev GTCGCGAGTGACGGCTTTGTAG 
125 60°C ECL7805 [4] 
 
a The other primers used in the PCR and colony hybridization by DNA probe are available at http://apzec.ca/en/Protocols 
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Supplementary Table 3. Distribution of major clinical signs among E. coli pathovirotypes 
Major clinical sign 
No. of E. coli pathovirotype (%)  
Total 
ETEC:F4 ExPEC STEC:F18 EPEC Others a 
Diarrhea 20(48.8) 1 (2.4) 4(9.7) 4 (9.7) 12(29.2) 41 
Oedema 1 (33.3) 0 2(66.6) 0 0 3 
Respiratory problem 4 (28.6) 7 (50) 0 1 (7.1) 2(14.2) 14 
Others include  other E.coli pathotypes (e.g. ETEC, ETEC:F5) or nontypeable.  
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Figure 1. Clustering analysis of genetic variation of 85 ESC-resistant clinical E. coli isolates 
from 1997 to 2012.  
The dendrogram was generated using the binary patterns (0, 1) of tested genes, Dice coefficient 
and unweighted pair group method with arithmetic mean. According to a similarity index of 
≥70%, ESC-resistant E. coli isolates are separated into 32 clusters. Abbreviations for 
antimicrobials are as follows: kanamycin (KAN), gentamicin (GEN), streptomycin (STR), 
ceftriaxone (CRO), ceftiofur (TIO), cefoxitin (FOX), nalidixicacid (NAL), trimethoprim-
sulfamethoxazole (SXT), sulfisoxazole (FIS), ampicillin (AMP), amoxicillin/clavulanicacid 
(AMC), chloramphenicol (CHL), tetracycline (TET). Black fields with “+” indicate the presence 
of genes or the resistance to described antimicrobial agents.  UN-Unknown. NT-Non typeable. 
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Figure 2. Frequency of β-lactamase genes among 85 ESC-resistant clinical E. coli isolates from 
pigs in Quebec, Canada over study time. 
For each β-lactamase gene the bars marked by different letters were significantly different 
(P<0.05). Arrows show that the blaCTX-M-positive isolates were negative for blaCMY-2. 
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Figure 3. Proportion of different levels of MDR in 85 ESC- resistant clinical E. coli isolates 
from pigs in Quebec, Canada over study time.  
MDR4: non-susceptible to at least 1 agent in only 4 antimicrobial categories, MDR5: non-
susceptible to at least 1 agent in only 5 antimicrobial categories, etc.  
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Figure 4. Frequency of the four most predominant Inc groups among clinical E. coli isolates 
from pigs in Quebec, Canada over study time. 
For each Inc group the bars marked by different letters were significantly different (P<0.05).  
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Figure 5. Clustering analysis of 45 ESC-resistant clinical E. coli isolates from 1997 to 2012 
based on PFGE patterns obtained by digestion of bacterial genomic DNA with XbaI.  
The dendrogram was generated using the Dice coefficient and UPGMA. According to a 
similarity index of ≥75%, ESC-resistant E. coli isolates are separated into 15 PFGE clusters (I to 
XV) and closely related groups of isolates (Dice similarity value ≥90%) are subclusters III-1, III-
2, III-3 and III-4 as well as cluster XIV. Abbreviations for antimicrobials are as follows: 
kanamycin (KAN), gentamicin (GEN), streptomycin (STR), ceftriaxone (CRO), ceftiofur (TIO), 
cefoxitin (FOX), nalidixicacid (NAL), trimethoprim-sulfamethoxazole (SXT), sulfisoxazole 
(FIS), ampicillin (AMP), amoxicillin/clavulanicacid (AMC), chloramphenicol (CHL), 
tetracycline (TET). Black fields with “+” indicate the presence of genes or the resistance to 
described antimicrobial agents. UN-Unknown. NT-Non-typeable. 
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General discussion 
Administration of antimicrobials in food animal production has been monitored 
over the past two decades since the emergence of multidrug resistance in bacteria has 
become one of the most important problems in animal and human medicine. Development 
of antimicrobial resistance increases the risk of failure of antimicrobial treatment in 
animals and humans. In particular, the emergence and prevalence of ESC-resistant E. coli 
in food producing animals is of great concern since third generation cephalosporins (e.g. 
ceftriaxone, ceftiofur) are clinically important β-lactam antimicrobials in human and 
animal medicine. In Enterobacteriaceae, ESC-resistance has been associated with 
production of AmpC β-lactamases (e.g. CMY-2) and ESBLs (e.g. CTX-M and some OXA) 
encoded by genes on transferable plasmids. The CTX-M family are important ESBLs in 
human medicine and have become a threat to public health (Li et al. 2007).  
Antimicrobial use as growth promoters, or as preventive or therapeutic agents 
during animal production can result in the development of AMR. These resistant bacteria 
and/or resistance genes may spread to humans directly or through food chain, resulting in 
potential public health risks (Johnston 2001; Wegener 2003). Also, the resistant bacteria 
are shed into the environment where they may persist for long periods (Chantziaras et al. 
2014). Therefore, animal feeds may be supplemented with feed additives as an alternative 
for the use of antimicrobials or a complement to the antimicrobials. For instance, the clay 
mineral, clinoptilolite, has been used in an attempt to improve performance and health but 
also as an alternative to the use of antimicrobials or together with antimicrobials for 
prevention of post-weaning diarrhea in piglets. However, little is known about the 
mechanism of action of clinoptilolite. A previous in vitro study showed that minerals 
induce bacterial mutation and increase genetic diversity of bacteria (Yoshida et al. 2004), 
DNA bound to clay minerals resist more to degradation by DNase I (Romanowski et al. 
1991). It has been demonstrated in in vitro studies that clay minerals boost horizontal gene 
transfer of AMR genes in different bacterial species (Lotareva and Prozorov 2000; 
Rodriguez-Beltran et al. 2013). These data imply that clay minerals may modulate the 
frequency of AMR and virulence genes of bacteria in the animal intestine. In weaned pigs, 
antimicrobials are administrated in feed mainly as a medication to prevent disease and thus 
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reduce mortality and morbidity (Cromwell 2002). Penicillin and tetracycline are among the 
used in-feed antimicrobials in pigs and often in mixture (Akwar et al. 2008). In-feed 
antimicrobial use in pigs has been associated with raised resistance of fecal E. coli within 
and between antimicrobials classes (Kim et al. 2005; Akwar et al. 2008).  
To shed a light on how feed supplements influence the virulence and AMR 
dynamics of E. coli in the intestinal ecosystem of pigs, we designed a series of experiments 
and as a first step, we focused on the effect of feed supplementation with clay minerals. 
We examined the changes in AMR phenotype as well as virulence and AMR gene profiles 
in E. coli isolated from pigs in a commercial farm that received a diet containing 
chlortetracycline and penicillin G in therapeutic doses following weaning and we 
investigated the effect of feed supplementation with a clay mineral, clinoptilolite, on this 
dynamic.  
Our results revealed that the frequency of resistant E. coli isolates to several 
antimicrobials (streptomycin, ceftriaxone, ceftiofur, cefoxitin, trimethoprim-
sulfamethoxazole, sulfisoxazole, ampicillin, amoxicillin/clavulanic acid, chloramphenicol, 
and tetracycline) was increased time dependently. This could be a result of continuous 
usage of medicated feed with chlortetracycline and penicillin G. These results are in good 
agreement with the data of Akwar et al. (2008) and Kim et al. (2005), who demonstrated 
that administration of antimicrobials in feed in pigs, may apply a selection pressure 
resulting in increased resistance of fecal E. coli within and between classes of 
antimicrobials (Kim et al. 2005; Akwar et al. 2008). Furthermore, Looft et al. (2012) 
showed that use of chlortetracycline, penicillin, and sulfamethazine (known as ASP250) 
may increase the prevalence of resistance genes not only for the administered antimicrobial 
but also for antimicrobials of other classes that were not used, likely due to co-selection 
(Looft et al. 2012). Also, Funk et al. (2006),  in a phenotypic resistance study, observed 
that adding of chlortetracycline in the pig diet has an effect on resistance to multiple 
antimicrobials, including ampicillin, ceftriaxone and tetracycline, in the gram negative 
fecal flora of the pig (Funk et al. 2006).  
Risk factors for development of AMR in food animal production are complex and it 
has been demonstrated that antimicrobial use and selection or co-selection pressure may 
not be the only factors increasing AMR with time in farm conditions. Thus, other 
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mechanisms such as clonal transmission of resistant E. coli, horizontal gene transfer 
between bacteria, adaptation, maintenance of some sets of resistant strains, transmission 
from animal to animal and farm conditions could also have been responsible for the 
development of AMR with time in the present study (Hoyle et al. 2005; Blahna et al. 2006; 
Sharma et al. 2008; Nilsson et al. 2014; Mazurek et al. 2015).  
Interestingly, in our study resistance to all antimicrobials except the cephalosporins 
and ciprofloxacin was observed in pigs at weaning, before they were given in-feed 
antimicrobials. The latter antimicrobials are not used in pigs in Canada, with the exception 
of injectable ceftiofur (CIPARS 2008). Even though the number of strains tested for 
antimicrobial susceptibility was relatively low, detection of resistance to ceftiofur, which 
was first found at day 7 and increased to day 28, was unexpected, as ceftiofur was not 
administrated in this batch of pigs. Further, we confirmed a positive association between 
ceftiofur-resistance and the presence of blaCMY-2 gene in E.coli isolated from healthy pigs, 
as observed in previous investigations (Diarra et al. 2007; Mataseje et al. 2010).  
Moreover in our study, the blaCMY-2 gene was detected in the pen environment 
before introduction of pigs and administration of chlortetracycline may have effected 
subsequent expansion of the blaCMY-2 gene. Similarly, in a recent 26 day metagenomic 
study in cattle, chlortetracycline use led to exacerbation of the number of blaCMY-2 gene 
copies/gram of feces following ceftiofur therapy (Kanwar et al. 2014). Further, Volkova et 
al. (2015) showed that a low but stable fraction of ceftiofur-resistant E. coli isolates could 
persist in the absence of ceftiofur pressure, being transmitted by horizontal and vertical 
transfer of plasmids harbouring AMR genes, and ingestion of resistant bacteria (Volkova et 
al. 2012). In addition, our results showed that resistance to chloramphenicol increased up 
to 50% although this antimicrobial has not been used in pig production in Canada since the 
1980s and florfenicol was not used in this batch. This is in consistent with Harada et al. 
who reported that co-selection with other registered antimicrobials in pig production, 
dihydrostreptomycin (DSM) and trimethoprim (TMP) apparently contributes to the 
selection and persistence of chloramphenicol resistant E. coli  (Harada et al. 2006). 
Furthermore, it has been demonstrated that the gene conferring resistance to 
chloramphenicol (catA1, cmlA,  floR) co-carried on the IncA/C plasmids with the genes 
encoding resistance to other antimicrobials that are approved for administration in food 
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animal such as qacEΔ1-sul1, sul2, aadB-blaOXA-21, aadA1, tetA, tetR, blaCMY-2, blaTEM and 
Int1 genes (Fernandez-Alarcon et al. 2011; Carattoli et al. 2012; Doublet et al. 2012). Also, 
Diarra et al. (2007) reported that, in the absence of antimicrobial selection pressure, certain 
resistance genes can be conserved due to a link with the genes encoding resistance to other 
antimicrobials that are approved for administration in food animal (Diarra et al. 2007).  In 
our study, almost all ESC-resistant E. coli strains were co-resistant to streptomycin, 
trimethoprim-sulfamethoxazole, sulfisoxazole, amoxicillin/clavulanic acid, ampicillin, 
chloramphenicol, and tetracycline. The association on the same plasmid of blaCMY-2 gene 
and genes conferring resistance to non-beta-lactam antimicrobials and co-transmission of 
resistance to non-beta-lactam antimicrobials with CMY-2 have been shown previously 
(Doublet et al. 2004; Blanc et al. 2008). 
The second objective of our first step in this study was to provide insights regarding 
the effect of clinoptilolite, as a feed supplementation, on the dynamic of AMR phenotype, 
virulence and AMR gene profiles in E. coli from pigs receiving in-feed antimicrobial 
medication following weaning. According to our understanding, this is the first study to 
investigate the feed supplementation with clay minerals in controlling the spread of AMR 
and virulence genes in E. coli in vivo in pigs in farm conditions. We showed that feed 
supplementation with clinoptilolite was associated with an early temporary increase in the 
frequency of the gene responsible for ESC-resistance, blaCMY-2, in the supplemented group 
E. coli isolates. On the other hand, a delayed increase in the frequency of blaCMY-2, or one 
of the virulence genes iucD and tsh, was found in the control group E.coli isolates. The 
initial temporary increase in frequency of isolates carrying blaCMY-2 in the supplemented 
group is in agreement with data from Rodriguez-Beltran et al. (2013)  who described that 
clay minerals (e.g. sepiolite) boost direct horizontal gene transfer (HGT) between bacterial 
species in in vitro conditions, which may be exacerbated by antimicrobial use as growth 
promoters. In addition, these authors demonstrated that the increase of HGT was due to 
plasmid transfer in certain conditions such as presence of septiolite (final concentration of 
100 µg/ml) and friction forces. Friction forces may have been provided by peristalsis in the 
intestine of the pigs receiving continuously clay mineral as a feed supplementation 
(Rodriguez-Beltran et al. 2013). On the other hand, the subsequent significant decline in 
the proportion of blaCMY-2-positive E. coli isolates, and the lack of increase in the frequency 
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of isolates carrying the plasmid-encoded virulence genes iucD and tsh in the supplemented 
group could be associated with accumulation of clinoptilolite in the gut of pigs over time 
after weaning which may lead to a decrease in the HGT as clay minerals effect on HGT is 
concentration depended. For instance, previous in vitro studies demonstrated that higher 
concentrations of clay minerals result in a decrease in the number of transformed cells, in 
other words, a reduction in HGT (Richaume et al. 1989; Lotareva and Prozorov 2000). 
Alternatively, the later decrease in the proportion of blaCMY-2-positive isolates observed in 
the supplemented group could be due to a direct or indirect antimicrobial activity of 
clinoptilolite or an interaction between clinoptilolite and chlortetracycline or penicillin G. 
The potential of clay minerals to reduce the number of pathogenic bacteria has been shown 
in vivo and in vitro (Haydel et al. 2008; Vondruskova et al. 2010). Besides, Wu et al. 
(2013) reported that the total number of Lactobacillus acidophilus bacteria was 
significantly increased from days 22 to 42 in broiler chickens fed with clinoptilolite and 
also they showed that small intestinal and cecal PH values in the treatment group were 
significantly lower than those in the control group, Besides, these authors showed that total 
viable counts of E. coli were significantly decreased by clinoptilolite (Wu et al. 2013). As 
probiotics containing L. acidophilus may eliminate growth of pathogenic bacteria by 
production of organic acids and antibiotic-like compounds (Lordelo et al., 2007; 
Vondruskova et al., 2010), an increase in L. acidophilus numbers due to the presence of 
clinoptilolite in the current study may have led to the later decrease in the proportion of 
blaCMY-2, iucD, and tsh-positive isolates. Whereas the possible interaction of clay minerals 
and antimicrobials is controversial, nonetheless, a potential interaction between 
clinoptilolite and some antimicrobials has been described. For instance, chlortetracycline, 
tylosin, and metronidazole can be absorbed strongly to clinoptilolite or other clay minerals, 
in in vitro conditions. The interference is probably related to polarity of the antimicrobial 
molecules, since no interaction was confirmed with sulfamethoxazole and β-lactams, 
which are highly polar compounds (Papaioannou et al. 2005; Allaire et al. 2006).  
So far, our findings showed an increased resistance to 10 antimicrobials, both 
within and between classes respecting to chlortetracycline or penicillin G used for feeding 
pigs following weaning. We observed that feed supplementation with clinoptilolite could 
decrease the frequency of E. coli carrying blaCMY-2 and certain virulence genes at least in 
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the first month after weaning. However the mechanism(s) of such influence was still 
unclear. To clarify, we expanded our study and investigated the mechanisms leading to an 
increase in the prevalence of blaCMY-2 conferring resistance to ceftiofur in a pig nursery 
barn in a batch of pigs receiving a feed medicated with chlortetracycline and penicillin G 
but not having received ceftiofur and studied the effect of clinoptilolite on this 
phenomenon. To do so, we characterized the blaCMY-2-positive isolates from this batch of 
pigs to investigate the relative role of bacterial clonal lineages and plasmids in the spread 
of blaCMY-2 gene in pigs and their environment. 
First we studied the genetic relationship of blaCMY-2-positive E. coli isolates 
resistant by PFGE typing, phylotyping and O serogrouping. PFGE analysis revealed 
heterogeneity among the studied isolates and displayed seven distinct clonal lineage among 
the 36 blaCMY-2-positive E. coli isolates examined based on a similarity of ≥90%. This is in 
accordance with previous studies which demonstrated CMY-2-producing E. coli from 
livestock to be highly polyclonal (Daniels et al. 2007; Hiki et al. 2013; Guo et al. 2014). 
Furthermore, PFGE patterns with 100% similarity between at least 2 isolates were found. 
This suggests that blaCMY-2 spreads both horizontally and clonally in our study, and some 
clonal lineages are more common than others. Despite the number of tested isolates for 
clonal analysis by PFGE was relatively low, taken together, the phylotyping and PFGE 
results reveal that that the blaCMY-2 -positive E. coli isolates were more clonally diverse in 
the control group than the supplemented group. In contrast, Bednorz et al. (2013) showed 
higher diversity of multi-resistant E.coli in zinc supplemented group in comparison with 
the control group (Bednorz et al. 2013). Moreover, blaCMY-2-positive E. coli genotypes 
were diverse and affected by sampling time within both groups in our study , likely as a 
result of continuous use of chlortetracycline and penicillin G in the feed. This is in 
agreement with Alexander et al. (2009) who showed a clear effect of treatment and time on 
genetic diversity of resistant E.coli in fecal samples from cattle (Alexander et al. 2009). In 
the current study, phylotypes A, B1 and D were found among  the blaCMY-2-positive E. coli 
isolates as was also observed in a previous study in food animals (Guo et al. 2014). It has 
been shown that phylotype D E.coli is related to disease in humans such as urinary tract 
infections (Johnson et al. 2005; Jakobsen et al. 2010).  
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Moreover, our results showed that certain clonal lineages became predominant. The 
clonal lineage phylotype A predominated in the supplemented group, whereas the clonal 
lineages phylotype B1 predominated with time, especially in the control group, the latter 
often positive for the ExPEC-virulence gene iucD. Furthermore, in our initial study where 
we studied a large collection of E. coli isolates, we had seen an increase in the proportion 
of iucD gene with time, especially in the control group (Jahanbakhsh et al. 2015). This 
finding could support the speculation of Mathers et al. (2015) that some ExPEC virulence 
genes such as sat, iutA, malX, usp, iha, hra, and ompT may play a part in the fitness and 
adaptation of ST131 E. coli isolates (Mathers et al. 2015).  
In our study, blaCMY-2-carrying plasmids of Inc groups, I1, A/C and ColE were 
observed in transformants. Similarly, several studies have reported that IncI1 and IncA/C 
are the most frequent blaCMY-2-positive plasmids in humans and animals worldwide 
(Carattoli 2009; Mataseje et al. 2010; Martin et al. 2012; Hiki et al. 2013). We showed a 
high frequency of IncI1 carrying blaCMY-2 plasmids in transformants on all sampling days 
in the present study as described  in a previous study over time in broilers (Agerso et al., 
2014). We found that IncI1 plasmids carrying blaCMY-2 confered resistance only to beta-
lactam antimicrobials, including ceftiofur, ceftriaxone, cefoxitin, ampicillin, 
amoxicillin/clavulanic acid as previosly shown (Folster et al. 2011; Martin et al. 2012; Hiki 
et al. 2013). The high frequency and persistence of IncI1 blaCMY-2-positive plasmids and 
resistance to ESCs in the absence of ceftiofur use could be a result of continuous 
administration of penicillin G in the feed. Similarly, Cameron-Veas et al. (2015) found that 
amoxicillin use resulted in an increase in the frequency of cephalosporin resistant-E. coli in 
pigs (Cameron-Veas et al. 2015) and Agerso et al. reported  that administration of 
aminopenicillins affected the persistence and spread of ESC-producing E. coli in broiler 
production (Agerso et al. 2014). 
Furthermore, a possible source of the blaCMY-2  gene for a new batch of weaned pigs 
could be the presence of this gene in the pen environment before animal arrival and 
inadequate pen sanitation may allow the blaCMY-2 gene to persist in the environment from 
previous batches. We recovered E. cloacae isolates, carrying blaCMY-2 encoding IncA/C 
plasmids, from the pens before introduction of the pigs of this batch. Notably,  Laanen et 
al. (2013) described and quantified a clear link between biosecurity measure and 
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antimicrobial treatment-related criteria in pig herds (Laanen et al. 2013). In addition, we 
confirmed the transferability of IncA/C plasmid harbouring blaCMY-2 from E. cloacae to E. 
coli DH5α in vitro by conjugation, being a natural horizontal gene transfer between 
bacteria which thus could have occurred on this pig farm. Similarly, transfer of AmpC 
beta-lactamase plasmids and AMR genes between E. coli and Salmonella among humans 
and animals has been shown (Winokur et al. 2001; Blake et al. 2003). In addition, 
dissemination between sows and piglets has been demonstrated, sow treatment with 
ceftiofur may lead to development of resistant E. coli isolates which are transferred to 
piglets. The inability to determine resistance to ceftiofur at day 0 in this study could be due 
to the low level of this phenotype in piglets initially and effect of selection pressure of 
antimicrobials over time (Thompson et al. 2008; Schierack et al. 2009; Volkova et al. 
2012). In the present study, the most frequently observed  blaCMY-2 encoding plasmid was 
IncI, while only IncA/C blaCMY-2 encoding plasmids were detected in E. cloacae isolates 
from the pens before introduction of the pigs. There is posibility of mobilization of  the 
plasmid-borne blaCMY-2 gene from IncA/C to IncI1. Yassine et al. (2015) showed the 
critical role of IS1294b (IS91 family) in the mobilization of the blaCMY-2 gene from IncA/C 
to IncI1 in Enterobacteriaceae and its contribution to the evolution of diverse 
incompatibility group plasmids (Yassine et al. 2015). 
Seven AMR patterns were found among blaCMY-2-positive E. coli isolates, all being 
multidrug resistant. Particular AMR patterns were found in certain clonal lineage, with 
those of phylotype D showing a unique AMR pattern. Similar AMR patterns were reported 
in a previous study (Mulvey et al. 2009). In our study, two main serogroups O83 and O101 
were detected O83 in phylotype D which has been related with porcine ExPEC isolates and 
O101 in phylotype A which has been associated with ETEC and ExPEC isolates in pigs 
(Gyles and Fairbrother 2010). Likewise, serogroup O83 has been associated with urinary 
tract infections (Johnson et al. 1994; Yamamoto 2007; Abe et al. 2008) In addition, 
Girardeau et al. (2003) demonstrated that serogroup O101 isolates caused extraintestinal 
infections in humans and cattle (Girardeau et al. 2003).  
A limiting factor in this part of our study was the fact that the number of tested 
blaCMY-2-positive E. coli isolates for clonal analysis by PFGE was relatively low (n=36). 
All details and criteria for isolates selection were described in materials and methods 
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section in article 2. However, phylogenetic grouping was performed on 138 blaCMY-2-
positive E. coli isolates and our conclusions are based on 138 strains selected from the 400 
blaCMY-2-positive E. coli isolates found in over 7000 total isolates initially examined, as 
well as the 36 isolates which we examined in more detail. Also, this study has relied on 
phylogenetic grouping definition of E. coli as was described by Clermont et. al. (2000) via 
profiling three target genes (Clermont et al. 2000). However, the same group improved 
their definitions recently by using four target as well as some complementary genes 
(Clermont et al. 2013). According to older version that was the only available definition at 
the time of this study, E. coli isolates fall into four groups A, B1, B2 and D however the 
most recent definition categorizes the E. coli isolates into seven groups A, B1, C, E, D, F, 
B2. However, phylotype A and B1 that are implied in our report as important phylotypes to 
differ between control and supplemented groups, are not really different in definition with 
respect to old and new methods. Addintionally, we studied genetic relatedness of E. coli 
isolates by performing PFGE which is a gold standard fingerprinting method. 
The second step of our study on healthy pigs of a commercial farm revealed that 
ESC-resistant E.coli isolates belonged to several different clonal lineages with diverse 
AMR patterns and possessed the blaCMY-2-carrying plasmids of the Inc groups I1, A/C, and 
ColE. Our results suggest that the blaCMY-2 gene spread both horizontally and clonally in 
these pigs and may have spread from previous batches of pigs via plasmids carried by E. 
cloacae and expanded in animals of the present batch in the presence of the selection 
pressure due to administration of chlortetracycline and penicillin G in the feed. Feed 
supplementation may have an effect on clonal diversity of blaCMY-2 -positive isolates. 
Based on our results we infer that implementation of improved hygiene measures, 
decreased use of certain antimicrobials on farm, and feed supplementation with a clay 
mineral may limit antimicrobial resistance spread between and within batches of animal. 
In the third step of our study, we studied E. coli clinical isolates in a wider range of 
farms over a 16-year period of time from 1997 when we first observed resistance to 
ceftiofur in clinical isolates. The aim of this step was to investigate the temporal 
characterization of ESC-resistant pathogenic E. coli with respect to pathogenic clonal 
lineages, plasmids and antimicrobial resistance. 
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In this study, PFGE clonal analysis demonstrated high diversity and revealed 36 
distinct clonal lineages among the 45 ESC-resistant E. coli isolates examined and  given a 
similarity of 75% isolates were grouped into 15 clusters. However, half of the isolates 
belonged to a single cluster which revealed the same pathovirotype, O serogroup and 
phylotype. Similarly, previous studies reported that ESC-resistant E. coli from livestock 
were highly polyclonal (Donaldson et al. 2006; Daniels et al. 2007; Hiki et al. 2013).  
Identical clonal lineages of ETEC:F4 were found in different years in the same 
farm indicating the persistence of certain clonal lineages between batches. Several identical 
clonal lineages were seen from multiple farms, suggesting potential transmission among 
the farms. In addition, those clonal lineages may have originated from a single source (e.g. 
same breeding pig farm), Similarly, Agerso et al. (2014) and Nilsson et al. (2014) have 
shown that the same blaCMY-2 –positive E. coli clones were observed in imported 
grandparent and in all levels of the Danish and Swedish broiler production, suggesting 
spread of ESC-producing E. coli clone and plasmids from imported parent animals to 
broilers and to broiler meat (Agerso et al. 2014; Nilsson et al. 2014). In our study, 
transmission may have happend because of imported and exported pigs, and also by the 
movement of water and wild animals and/or through contaminated food (Yamamoto et al. 
2014). It is good to mention that currently only 44% of farms in Quebec are «farrow-to-
fattening», that is, on a single site, as compared to 33% fattening and 23% farrowing farms 
which together constitute multisite farms. Transport of pigs between these sites would 
result in a more widespread spreading of clonal lineages (Lacroix and Morin 2015). 
Likewise, as previously described, E. coli could be transmitted farm to farm by vehicles 
such as transport trucks and visitors on farms (truck drivers, veterinarians, producers, 
technicians) or by farm workers (Lim et al. 2010; Abraham et al. 2015).  
Heterogeneity among ESC-resistant isolates was observed, indicating that their 
spread is not only due to the dissemination of successful E. coli clonal lineages, and 
horizontal gene transfer may be contributing to the emergence of ESC-resistance in pigs as 
described by others (de Been et al. 2014). In our study a remarkable finding was that, 
among ETEC:F4, O149 E. coli isolates, the more virulent E. coli clonal lineages with the 
virotype LT:STa:STb:F4 were mostly observed prior to 2006 (subcluster III-1) whilst from  
2006 to 2012 most clonal lineages showed the virotype LT:STb:F4 (subclusters III-2,3,4). 
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In agreement with previous studies the changes were observed in O149 clonal lineages 
with time in this study probably reflect overall changes in the pathogenic population, in 
that an overall predominance of LT:STa:STb:F4 isolates was  found in the early 2000s 
(Noamani et al. 2003; Fairbrother et al. 2005; Leclerc et al. 2007).  
Interestingly, the plasmid IncA/C was mostly observed prior to 2006 in ETEC:F4 
O149 clonal lineages of subcluster III-1, however it re-emerged in 2009-2012 clonal 
lineages (III-4) on one particular farm. In 85 ESC-resistant E. coli, IncA/C was 
significantly associated with resistance to gentamicin, kanamycin, streptomycin, 
trimethoprim-sulfamethoxazole, sulfisoxazole, chloramphenicol and tetracycline, and the 
presence of blaTEM and Int1(Johnson et al. 2012). Also, IncA/C plasmids carrying blaTEM 
and Int1 and genes conferring resistance to these antimicrobials have been demonstrated 
(Fernandez-Alarcon et al. 2011; Carattoli et al. 2012; Doublet et al. 2012). The decrease in 
resistance to gentamicin, kanamycin and chloramphenicol in ESC-resistant E. coli over the 
study time could be a result of less administration of these antimicrobials in pig 
production. The ban on the administration of chloramphenicol in food animals in Canada 
since the 1980s could result on the decrease in resistance to chloramphenicol over time. 
Likewise, a tendency to less prescribing of gentamicin has recently been observed based on 
anecdotal evidence from local authorities and veterinarians. On the other hand, kanamycin 
is not used in pig production in Canada. As previously shown, the emergence and 
prevalence of antimicrobial resistance in bacteria are likely to be linked to antimicrobial 
use in animals through cross-resistance or co-resistance (Harada and Asai 2010). It can 
also be related to administration of disinfectant and usage of metals like copper and zinc as 
feed additives (Bednorz et al. 2013). 
In the current study, we found a relationship between certain pathotypes and 
plasmid Inc types. Our finding that ETEC:F4 was positively associated with IncFIB and 
IncFIC but negatively with IncB/O and IncP confirms the observations in a recent study of 
pig isolates in Australia (Abraham et al. 2014). Moreover, ExPEC showed a positive 
association with the presence of IncB/O and negative association with the presence of 
IncI1 and IncFIC groups. Johnson et al. described a similar trend in human ExPEC strains 
(Johnson et al. 2008). Future investigations will further look at the relative role of 
pathogenic clonal lineages and the various plasmids in the spread of the blaCMY-2 gene. 
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This study showed the recent emergence of multidrug resistant CTX-M-producing 
ETEC:F4 E. coli isolates in pigs in 2011-2012. Since blaCTX-M was detected in distinct 
clonal lineages, the spread of blaCTX-M may have occurred by horizontal transmission. To 
our knowledge, this is the first report of blaCTX-M- positive, ESLB-producing pathogenic E. 
coli isolates from pigs in Quebec, Canada. Although the presence of blaCTX-M gene in E. 
coli isolated from pigs has been reported from other countries (Hansen et al. 2013; Hu et 
al. 2013; Freire Martin et al. 2014).   
In the current study, the ESC-resistant E. coli isolates belonged to phylotypes A, 
B1, B2 and D, phylotype A being the most predominant one, as  with previous studies in 
food producing animals (Tan et al. 2012; Hu et al. 2013; Marchant et al. 2013; Rao et al. 
2014). Three distinct phylotype B2 clonal lineages were found which were ExPEC O4 and 
O88 and ETEC O98. As previously described, phylotype B2 and D E.coli are related to 
disease in humans such as urinary tract infections (Johnson et al. 2005; Jakobsen et al. 
2010). In addition, O4 serogroup is urinary tract infection (UTI)-associated (Johnson et al. 
1994; Yamamoto 2007; Abe et al. 2008) suggesting a zoonotic potential (Tan et al. 2012).  
Initially, 85 ESC-resistant E. coli isolates were clustered based on tested genes. 
Gene clustering analysis separated ESC-resistant E. coli isolates according to O serogroup 
and revealed similar comparison results to those of PFGE. Our findings suggested that the 
gene panel used in this study may be appropriate to study genetic relatedness in large 
numbers of isolates. 
The results were seen in this study are based on our collection that includes 91% 
pathogenic E.coli from clinical cases. Nevertheless, the discussed patterns could be 
different in commensal E.coli as was described by Boerlin et al (2005) who showed that 
AMR differs significantly between pathogenic and commensal E. coli isolates (Boerlin et 
al. 2005).  
We recognized that in this study the small sample size (compared to similar 
studies) may have limited our ability to subsequently generalize our results. However, in 
EcL collection of E. coli strains (our only source), we only identified 85 ceftiofur-resistant 
E. coli isolates over the study time (1997-2012) that all were included in this report. 
Among these isolates, some were from the same farm at the same year with the same 
patterns of tested traits, so we had to eliminate them before performing PFGE that further 
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reduced the number of isolates to almost 50% (n=45) of total which were representative for 
all years, pathovirotypes, phylotype, farms, production phase (age) etc. However, despite 
this limitation of the study, our findings provide a significant advance in our understanding 
of the temporal molecular epidemiology of ESC-resistant E.coli. Similarly to previous part 
of our study, the phylogenetic grouping method may be considered as another study 
limitation. However, we investigated genetic relationships of ESC-resistant E. coli isolates 
by PFGE. 
  In last step of our study, our findings reveal that ESC-resistance was mostly 
associated with the blaCMY-2 gene and that the blaCTX-M gene has recently emerged. ESC-
resistant E.coli are polyclonal with diverse AMR patterns and often carried plasmids of 
several Inc groups. However, there was no predominant clonal lineage over the study time. 
Further, we confirmed that some identical clonal lineage were present at multiple farms in 
the same and different years. Further, the blaCMY-2 spreads both horizontally and clonally in 
this study and the spread of blaCTX-M gene may have occurred by horizontal transmission. 
Indeed, Resistance to gentamicin, kanamycin, chloramphenicol, and the frequency of 
blaTEM and IncA/C plasmid significantly decreased over the study of time. Whereas, IncI1 
and MDR7 significantly increased over the period of time. To our understanding, this is the 
first study describing characteristics of ESC-resistant E.coli isolated over a long period. In 
addition, we believe this to be the first report of blaCTX-M positive, ESLB-producing 
pathogenic E. coli strains from pigs in Quebec, Canada. Our findings underline the 
importance of monitoring E. coli isolates from pigs for the presence of blaCTX-M in the 
future since they could be transmitted to humans via the food chain or by direct contact. 
The CTX-M family are important ESBLs in human medicine and a threat to public health. 
Widespread occurrence of antimicrobial resistance plasmids in ESC-resistant E. coli from 
the pig is a concern for animal and public health and warrants further attention. 
  
 
 
 
 
 
 
 
 
 
 
 
Chapter 5: General Conclusion and Future perspective 
 
  
General conclusion 
In conclusion, the studies reported in this thesis reveal an increased level of 
resistance, lasting at least 4 weeks, to several antimicrobials in E. coli from weaned pigs 
with medicated feeding. It is also shown that feed supplementation with clinoptilolite 
decreases the proportion of fecally shed E. coli possessing certain virulence and 
antimicrobial resistance genes, at least in the first month after weaning. In addition, 
horizontal and clonal spread of blaCMY-2 suggest that implementation of improved hygiene 
measures and decreased administration of certain antimicrobials on farm, and feed 
supplementation with certain ingredients may limit antimicrobial resistance spread 
between and within batches of animals. By studying the temporal characterization of ESC-
resistant pathogenic E. coli with respect to pathogenic clonal lineages, plasmids and 
antimicrobial resistance in wider range of farms over 16 years, we have shown herein the 
importance of monitoring E. coli isolates from pigs for the presence of blaCTX-M, with 
regards to CTX-M family as an important ESBL in human medicine, since their 
transmission to humans via the food chain or by direct contact is a threat to public health. It 
was also inferred that the widespread occurrence of antimicrobial resistance plasmids in 
ESC-resistant E. coli from pigs, as observed in our studies, is a concern for animal and 
public health and warrants further attention. 
 
Future perspective 
1- Regarding the impact of feed supplementation with clinoptilolite, since in farm 
conditions various factors may contribute, further studies involving more pigs from 
different farms and a longer time after weaning will be required to confirm our 
findings over the long term.  
2- To gain insight into evolution of ESC- resistant E.coli over time, further 
investigations are needed using Multilocus sequence typing (MLST) and/or whole 
genome sequencing technology for phylogeny of ESC-resistant E.coli isolated from 
pig farms in Quebec, Canada to compare worldwide. Moreover, plasmid 
classification can be carried out by PCR-based plasmid replicon typing on 
transformants or conjugants and/or plasmid sequencing. 
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